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Abstract 
 
With growing populations and climate change associated drought predicted for the future, 
cassava can provide one solution for food security and a source of starch for industrial use 
and biofuels in South Africa, and other countries in the SADC region. One of the severe 
constraints on cassava production is cassava mosaic disease (CMD) caused by cassava 
infecting begomoviruse species, including African cassava mosaic virus (ACMV), South 
African cassava mosaic virus (SACMV) and East African cassava mosaic virus (EACMV). 
Cassava begomoviruses (CBVs) are responsible for significant yield loss of the starchy 
tubers. Since no chemical control of virus diseases of plants is possible, one approach to 
develop virus resistance is via biotechnology, through genetic engineering (GE) of cassava 
with hairpin RNA (hpRNA) silencing constructs that express small interfering RNAs 
targeting CBVs and preventing severe disease development. The aim of this project was to 
subject previously transformed  five CMM6 cassava lines (cv. 60444 transformed with a non-
mismatched Africa cassava mosaic virus-[Nigeria:Ogorocco;1990] (ACMV-[NG:Ogo:90])-
derived hpRNA construct, six AMM2 (cv. 60444 transformed with a mismatched ACMV-
[NG:Ogo:90]-derived hpRNA construct), six CMM8 cassava lines (cv.60444 transformed 
with a non-mismatched SACMV BC1-derived hpRNA construct) and seven AMM4 cassava 
lines (cv.604444 transformed with a mismatched SACMV BC1-derived hpRNA construct) to 
reproducible trials, and evaluate for response to virus challenge. The ACMV-[NG:Ogo:90] 
hpRNAi constructs target 4 overlapping virus open reading frames (ORFs) (AC1 replication 
associated protein/AC4 and AC2 transcriptional/AC3 replication enhancer), while the 
SACMV hpRNAi constructs target the cell-to cell movement BC1 ORF. Non mismatched 
constructs consist of a transformation cassette that has an intron separating the sense and 
antisense arms of the viral transgene whilst mismatched constructs have the sense arm of the 
viral transgene treated with bisulfite to induce base mutation. This mutated sense arm is then 
separated from the non mutated antisense arm by a small spacer. Furthermore, a 229 bp 
inverted repeat hpRNA construct (DM-AES) was designed to target ACMV-[NG:Ogo:90] 
117 nt putative promoter region (2714-49 nt), a 91 nt overlapping sequence (1530-1620 nt) 
between ACMV-[NG:Ogo:90] AC1 3’ end  and AC2 5’ end (AC1 3’/AC2 5’-ter) as well as 
being efficient against SACMV and EACMV due to the inclusion of a 21 nt conserved 
sequence (1970-1990) of AC1/Rep shared between ACMV, EACMV and SACMV. Cassava 
landrace T200 friable embryogenic callus (FEC) were transformed with this construct. The 
vi 
 
selected transgenic lines were infected with either ACMV-[NG:Ogo:90] (CMM6 and AMM2 
transgenic lines) or SACMV (CMM8 and AMM4 transgenic lines) by agro-inoculation and 
monitored at 14, 36 and 56, 180 and 365 days post infection (dpi) for symptom development, 
plant growth and viral load. From the ACMV trials 3 lines (CMM6-2, CMM6-6 and line 
AMM2-52) showed significantly lower symptom scores and lower viral load at 36, 56 and 
365 dpi, compared with viral challenged untransgenic cv.60444. This phenotype is described 
as tolerance, not resistance, as despite ameleriorated symptoms virus replication persists at 
lower levels. From the SACMV infectivity trials even though all CMM8 and AMM4 
transgenic lines had lower symptom severities and viral loads compared with infected 
untransformed cv.60444, the results were not highly significant (p˃ 0.05). From this study, 
tolerance or reduction of viral load and symptoms was attributed to the accumulation of 
transgene-derived siRNAs prior to infection. However there was no observable correlation 
between levels (semi-qauntitative northern blots) of siRNAs and tolerance or susceptible 
phenotypes. Tuber yield evaluation of the three tolerant lines (CMM6-2, CMM6-6 and line 
AMM2-52) showed that the tuber fresh and dry weight at 365 dpi was not affected by the 
viral presence. These are promising lines for larger greenhouse and field trials. A comparison 
between the two different constructs showed that the two tolerant CMM6 lines-2 and 6 
appeared to perform better (viral load) compared with AMM2 tolerant line-52 with regards to 
levels of viral amplification. The mismatched construct in AMM4 lines and the non-
mismatched construct in CMM8 lines induced the same viral and symptom severity score 
(sss) reduction. Transformation of T200 FECs with the DM-AES construct was unsuccessful 
due to the age (more than six months old) of the FECs. FECs are more likely to lose their 
regeneration and totipotent nature with age. We therefore propose the use of fresh T200 FECs 
in future transformation studies to test the DM-AES construct. 
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Chapter 1 Literature Review 
1.1. Cassava 
Cassava (Manihot esculenta Crantz) is a tropical, perennial root crop mostly grown in 
subtropical regions of Africa, Asia and Latin America (Lebot, 2009; Legg et al., 2015). It 
belongs to the Family Euphorbiaceae which is most common in the tropics and exists either 
as shrubs, herbs or trees. The Euphorbiaceae family includes rubber, castor beans and 
cassava (Puonti-Kaelas, 1998). Cassava origins traces back to tropical Southern America and 
it was introduced in Africa in the 16
th
 century and later Asia by Portuguese traders (Leotard 
et al., 2009; Olsen et al., 1999).  
The cassava plant grows to between one and three meters in height. Cassava tuber root is 
cylindrical in shape and has a circular cross section (Sayre et al., 2011). The cross section of 
the root shows three distinct sections, the bark also called periderm, the peel layer also called 
phelloderm and the parenchyma which represents the greater percentage of the root and a 
major hub of starch storage (Lebot, 2004). 
 
Figure 1. 1 Cassava (Manihot esculenta Crantz) plant (left) and high carbohydrate tuberous 
roots (right) (Stupak et al., 2006) 
1.2. Agricultural Importance of Cassava 
Cassava is mainly cultivated for its starchy roots. As the cassava plant grows a few of its 
roots develop into tubers which act as its major storage unit, and this is the edible portion. 
Cassava is important because 85% of its tuberous root dry weight is starch. In tropical regions 
cassava is ranked as the third most important food crop behind maize and rice (FAOSTATS, 
2013). Among these top ranked important crops, cassava over the period 1980 to 2013 has 
had the highest increase in global harvest area, amounting to a 44% expansion. In this same 
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period 1980-2013 global cassava tuber production has increased from 124 million tonnes to 
255 million tonnes (FAOSTATS, 2013). In the wake of climate change, cassava has become 
a vital crop for food security in Sub-Saharan African. Cassava has an added advantage of 
being able to grow in poor soils and to survive prolonged dry spells (El Shawkawy, 2004). 
Mature cassava can be stored 2 to 3 years in the ground making it easy to be drawn upon in 
times of drought or social challenges. It is these advantages that make it a very reliable 
subsistent crop for low income farmers (FAOSTATS, 2013; Lebot, 2004). 
In most developing countries such as Africa, 90% of the crop harvest is for human 
consumption, and this is mainly because it is the cheapest source of calories of all the staple 
crops (Pounti-Kaelas, 2004). Despite its importance as a food source, cassava has growing 
industrial potential especially as a source of industrial starch and ethanol. The production of 
ethanol from cassava and utilization of its waste products (peels) is being explored by various 
cassava-producing countries. According to Adelekan. (2012) the total cassava production 
from tropical countries could potentially produce 133 million gallons of ethanol per year. 
Cassava is also being used to produce starch for industrial and food additive purposes. Maize, 
wheat and rice are major raw materials sources for starch production, but the usage of cassava 
starch is increasing due to its large starch content, and it has become a major raw material for 
paper production, detergent manufacturing and bond agents for tablets (Tonukari et al., 
2015). Nigeria recently embarked on new projects for the production of adhesives from 
cassava starch and it was found to be equally effective as common chemical adhesives 
(Ozemoya, 2007). 
1.3 Constraints of Cassava 
Despite several steps being taken to elevate its importance and establishment of a diverse 
cassava based industry, several issues still challenge such establishment. Cassava production 
suffers from several biotic (pests and diseases) and abiotic challenges. One post harvest 
challenge of cassava is the short storage life of the harvest roots (Bull et al., 2011). Biotic 
stresses that affect cassava include pests and diseases. Although a number of crop protection 
methods can be implemented to reduce the occurrence of diseases, such as crop rotation and 
using healthy planting material, cassava still remains vulnerable to many diseases. Among the 
chief menacing diseases is bacterial blight caused by a proteobacterium, Xanthomonas 
axonopodis, which is mainly transmitted from plant to plant (Bart et al., 2012). The other 
major challenges of cassava are viral diseases, including cassava brown streak disease and 
cassava mosaic disease (CMD). To date, based on homologous demarcations eleven cassava 
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mosaic geminiviruses are known to cause CMD (fig 1.2), two being Asian species, namely 
Indian cassava mosaic virus (ICMV) and Sri Lanka cassava mosaic (SLCMV). Africa has 
the highest dynamism of CBVs with nine different species: African cassava mosaic virus 
(ACMV), East African cassava mosaic Malawi virus (EACMMV), East African cassava 
mosaic Zanzibar virus (EACMZV), South African cassava mosaic virus (SACMV), East 
African cassava Cameroon virus (EACMCV), East African cassava mosaic virus (EACMV), 
East African cassava mosaic Kenya virus (EACMKV), African cassava mosaic Burkina Faso 
virus (ACMBFV) and Cassava mosaic Madagascar virus (CMMGV) (Fauquet et al., 2007; 
Legg et al., 2015). Three distinct cassava geminivirus species are more prevalent in Southern 
Africa (Zimbabwe, South Africa and Mozambique) namely EACMV, ACMV and SACMV 
(Berry and Rey, 2001). 
1.3.1 Cassava Mosaic Disease (CMD) 
Cassava mosaic disease is currently one of the most endemic viral diseases for cassava in 
Africa (Legg et al., 2015; Patil and Fauquet, 2009). The virus induced disease mainly occurs 
in India and Africa, but was first reported in Tanzania in 1894 by Warburg. It was only in 
1906 that Zimmerman suggested that CMD was a direct result of virus infection. CMD has 
been reported in India, central, eastern and southern Africa causing loses of over US$1 billion 
annually (IITA, 2014; SciDev, 2016). Cassava mosaic disease is spread by the use of infected 
plant material or by an infecting whitefly vector Bemisia tabaci (Gennadius) (fig 1.3) (Brown 
et al., 1995; Carabali et al., 2010; Legg et al., 2015; Maruthi et al., 2004). Since cassava is 
vegetatively propagated transmission by infected plant material is widespread. B. tabaci is the 
only known vector to spread CMD, and is also responsible for the transmission of cassava 
brown streak viruses (CBSVs) (Maruthi et al., 2004). Several B. tabaci haplotypes forming 
distinct sub-Saharan clades have been shown to transmit CBVs in southern and eastern Africa 
(Berry et al., 2004; Esterhuizen et al., 2012; Sseruwagi et al., 2004). Whiteflies feed on 
phloem sap in all growth stages of the plant (Thresh, 1998). Whiteflies can be extensively 
spread in tropical regions with immigration of close to 7 km downwind (Hirano et al., 1993). 
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Figure 1. 2 Map showing Geographical distribution of cassava-infecting begomoviruses together 
with all the species and strains of cassava mosaic begomoviruses (CB8Vs) in Africa as well as the 
Indian subcontinent. The green coloured regions indicate areas under cassava cultivation and 
different coloured dots represent specific specie (Patil and Fauquet, 2009). 
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Figure 1. 3 The whitefly Bemisia tabaci (Gennadius) (Cuthbertson, 2013) 
 
Cassava mosaic disease symptoms vary between varieties, cultivars and landraces, due to a 
number of factors such as plant age, temperature and differences in viral strains. Generally, 
CMD causes chlorotic mosaic on infected leaves. The mosaics are either yellow or green 
regions on the leaves. Green mosaics usually appear as alternating light and dark green 
regions on the leaf (Legg et al., 2004). Green mosaics are usually mild or moderate. The 
more severe mosaics appear as yellow and green regions. Yellow regions show areas where 
the leaves have lost photosynthetic ability this in turn results in reduction of leaf size and 
plant stunted growth (Vanitharani et al., 2005). ACMV and SACMV symptoms of leaf 
curling, twisting/malformation and blistering are often also observed (Legg et al., 2004; 
Vanitharani et al., 2005). Some of the symptoms are shown in fig 1.4. Infection with CMD 
greatly reduces yield and tuber size. In severe cases leaves may be distorted, this is because 
the chlorotic regions seize to grow whilst other surrounding regions grow causing uneven leaf 
expansions (Thresh et al., 1998). 
1.4 Geminiviruses 
Geminiviruses belong to the family Geminiviridae (Brown et al., 2015). Geminiviruses affect 
a range of dicots and monocots causing diseases and deformities. Geminiviruses are 
characterised by a geminate icosahedral structure, and their genome consist of a single 
stranded circular DNA (Gutierez, 2000). They replicate by a unique form called rolling circle 
mechanism in the host cell nucleus, where they rely on host cell replication mechanism 
(Stanley, 1995; Wang et al., 2008). The geminiviridae family is further divided into 7 genera 
based on genome organisation. The seven generas of geminiviruses are Begomovirus, 
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Mastrevirus, Curtovirus, Topocuvirus, Becurtovirus, Turncurtovirus and Eragrovirus 
(Adams et al., 2013). Of these seven begomoviruses, mastreviruses, curtoviruses, 
topocuviruses have been extensively studied. Begomoviruses make up 80% of geminivirus 
species (Brown et al., 2015). 
 
Figure 1 4 Symptoms of CMD: A green leaf mosaic B, yellow leaf mosaic, C severe leaf 
deformation (Vanitharani et al., 2005) 
1.4.1 Begomoviruses 
Begomoviruses exist as either mono-or bipartite viruses. Their genome sizes range from 2.5 
to 5 kb and usually consist of 6 to 7 genes (Brown et al., 2015; Raja et al., 2010). 
Begomoviruses usually have 2 genetic components called DNA-A and DNA-B. DNA-A has 
six open reading frame coding for four complementary sense genes, namely AC1 to AC4 and 
two virion sense genes AV1 and AV2 (Brown et al., 2012; Vanitharani et al, 2005) (fig 1.5). 
AC1 codes for the Rep protein 358 aa in length, and is essential for initiation of replication. 
AC2 codes for a 135 aa protein (TrAP) which is essential for transcriptional activation, while 
AC3 codes for REn a 134 aa protein essential for replication enhancement. AC4 is reported in 
some geminiviruses as a suppressor of RNA silencing (Vanitharani et al., 2004). AV1 codes 
for a coat protein of 258 aa and AV2 encodes a pre-coat protein (Vanitharani et al., 2005; 
Wang et al., 2014). AV2 is also known to be a virus suppressor of silencing (VSR) and 
contribute to symptom severity (Vanitharani et al., 2004). 
DNA-B has 2 open reading frames coding for a complementary sense gene (BC1) and a 
virion sense (BV1) gene. BV1 encodes a nuclear shuttle protein (NSP) and BC1 encodes a 
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cell-to-cell movement protein (MP) (Varma and Malathi, 2003). Geminivirus DNA is 
replicated in the nucleus so NSPs transport the DNA complex to the cytoplasm where MP is 
responsible for transportation from one cell to the other. Synonymous to both DNA-A and 
DNA-B is a 200bp common region within the intergenic region (IR) (Brown et al., 2015). In 
begomoviruse transcription occurs bi-directionally from the IR (Ashraf et al., 2014; Eagle 
and Harnley-Bowdoin, 1997; Stanley, 1995). Opposite oriented promoters exist on either side 
of the origin of replication site. The common region also contains a small hairpin structure 
which acts as the initiation site of the rolling circle replication (reviewed by Rizvi et al., 
2014). The common region also consists of 2 TATA motifs and a Rep-associated protein 
binding sites called iterons (Ashraf et al., 2014;Varma and Malathi, 2003). 
 
Figure 1. 5 Bipartite genome of begomoviruses showing their respective open reading frames 
(Palmer and Rybicki, 1997) 
1.5 Plants response to viral infection 
Plants offer resistance to viruses using various mechanisms. Once a virus has infected a plant, 
plants are able to counteract the infectivity. Plant resistance to viruses has been described to 
occur at four different levels by various mechanisms and these are inhibition of replication, 
inhibition of cell-to-cell movement, inhibition of systemic infection as well as defence 
response mechanisms (Reviwed by Palukaitis and Carr, 2008). The first line of defence for 
plants to viral infection is physical and chemical barriers. The second barrier of defence is the 
plants recognition of virus virulence factors. Once these virulence factors have been 
recognised the defence response would include the involvement of basal immunity or RNA 
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silencing (Pallas and Garcia, 2011). Despite these defence mechanisms viruses may 
overcome them by producing silencing suppressors (Pallas and Garcia, 2011). 
1.6 RNA silencing 
RNA silencing is a gene regulatory mechanism resulting in sequence specific mRNA 
degradation (Balcombe, 1999; Vantharani et al., 2005). RNA silencing involves two classes 
of short RNAs, namely small interfering RNAs (siRNA) and microRNAs (miRNA), 21 to 26 
nucleotide (nt)  in size, which are involved in the regulation of gene expression, regulation of 
chromatic structure and defence mechanisms against transposons and viruses in eukaryotic 
organisms (Baulcombe, 1999, 2004; Cerutti et al., 2011; Holoch and Moazed, 2015). The 
same mechanism occurs in fungi and animals where it is called quelling and RNA 
interference, respectively (Cogoni et al., 1997; Napoli et al., 1990). Plants main natural 
defence mechanism against viruses is by RNA silencing. This mechanism of RNA silencing 
in plants occurs as post transcriptional gene silencing (PTGS) or transcriptional gene 
silencing (TGS).  
1.6.1 Post transcriptional gene silencing 
PTGS occurs by cytoplasmic siRNA or miRNA silencing of endogenous mRNA 
(Baulcombe, 1999, 2004; Hammond et al., 2000). TGS downregulates gene expressions 
through siRNA guided methylation of gene promoters or histones resulting in inhibition of 
transcription. PTGS and TGS have similar mechanisms and both rely on initiation by 
recognition of double-stranded RNA (dsRNA) from within or outside the cell and their 
subsequent cleavage by Ribonuclease III like enzymes called Dicers into small nucleotides 
with size ranging from 21-26 nucleotides (Bernstein et al., 2001). Small interfering RNAs are 
divided into two classes, short class 21-22 nucleotides and longer class 24-26 nucleotides 
(Hamilton et al., 2002). These act as guides in sequence specific degradation of homologous 
target RNA for gene regulation or viral degradation (Hammond et al., 2000; Raja et al., 
2010). Dicer structure has been reported to have a 10-residual segment consisting of an 
enzyme site that directly aligns with the dsRNA sequence (MacRae et al., 2007). Different 
Dicer-like enzymes (DCL) have been distinguished based on their different functions, DCL 1 
is involved in miRNA biogenesis, DCL2 is involved in viral siRNA production and DCL 3 is 
involved in retroelements and transposon siRNA production (Garcia-Ruiz et al., 2010; Parent 
et al., 2015; Xie et al., 2004). Unlike most viruses which have an RNA genome, 
geminiviruses have a single stranded DNA (ssDNA) genome. RNA silencing is triggered in 
9 
 
viruses with RNA genomes by dsRNA that exist as either viral replication intermediates or 
folding secondary structures by ssRNA or ssRNA-encoded mRNA (Vanitharani et al., 2005). 
Geminiviruses are circular single-stranded DNA and replicate through a dsDNA 
intermediate, and trigger PTGS. Double stranded viral genome induces PTGS in several 
ways. Firstly, the mRNA of the geminivirus which are a product of bi-directional 
transcription and overlap at the 3’end forming dsRNA by 3’ extension by RNA dependent 
RNA polymerase (RDRP) 1 or 6 which triggers PTGS. Secondly, early abarrent AC1 
transcripts could also serve as templates for dsRNA formation leading to PTGS and lastly the 
strong tendency of geminiviruses transcripts to fold can easily attract Dicer to cleave the 
transcripts giving siRNA (Garcia-Luiz et al., 2010; Vanitharani et al., 2005; Wang et al., 
2010). Duplex siRNA generated by Dicer act as effectors of the silencing mechanism 
(Brodersen and Voinnet, 2006). The siRNA duplexes are unwound by helicase activity into 
two separate strands and either the sense or antisense strand can be loaded into an effector 
complex called RNA induced silencing complex (RISC), consisting of Agonaute proteins 
(reviewed in Sherman et al., 2015; Vasquez and Hohn, 2013; Voinnet et al., 2009). The 
Agonaute proteins have dicing properties and it guides the siRNA to homologous mRNA 
where it binds to specific homologous sequences (21-26 nt). The specific mRNA is then 
subjected to enzymatic cleavage and subsequent degradation (reviewed in Vaucherets, 2008). 
Short class siRNAs (21-23 nt) are involved in mRNA degradation whilst longer siRNAs (24 
nt) have been implicated in DNA methylation (Hamilton et al., 2002). The overview of the 
RNAi pathway is shown in (fig 1.6). 
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Figure 1. 6 Overview of steps involved in RNAi pathway involving (1, 2) processing of 
dsRNA intermediates by Dicer into primary siRNA production. (3, 4) siRNA unwinding and 
incorporation into RISC complex (5) sequence-specific degradation of complementary 
mRNA (Sherman et al., 2015) 
1.6.2 Transcriptional gene silencing  
Down regulation of transposons, chromosomes as well as protein coding gene is called 
transcriptional gene silencing (TGS) (Nishumura et al., 2012). TGS occurs by three methods 
(i) DNA methylation (ii) heterochromatic formation and (iii) programmed DNA elimination 
(Shah et al., 2012; Vaucherets et al., 2001). Heterochromatic formation occurs when changes 
are induced on the chromatin by deacetylation of Histone H3 and methylation at the lycin 9 of 
the chromatin (Shah et al., 2012). The methylated lycin is then bound by heterochromatic 
binding proteins which cause chromatic condensation and subsequent blocking of 
transcription (Shah et al., 2012). DNA methylation involves the addition of a methyl group to 
DNA base cytosine by DNA methyltransferase. Methyl binding proteins bind to the 
transcriptional factor binding site on the promoter and this inevitably stops transcription. 
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RNA dependent-DNA methylation involves the methylation of DNA regions homologous to 
dsRNA sequence (Vaucherets et al., 2001). RNA dependent-DNA methylation is initiated by 
dsRNA derived from transgene or subsequent siRNAs from that transgene. The siRNAs are 
then incorporated into the RNA induced initiation of transcriptional gene silencing (RITS). 
The RITS/siRNAs complex then directs methylation of target DNA that is homologous to the 
siRNAs (Wu et al., 2010; Xie et al., 2004). Plants infected by geminiviruses such as Tomato 
yellow leaf curl Sardinia virus (TYLCSV) and Cabbage Leaf curl virus (CaLCuv) have been 
shown to trigger TGS by hypermethylation or chromatic methylation of the virus (Paprotka et 
al., 2011; Raja et al., 2008). Transgenic plants with geminivirus promoter transgene have 
been shown to induce hypermethylation thereby reducing accumulation of infecting 
geminiviruses (Reviewed in Rodriguez-Negrete et al., 2013). 
1.6.3 Role of miRNAs in silencing 
Lee et al. (1993) reported Caenorhabditis elegans lin-4 gene produced small RNA instead of 
coding for a protein. These small RNAs were termed micro RNA (miRNA). Micro RNAs are 
small endogenous non coding RNAs found in plant animals and viruses. These 21-22 
nucleotide are produced from ~70 nucleotide long endogenous precursors called pri-miRNA 
(Bartel and Bartel, 2003; Voinnet, 2009). DCL1 then processes the pri-miRNA into 21-22 
nucleotide miRNA. In plants Dicer DCL1 has been implicated in miRNA precursor 
processing. Silencing by miRNA can occur in 2 pathways (i) the 3’UTR of the mRNA can 
base pair with miRNA/RISC complex and inhibit transcription (ii) they can degrade mRNA 
by sequence specific binding (Finnegan and Matzke, 2003). The complementarities of the 
miRNA to the target mRNA determines which silencing pathway is taken. In animals 
translation repression usually occur due to the imperfect base pairing between the miRNA 
and the target mRNA whilst mRNA degradation occurs in plants due to their high 
complementarity to target mRNA (Llave et al., 2002; Tang et al., 2003). 
Unlike siRNA, miRNA are not only involved in gene expression regulation but are also 
response to virus infection. Host miRNA bra-miR158 and bra-miR1885 were upregulated 
when host Brassica rapa was infected with Turnip mosaic virus (TuMV) (He et al., 2008). 
Recently EACMV viral miRNA encoded from AC2 and AC4 ORFs targeting the host and 
itself were identified (Maghuly et al., 2014). The identification of premiRNA encoded from 
the viral ORF could be used to engineer plants against the virus.  
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1.7 Viral RNA silencing suppressors 
To counteract plants’ viral RNA silencing mechanisms PTGS and TGS, viruses have 
developed suppressor proteins. The level of suppression exerted by different viruses varies, 
where some viruses suppress in all infected tissues of the leaves whilst some exert 
suppression in newly formed leaves (Voinnet et al., 1999). Viral suppressors of RNA (VSRs) 
are capable of stopping the silencing mechanism and generation of siRNA targeting the virus 
(vsiRNAs) at its most important stages such as RISC assembly, dsRNA recognition and 
translational inhibition (Burgya and Havelda, 2011). Brigneti et al. (1998) showed that 
Cucumber mosaic virus (CMV) produced a protein 2b which suppresses PTGS in Nicotiana 
benthamiana. The model of suppression by the protein has since been implicated in 
disrupting silencing signal and disruption of the production secondary vsiRNAs (fig 1.7) 
(Diaz-Pandon et al., 2007; Guo and Ding, 2002). Since then several proteins have been 
shown to suppress silencing. Cauliflower mosaic virus (CaMV) P6 protein was shown to 
disrupt dsRNA-binding protein (Hass et al., 2008; Love et al., 2007). P14 and P38 proteins 
from Pothos latent auresvirus and Turnip crinkle virus have been proven to disrupt 
production of siRNAs (Merai et al., 2005, 2006). Double stranded siRNAs produced against 
the virus are also a target of VSR. The p19 protein from plant Tombusviruses have been 
proven by crystallography studies to attach with high degree of affinity to double stranded 
siRNAs thereby preventing siRNA/RISC complex formation (Silhavy et al., 2002). 
13 
 
 
Figure 1. 7 Model of antiviral RNA silencing mechanism in plants and its suppression by 
virus-encoded silencing suppressors. The model shows the various target area on the 
silencing mechanism were certain VSRs (i.e. P14, P38, 2b, P6, P21, P0) interact with the 
silencing pathways (Burgyan and Havelda, 2011) 
1.7.1 Cassava infecting geminiviruses as silencing suppressors 
Voinnet et al. (1999a) reported that ACMV AC2 open reading frame acted as a PTGS 
suppressor. Nicotiana benthamiana was transformed with a strain of Agrobacterium 
tumefaciens expressing a green fluorescent protein (GFP) transgene inserted into its Ti 
plasmid. A few days after transformation the N. benthamiana leaves, which had shown green 
fluorescence, showed red illumination because of PTGS. N. benthamiana was then 
transformed again with an AC2-PVX expression vector, and days after post infiltration N. 
benthamiana leaves showed green flourescence leading to the conclusion that GFP’s PTGS 
was being suppressed upon infection of N. benthamiana with the ACMV AC2 gene 
construct. The result showed that AC2 was a suppressor of PTGS. 
Vanitharani et al. (2004) also reported using the similar GFP transgene method that the AC4 
gene which lies in the Rep encoding region of ACMV was a suppressor of PTGS. Like 
previously done by Voinnet et al. (1999), N. benthamiana with a GFP trangene showed 
PTGS suppression when infected with an Agrobacterium tumefaciens baring an AC4 
construct. Vanitharani et al. (2004) also showed that the silencing ability of AC4 was virus 
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specific. AC4 obtained from ACMV-[CM] showed no suppression activity whilst AC4 from 
ACMV and SLCMV both showed PTGS suppression. 
1.8 Manipulation of RNA silencing mechanisms to combat plant diseases 
Advances in plant biotechnology and understanding of silencing mechanisms in the late 1990 
lead to the development of molecular tools for possible introduction of foreign genes. 
Introduction of foreign genes into plants is termed genetic engineering (GE). Using the 
siRNA-mediated RNA silencing molecular mechanisms, introduction of a transgene 
consisting of a partial fragment from the pathogen genome results in production of trangene-
derived siRNAs which aid the plants natural defence mechanism PTGS subsequently leading 
to resistance. This mechanism of introducing pathogen genes in plants is called pathogen 
derived resistance (PDR) (Peele et al., 2001). 
1.8.1 Pathogen Derived Resistance (PDR) 
PDR was first suggested by Sanford and Johnson (1985). Two methods are popular for 
pathogen derived resistance; the use of a viral gene coding for a protein which offers 
(protein-mediated resistance) and the use of viral genomic sequences which offer resistance 
(Peele et al., 2001). Powell-Abel et al. (1986) first demonstrated the use of Tobacco mosaic 
virus (TMV) coat protein gene for transgenic protein-mediated resistance. Their finding 
showed that transgenic tobacco with TMV coat protein genes offered resistance to TMV. 
Since then several viral proteins including movement proteins and replication-associated 
proteins have been used to induce resistance (Canto et al., 1998; Challappan et al., 2004; Sjen 
et al., 1996). At first it was believed that expression of the complete viral protein was 
necessary for silencing to occur but it has since been shown that the transcribed viral sense or 
antisense only can induce resistance (Fagoaga et al., 2006; Harrison et al., 1987). It became 
clear that silencing was being brought about by the transgenic-expressed RNA rather than the 
protein itself as expression of mutated proteins work too. 
1.8.2 RNA silencing constructs 
The use of sense or antisense transgenes was extensively studied in the early 1990s to 
compare their efficacy in inducing viral resistance (Fire et al., 1991; Smith et al., 1990; 
Takayami et al., 1990). Antisense RNA-mediated resistance uses an antisense strand which is 
specific to a viral sense strand, and complimentary binding of the expressed transgene 
antisense strand and the viral sense strand results in dsRNA which can be degraded via 
PTGS. The resulting siRNAs can then act as guide to degradation of homologous infecting 
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viral molecules. Smith et al. (1990) experimented with transforming tomato with 
polygalactoronase (PG) gene with either sense or antisense strand. Both methods resulted in 
reduction in expression of PG protein. However, the use of sense or antisense transgene has 
been reported to be unstable due to the low accumulation of siRNAs (Duan et al., 2000). 
Waterhouse et al. 1999 reported that simultaneous expression of a trangene with antisense 
and sense viral sequence in a plant induces more efficient virus silencing than antisense or 
sense alone. They reported that N. benthamiana plants transformed with a transgene 
expressing both arms of the Nia-Protease (Pro) gene of potato virus Y (PVY) had higher 
resistance compared with transgenes expressing either the sense or antisense polarity. The 
ability of the transgene to transcribe a RNA that can form a duplex/inverted repeat or hairpin 
meant it was more plausible for gene degradation to occur at a higher degree. Complete 
resistance could not be reached because the homologous nature of the sense and antisense 
strands meant secondary structures in the form of cruciform or Holliday junction like 
structures could easily form (Eichman et al., 2000; Holliday et al., 1985). 
To circumvent the formation of secondary structures, intron sequences were introduced 
between the sense and antisense sequence to form inverted repeat (IR) constructs (Smith et 
al., 2000). Due to the ability of the intron to align the sense and antisense arm in perfect 
complementarity these IR constructs have been reported to confer higher levels of resistance 
to viruses (Smith et al., 2000; Wesley et al., 2001). Using this model several generic vectors 
for IR/Hairpin constructs have been made. Helliwell and Waterhouse (2003) made 
pHANNIBAL, pKANNIBAL and pHELLSGATE generic vectors. These generic vectors 
require the insertion of de novo amplified arm of the transgene with suitable flanking sites, 
into the vectors by using the Gateway directed recombination. 
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Figure 1. 8 An overview of the Hellsgate cloning strategy. The target gene is amplified and 
attB1 sites are added to both flanks of the gene. The target gene is then cloned into the 
attP1/attP2 or attP2/attP1 in sense or antisense orientation in respect to the intron using 
Gateway recombination. The recombination sites have a ccdB gene for easy selection. The 
pHellsgate backbone has a Cauliflower mosaic virus (CaMV) 35S promoter that drives the IR 
cassette, Agrobacterium nopaline synthase gene; OCS terminator, the terminator sequence of 
the Agrobacterium octopine synthase gene, Right border and left border sequence from the 
Agrobacterium Ti plasmid (Wang and Waterhouse, 2001) 
1.8.3 Artificial miRNA constructs for virus resistance 
The ability of miRNA to specifically target mRNA transcripts has been adopted to make 
artificial miRNA (amiRNA) constructs for viral resistance. It was observed that changing 
several nucleotide bases within a mature mRNA would not affect its functionality hence 
artificial miRNA could be derived from modification of plant endogenous miRNA 
precursors. Artificial miRNA have been used to interfere with viral mRNA (Duan et al., 
2008; Niu et al., 2006; Zhang et al., 2011). Recently Wabaya et al. (2016) recorded 
resistance ranging from 20-60% against cassava brown streak virus when transformed 
N.bentamiana was transformed with an amiRNA targeting a 21 nucleotide conserved 
sequence of the virus. The advantage of using amiRNA for viral resistance is that they 
produce short cDNA sequences which reduce the possibility of off targets synonymous with 
long cDNA sequences (Galun, 2005). 
1.9 Resistance strategies against cassava mosaic disease 
Crop production faces several biotic and abiotic constrains in their growth and management. 
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Traditional plant breeding has been the major method of enhancing crop physiological and 
genetic characteristics. Despite its success in other crops, cassava heterozygosity makes 
traditional breeding methods difficult and time consuming (Bull et al., 2011). Since the 
development of virus resistance strategies such as protein and RNA mediated resistance, both 
these strategies have been achieved to induce maginal tolerance or in some cases resistance in 
cassava against cassava begomoviruses (CBVs) via PTGS or TGS (Vanderschuren et al., 
2007). While introduction of viral coat protein (CP) in tobacco was able to offer resistance 
against TMV (Abel et al., 1986), this strategy was not successful using CP of cassava-
infecting ACMV to induce resistance (Frischmuth and Stanley, 1998). It was later determined 
that using the CP of bipartite geminiviruses such as ACMV would not work because their 
function in the spread of the virus can be substituted by the BC1 cell-to-cell movement 
protein (Frischmuth and Stanley, 1998). 
Perhaps the best results in developing resistance in cassava has been the use of antisense or 
IR hairpin constructs consisting of viral coding sequence (Vanderschuren et al., 2007). 
Challappan et al. (2004a) observed that the Rep C-terminal region produce high amounts of 
viral siRNA suggesting that this region could be used to interfere with viral replication if 
introduced as a transgene (discussed in Chapter 4). Zhang et al. (2005) transformed cassava 
with antisense constructs of AC1, AC2 and AC3 sequences. The infectivity trials of the 
transgenic cassava with ACMV viral clones showed reduced viral accumulation in the 
transgenic plants and in addition short sense and antisense RNA homologous to the AC1 
transgene were identified and thought to be responsible for triggering PTGS. Inverted repeat 
constructs consist of a sequence coding for a viral gene, or partial fragment which is followed 
by a reverse of that same sequence, resulting in dsRNA hairpin when expressed. Transgenic 
cassava expressing ACMV AC1 homologous hairpin dsRNAs were reported to be resistant to 
ACMV infection (Vanderschuren et al., 2009). The resistance was directly linked to the high 
accumulation of siRNAs homologous to the AC1 transgene. Previously Vanderschuren et al. 
(2006) showed that IR constructs expressing the common region-containing bidirectional 
promoter of ACMV-[NG:Ogo:90] DNA-A produced homologous siRNAs that offered 
resistance to ACMV-[NG:Ogo:90] infection. Taylor et al. (2012) noted that IR constructs 
with a pdk intron were not stable resulting in difficulties in cloning. They suggested 
improving the structure of the IR hp contructs by replacing the intron with a few bases 
(spacer) and stabilizing the hairpin by introducing mismatches to the sense arm of the IR 
hairpin construct using bisulfite treatment. Mutated sense arm IR constructs of SACMV BC1 
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were made by sodium bisulfite treatment and expression of SACMV BC1 mismatched IR 
constructs in N.benthamiana resulted in a reduction in SACMV viral infection (Taylor et al., 
2012). 
1.10 Genetic engineering 
Knowledge on CBVs viral genome structure, replication and movement of the virus has made 
it possible to identify possible strategies such as RNA silencing to engineer cassava resistant 
to CMD (Vanderschuren et al., 2009). This is made possible by introduction of new DNA 
with a desired trait to an organism by a process termed genetic engineering (GE). Plants 
which express a foreign desired trait due to a gene introduced by GE are called transgenic 
plants or genetic modified (GM) plants (Bull et al., 2011). Two processes are involved in 
production of transgenic plants; development of efficient transformation and regeneration 
procedures. The totipotent nature of plants allows for the generation of new plants from a few 
cells. Several key steps have been taken to genetically improve cassava for resistance against 
CMD. The required trait represented by the gene or a section of the gene is introduced into 
the plant via a disarmed Ti plasmid of A. tumefaciens (Gelvin, 2003). Once the construct with 
the gene of interest has been inserted into the Ti plasmid genome cassava explants are then 
chosen for the transformation. In cassava, friable embryonic callus (FEC) and somatic 
cotyledons are the mostly used explants for transformation (Taylor et al., 2004). 
1.10.1 Transformation of Cassava 
Plant transformation involves the stable integration and expression of foreign genes in a plant 
genome (Gelvin, 2003). Several factors have hampered the improvement of cassava by 
traditional breeding, among them low fertility and the alloploidy nature of the plant 
(Munyikwa et al., 1999). Plant transformation has been used to genetically improve cassava 
germplasm for resistance against CMD. The major breakthrough in cassava transformation 
was originally based on development of friable embryogenic callus (FECs) suspension 
cultures for transformation and regeneration by Taylor and other researchers in the 1990s 
(Raemakers et al., 1996; Schopke et al., 1996; Taylor et al., 1996). A more recent improved 
method using FEC has been developed (Bull et al., 2011). Three methods of gene transfer are 
commonly used to genetically transform cassava, and these are microparticle bombardment, 
electroporation and Agrobacterium-mediated transformation. Electroporation involves 
mixing the plant cells with the vector DNA in a conductive solution such that when a high 
electric voltage is passed through the solution temporary pores are formed on the 
phospholipid bilayer allowing the vector DNA to move into the cell (Neumann et al., 1982; 
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Sukharev et al., 1992). In microparticle bombardment the vector DNA is coated on small 
metal particles which are then fired into the host plant tissue (Christon, 1992). The DNA 
coated particles are propelled into plant cells using high pressure. The third method 
(discussed below) by Agrobacteirum tumefaciens is the most widely used. 
1.10.2 Agrobacterium tumefaciens-mediated transformation 
Agrobacterium tumefaciens is a soil bacterium that has a Ti plasmid consisting of vir genes 
and T-DNA used by the Agrobacterium for infectivity (Gavin, 2003). The T-DNA has repeat 
sequence called right border and left border which aid in T-DNA integration into the host. 
Insertion of a foreign gene into the T-DNA segment would result in the foreign gene being 
transferred to host cells (reviewed by Yuan and Williams, 2012; Pitzschke, 2013). However 
due to lack of restriction sites on the T-DNA it proves difficult to clone foreign gene into the 
T-DNA (Gavin, 2003a). Binary vectors systems have been developed (Hoekema et al., 1983), 
where the T-DNA and vir gene are separated with one replicon consisting of vir (vir helper) 
and the binary vector consisting of the T-region (reviewed by Murai, 2013).  
Many binary vectors have been developed and perhaps the most common are the pCambia 
vectors (Hajdukiewicz et al., 1994). pCambia consist of a multiple cloning site (MCS) 
flanked by the right and left border. These cassettes also include an antibiotic marker gene 
and some have GFP (reviewed in Murai, 2013). The gene of interest can be cloned within the 
multiple cloning sites for transformation into host cells. The transformed pCambia vector can 
then be transformed into one of the many disarmed Agrobacterium strains that only have the 
(vir helper replicon) and the origin of replication. Commonly used disarmed Agrobacterium 
strains include LBA4404 (Ooms et al., 1981) and EHA105 (Hood et al., 1993). 
1.10.3 Transformation explant material 
Another factor to consider for successful production of transgenic cassava for viral resistance 
is the type and quality of transformation material. Somatic embryos (SEs) as transformation 
material have been reported (Ntui et al., 2015; Raemakers et al., 1997; Zhang and Puonti-
Kaelas, 2000). However the use of SEs for transgenic integration often leads to development 
of chimeras and is highly inefficient (Raemakers et al., 1997). Cassava embryogenic cell 
suspensions have also been used as transformation material (Raemakers et al., 1996; Schopke 
et al., 1996; Taylor et al., 1996). Currently the production of large numbers of independent 
transgenic plants relies on the use of friable embryogenic callus (FECs) as transformation 
material. Friable embryogenic callus have a unicellular origin and are totipotent making them 
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ideal for genetic manipulation by introduction of foreign genes (Taylor et al., 1996). 
Transformation of FECs from model cultivars as well as farmer preferred landraces have 
been reported successfully (Bull et al., 2009; Chetty et al., 2013; Nyaboga et al., 2015; 
Taylor et al., 2012). In vitro cultivation of FECs however requires optimisation for each 
particular cultivar targeted for genetic manipulation (Nyaboga et al., 2015). 
1.11 Public perception on GM crops and the state of GM technology in 
Africa 
Genetic engineering of crops comes as a solution to the many biotic and abiotic stresses 
causing food security problems worldwide. Despite a decline in food production in Africa the 
adaptation of GM crops still faces a lot of challenges. Thus far only South Africa, Egypt, 
Burkina Faso and Sudan are actively producing GM crops in SSA (James, 2013), whilst 
countries like Zimbabwe and Zambia have banned GM crop imports. Concerns have been 
raised about the potential risk of GM crops’ transgenes being introduced into the environment 
through gene flow from GM crops to natural crops, and also potential pest resistance and 
health issues including toxicity and allegenicity. Significant research has been done over the 
years to determine if GM crops pose any negative impact on human health or the 
environment, and thus far results have been inconclusive. There has been contrasting reports 
on the potential health issues arising from ingestion of GM crops. Jennings et al. (2003) 
proved that glyphosphate resistant genes could not be detected in the gut of pigs fed with 
glyphosphate tolerant soybeans. In other reports transgene DNA was detected in white blood 
cells of mice that had been feed with GM crops (Beever and Kemp, 2000). As a result the 
public perception is still divided as to whether they should accommodate GM crops or not. 
Countries like Nigeria, Kenya and Uganda are still doing experimental field trials (Okeno et 
al., 2013). However more recent reviews have shown that GM crops are safe for consumption 
(Jose and Zapeda, 2016; NAS, 2016), and that environmental risk assessments are in place to 
mitigate the potential risk of gene transfer from GM crops or products containing dsRNA 
(Heinemann et al., 2013).  
South Africa has adopted G.M technology, and currently transgenic maize, soybeen and 
cotton are under cultivation (Bothma et al., 2010). The adaptation of GM crops has also been 
hindered by lack of proper GM legislation in Africa for example development of Bt potato in 
South Africa by Syngenta and Michigan State University was blocked due to fear of possible 
trans-boundary movement into its neighbouring countries without proper GM regulation 
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measures (Eicher et al., 2006). Although South Africa is leading in terms of GM technology 
development and legislation it will not fully develop its potential until its neighbours and the 
rest of Africa follows suit. There is need by African governments to develop biotechnology 
frameworks that initiate the development of human resources to properly investigate these 
concerns as well as draft legislation that implement biosafety measures. 
The recent discovery of foreign Agrobacterium genes in sweet potato (Kyndt et al., 2015) 
many shift the general perception on GM crops. This discovery means sweet potato is a 
natural GMO and peoples have been consuming it for decades without consequence. This 
finding may allay the fears of the public to some extent since it argues for the fact that 
transfer of genes happens in nature. 
1.12 Rationale for study 
Cassava is one of the four most important staple food sources in the world. Cassava is an 
excellent staple crop in developing countries due to its high carbohydrate source and its 
ability to produce sizeable yield in adverse growing conditions. Despite its importance as a 
security crop in developing countries with limited agricultural resources, commercialisation 
of cassava in Africa is still limited due to several constraints. In South Africa (SA) cassava is 
grown as a subsistence crop and most of its production is by small scale farmers with limited 
resources in areas such as Mpumalanga, Limpopo and Kwazulu- Natal. 
SA like most countries in Sub Saharan Africa has recognised cassava as an alternative food 
source and a potential source of food security, but major intrest is in realising cassava’s 
industrial potential. More recently, commercial cassava cultivation has moved to Swaziland. 
The Cassava Industry Association of Southern Africa (CIASA) is now registered as an  Non 
profit organisation (NPO) with the Department of Social Welfare. Resources have been 
allocated by the Technical Innovation Agency (TIA), Department of trade and industry (DTI) 
and Agriculture Research Council (ARC) to launch cultivation trials of cassava varieties 
suitable for starch production in SA in the future. The ARC is also looking at mechanization 
for small scale on-site processing. Starch production here in SA is currently used as raw 
material for industries such as Monde and Sappi for paper as well as food and textile 
companies. Cassava is also imported from Thailand to meet local demand. In 2013, South 
African cabinet approved the National Bio-economy Strategy for SA. One of the pillars of the 
strategy is addressing commercialization and agro-processing requirements and since cassava 
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is important for its agro-processing our rationale to improve is yields and subsequent 
agroprocessing is aligned with the national bio-econony stategy. 
Cassava agro-processing potential cannot be fully realised until its major constraint (yield 
loss due to CMD) is dealt with. One of the focus areas currently is the genetic engineering of 
cassava for resistance against CBVs. This scientific approach allows for introduction of 
desired traits into existing cultivars. The Plant Biotechnology Program at The University of 
the Witwatersrand over the past ten years has been developing transformation and 
regeneration systems to be able to genetically engineer desired traits into cassava. Currently 
the laboratory has genetically engineered T200, a high starch landrace variety and cv. 60444 
(model laboratory based cultivar) for resistance against EACMV, SACMV and ACMV, but 
these need to be evaluated. The rationale of this study is to vigorously test these previously 
transformed lines for potential resistance against CBVs. Once proof of concept is achieved 
the resistant lines will be used in larger commercial field trials. 
The use of sense or antisense constructs has been mostly used for engineering cassava for 
resistance against CBVS, although this method has resulted in reduced symptoms in several 
research projects, inverted repeat (IR) transgenes have been proved to be more efficient  
compared to sense/antisense in inducing PTGS of incoming viruses (Vanderschuren et al., 
2007). Inverted repeat constructs consist of a sequence coding for a viral gene, or partial 
fragment which is followed by a reverse of that same sequence, resulting in dsRNA hairpin 
when expressed. Despite the efficiency of IR their main drawback is the instability of the 
sequence which causes cruciform structures (Duckett et al., 1988). To counter this formation 
of cruciforms Taylor et al. (2012) treated the sense arm sequence with bisulfite to induce base 
pair mismatch on the sense strand before the assembly of IR or hairpins (hp), in order to 
stabilize the construct. Several IR constructs have been made in our laboratory in order to 
produce lines which are CBV resistant using this RNA silencing mechanism. Transgenic 
cassava from four transformation events lines namely; AMM2, CMM6, AMM4 and CMM8 
have shown promise for tolerence in small laboratory trials, and will be targeted for this 
study. Transformed cv.60444 lines transformed with a partial BC1 (cell to cell movement) 
transgene of SACMV are coded CMM8. The partial BC1 sense strand was treated with 
bisulphite to create mismatches. Transformed cv.60444 cultivars transformed with the 
cognate corresponding mismatched partial BC1 constructs are called AMM4. Transformed 
cv.60444 lines with a mismatched AC1/4 and AC2/3 IR construct targeting the Rep/VSR and 
TrAP/Ren ORFs, respectively, are coded AMM2 lines. Transformed cv. 60444 cultivars with 
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the cognate corresponding non-mismatched AC1/4 and AC2/3 constructs are coded CMM6. 
This study compares mismatched AMM2 lines and non-mismatched CMM6 lines as well as 
non-mismatched CMM8 and mismatched AMM2 for resistance or tolerance against ACMV 
and SACMV, respectively. 
The study also includes designing an inverted repeat hpRNA construct (DM-AES) was 
designed to target ACMV-[NG:Ogo:90] putative promoter region, an overlapping sequence 
between ACMV-[NG:Ogo:90] AC1 3’ end  and AC2 5’ end (AC1 3’/AC2 5’-ter) as well as 
being efficient against SACMV and EACMV due to the inclusion of a 21 nt conserved 
sequence of AC1/Rep shared between ACMV, EACMV and SACMV. The construct was 
designed with aim of improving the efficiency of RNA silencing and due to the combination 
of three chosen genomic regions on ACMV-[NG:Ogo:90]. Sharma et al. (2014) proved that 
siRNA have been found to trigger TGS by, methylation of target promoter sequences 
(hotspots) on the intergenic region of geminiviral DNA thereby leading to reduction of 
transcription levels. Vanderschuren et al. (2007) proved that cassava plants transformed with 
a viral sequence of the ACMV-[NG:Ogo:90] promoter region showed signs of recovery when 
infected with ACMV-[NG:Ogo:90]  viral strain. The construct was transformed into cassava 
T200 FECs in preliminary experiments. 
1.13 Research Objective and Specific aims 
The objective of this study is to undertake green house trials to evaluate selected transgenic 
plants (CMM6, CMM8, AMM2 and AMM4) for response to geminiviruses infection in order 
to identify resistance/tolerance. Furthermore, a construct targeting ACMV-[NG:Ogo:90] 
putative promoter region, a 21 nt conserved sequence of AC1/Rep shared between ACMV, 
EACMV and SACMV and the overlapping sequence between ACMV-[NG:Ogo:90] AC1 3’ 
end and AC2 5’ end (AC1 3’/AC2 5’-ter) was made and subsequently transformed into 
cassava T200 FECs. 
Specific aims 
Aim 1: Evaluation for resistance of selected cassava transgenic plants in green-house 
trials, and compare transformed lines with mismatched or non-mismatched constructs 
(a) To confirm successful integration of the transgenes in previously transformed CMM6, 
AMM2, AMM4 and CMM8 cassava plants selected for virus resistance evaluation trials in 
this study.  
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Experimental tasks: 
 DNA extraction (CTAB method). 
 PCR using GUSPLUS, hygromycin and transgene insert primers. 
 Southern blot to determine DNA copy number. 
 Total RNA extraction and Northern blot to determine siRNA. 
 
 (b) Viral challenging of transformed cassava plants 
Experimental tasks 
 Macropropagation and multiplication of selected transformed lines. 
 Acclimatization and Agroinoculation with ACMV-[NG:Ogo:90] (CMM6 and 
AMM2) or SACMV (CMM8 and AMM4) infectious clones. 
 Agroinoculation of wild-type healthy cv.60444 and ACMV-[NG:Ogo:90] resistant 
transgenic line dsAC1-RNAi. 
 
(c) Characterisation of ACMV and SACMV challenged transgenic plants for resistance or 
susceptibility at 5 time points post inoculation (14, 36, 56, and depending on results at later 
time point 180 and 365dpi) 
Experimental task; 
 Evaluate leaf symptom severity and (plant height) at all time points. 
 Viral load determination using real time q-PCR at 36 and 56 dpi (depending on 
results at later time points). 
 Root yield evaluation after 365dpi. 
 
AIM 2: Design of a construct targeting ACMV-[NG:Ogo:90], EACMV and SACMV.  
 Construction of RNAi IR/hairpin transgenes and transformation into pCambia 1305.1 plant 
transformation vector 
Experimental tasks 
 Identifying the sequence of the three target regions and designing an IR hairpin 
construct. 
 Clone the IR constructs into pART7 expression vector. 
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 Clone the hairpin cassette constructs into plant transformation vector pCambia 
1305.1. 
 Transform Agrobacterium LBA-4404 with pCambia/IR. 
 
     (b)Transform and regeneration of cassava T200 FECs 
     Experimental task 
 Agrobacterium-mediated transformation of FEC with pCambia/IR construct 
 Regeneration of transformed FECs. 
 Selection of plants for transgene integration using visual and molecular screening 
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Chapter 2 
Screening of cassava expressing stacked non-mismatched or 
mismatched hairpin RNA constructs derived from African 
cassava mosaic virus [NG] ORFs 
2.1 Introduction 
Cassava is a very important crop in poverty alleviation in sub-Saharan Africa (SSA), and it 
contributes to 60% of the daily calorie intake. One major constrain to cassava cultivation is 
cassava mosaic disease (CMD) (Legg et al., 2015; Thresh & Cooter, 2005). CMD is caused 
by bipartite cassava begomoviruses species including African cassava mosaic virus (ACMV). 
African cassava mosaic virus consists of a single-stranded circular bipartite genome 
comprising of DNA-A and DNA-B. DNA-A has six open reading frame coding for four 
complementary sense genes that is AC1 to AC4 and two virion sense genes AV1 and AV2 
(Vanitharani et al, 2005). AC1 codes for the (Rep) 358 amino acids (aa) protein, and Rep is 
essential for replication initiation. AC2 codes for a 135 aa protein called (TrAP) which is 
essential for transcriptional activation as well as suppression of post-transcriptional gene 
silencing. AC3 codes for (REn) a 134 aa protein essential for replication enhancement. AC4 
functions as a suppressor of RNA silencing (VSR) and symptom modulator. AV1 codes a 
coat protein of 258 aa and AV2 encodes a pre-coat protein (Vanitharani et al., 2004; 
Vanitharani et al., 2005). DNA-B has 2 open reading frames coding for a complementary 
sense gene (BC1) and a virion sense gene (BV1). BV1 encodes a nuclear shuttle protein 
(NSP) and BC1 encodes a cell to cell movement protein (MP) (Varma and Malathi, 2003). 
Plants have a natural defence mechanism called RNA silencing which protects them from 
virus invasion (Bologna and Vionnet, 2014; Ribeiro et al., 2006; Zvereva and Pooggin, 
2012). RNA silencing results in sequence specific inhibition of transcription or translation 
(Balcombe, 1999). Post transciptional gene silencing (PTGS) plays a major role in plant 
defence against viral pathogen invasion (Balcombe, 1999; Waterhouse et al., 2001). The 
process is dependent on the recognition of foreign double stranded RNA (dsRNA). 
Ribonuclease III like enzymes called Dicer then processes dsRNA to short interfering RNA 
(siRNA) (Bologna and Vionnet, 2014; Hamilton et al., 2002). Subsequently, one strand of the 
siRNA then acts as guide strand for RNA induced silencing complex degradation of 
homologous RNA molecules (Arreger et al., 2012; Hammond et al., 2000; Tang et al., 2003). 
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Several studies in cassava or other related plants which can be affected by geminiviruses have 
shown that introduction of full-length or truncated segments of the different geminivirus 
genes induces varying levels of viral tolerance (Hong and Stanley, 1996; Norris et al., 1996; 
Ntui et al., 2015; Vanderschuren et al., 2007). Significant levels of resistance to ACMV have 
been reported in transgenic plants expressing antisense mRNA of Rep, TrAP and REn 
proteins (Zheng et al., 2005). Increased resistance has also been reported in transgenic plants 
expressing sense and antisense RNA homologous to Sri Lankan cassava mosaic virus 
(SLCMV) AV1/AV2 overlapping region (Ntui et al., 2015), and transgenic plants expressing 
sense and antisense RNA homologous to ACMV-[NG:Ogo:90] AC1 (Vanderschuren et al., 
2009). Constructs with self complementary sense and antisense strands forming inverted 
repeat (IR) are more efficient PTGS inducers as opposed to either sense or antisense 
strategies (Wang et al, 2008; Waterhouse et al, 1998). Expression of the IR contruct would 
result in formation of a hairpin RNA (hpRNA) which is recognised as being double stranded 
thereby efficiently triggering PTGS (Aregger et al., 2013; Duan et al., 2012). 
High-throughput gene silencing vectors such as pHELLSGATE and pHANNIBAL which 
facilitate insertion of the transgene by Gateway recombination in the sense and antisense 
orientation whilst being separated by a sliceable intron are commonly used in designing IR 
constructs (Helliwell and Waterhouse, 2003; Wesley et al., 2001). However, large introns in 
generic vectors like pHellsgate often result in T-DNA deletion and recombination (Nakano et 
al., 2005). Taylor et al. (2012) from our laboratory developed a method to avoid the use of 
large introns by replacing the intron with a few bases (spacer) and stabilizing the hairpin, by 
introducing mismatches in the sense arm of the IR hairpin construct using bisulfite treatment. 
Amplification of the converted fragment would result in uracil being replaced by thymine 
causing base mismatches. The use of mismatched constructs to induce PTGS in tobacco for 
virus resistance was successfully reported (Taylor et al., 2012).  
In this chapter transgenic cassava was evaluated for resistance/tolerance to CMD. The 
transgenic plants were from two transformation events with either a mismatched (AMM4) or 
non-mismatched (CMM6) Africa cassava mosaic virus-[Nigeria:Ogorocco;1990] (ACMV-
[NG:Ogo:90]) IR construct derived from stacking the overlapping AC1/AC4 (2437-2572 nt) 
and AC2/AC3 (1297-1479 nt) viral sequences, were screened. The ACMV-[NG:Ogo:90] 
derived (non-mismatched construct) was constructed using the Gateway method where the 
sense and antisense arms are separated by a 800 bp pdk intron; and the mismatched transgene 
by bisulfite treatment for introduction of mismatches (C to T) in the sense arm of the identical 
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ACMV-[NG:Ogo:90] IR sequence (Rey et al., 2015; Taylor et al., 2012). CMM6 and AMM4 
transgenic lines were derived from previous transformation of the model cassava cultivar 
cv.60444. 
The current study evaluates CMM6 and AMM2 lines for viral resistance or tolerance to 
ACMV-[NG:Ogo:90] by monitoring symptoms, viral replication and plant height in 
comparison with untransformed cv.60444. Symptoms were evaluated using a 0-3 scale 
similar to the one described by Ntui et al. (2015). The current study evaluates if there is a 
correlation between the symptoms and the viral load as this helps in defining whether the 
plants are tolerant or resistant. For resistance/tolerance trials in our laboratory we adopted 
definitions for virus resistance, tolerance or susceptibility from (Bengyella and Rey, 2014; 
Lapidot and Friedman, 2002): resistant plants show no symptoms as a result of no virus 
replication; tolerance is defined as the presence of mild symptoms due to low virus levels; 
and susceptibility refers to the presence of severe symptoms due to uncontrolled virus 
replication. Small interfering RNA generation was also evaluated to determine if 
tolerance/resistance correlated with the siRNAs being produced. The infectivity trials were 
done in growth facilities and the green-house with controlled environmental conditions. 
Resistance or tolerance has been shown to differ when conditions vary greatly, such as 
temperature, viral dosage and light intensity (Chellappan et al., 2005; Szittye et al., 2003; 
Vanderschuren et al., 2009). The tuber yields of tolerant lines from this trial were evaluated 
to determine if tolerance resulted in less yield loss of the storage roots, and also if insertion of 
the transgene would interfere with root formation. 
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2.1.1 Specific Aims 
The aim of this research was to subject selected transgenic non-mismatched CMM6 lines 2, 
3, 5, 6 and 7, and corresponding mismatched AMM2 lines 30, 41, 44, 52, 53 and 54 lines to 
reproducible trials and evaluate for response to virus challenge and select potential 
resistant/tolerant lines for further larger GM trials in future.  
Steps in achieving our aim 
i. To confirm successful integration of transgenes in previously transformed lines 
ii. Micro-propagation of CMM6 and AMM2 transgenic cv.60444 lines and 
acclimatization for (6 weeks) 
iii. Agro-infection of transgenic lines with ACMV-[NG:Ogo:90] infectious virus clones 
iv. Plant evaluations for virus symptom severity, plant height and viral load at 14, 36, 56 
and 365 days post inoculation (dpi) 
v. Tuber yield evaluation at 365 dpi 
vi. Northern blots to determine siRNA production pre and post infection 
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2.2 Methodology flow chart 
 
 
Figure 2. 1 Work flow diagram for screening of transgenic cassava lines for resistance 
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2.3 Materials and Methods 
 
Characterisation of transgenic lines 
2.3.1 DNA extraction 
Leaf tissue approximately (50 mg) was collected from each of the five CMM6, six AMM2 
trangenic lines and non-infected healthy cv.60444. The leaf samples were collected in 
eppendorf tubes, snap-frozen in liquid nitrogen and crushed into a fine powder. The 
Cetylmethylammonium bromide (CTAB) method (Doyle and Doyle, 1987) was used for total 
nucleic acid (TNA) extraction. To each eppendorf tube, 500 µl of preheated CTAB extraction 
buffer (2% hexadecyltrimethylammonium bromide, 1.4 M NaCl, 20 mM Ethylene diamine 
tetra-acetate (EDTA), 100 mM Tris-HCl, pH 8.0) supplemented with 0.2% 2-
mercaptoethanol was added, and the sample mixture was vortexed. The sample mixture was 
then incubated in a 65°C water-bath for 60 min. After 60 min of incubation, 500 µl of 
chloroform-isoamyl alcohol (24:1) was added followed by mixing and centrifugation at 
13,000 rpm for 10 min at 4°C. The resulting aqueous layer after centrifugation containing the 
TNA was placed into an eppendorf tube and 500 µl of 24:1 mixture of chloroform-isoamyl 
alcohol was added followed by mixing and centrifugation at 13,000 rpm for 10 min at 4°C. 
The TNA in the resulting aqueous layer was precipitated using 500 µl isopropanol by mixing 
then centrifugation for 10 min at 13,000 rpm at 4°C. The supernatant was discarded and the 
remaining TNA pellet was washed with 500 µl of ice-cold 70% ethanol followed by 
centrifugation for 10 min at 13,000 rpm at 4°C. The washing step was repeated again. The 
eppendorf tube was blotted on tissue paper and air dried for 60 min. The pellet was then 
resuspended in 50 µl TE buffer (10 mM Tris pH 8.0 and 1 mM EDTA) supplemented with 20 
µg/ml RNase A (Fermentas). The extracted DNA was quantified and checked for quality on 
the Nanodrop 1000 spectrophotometer (Nanodrop). 
2.3.2 Southern blot screening for transgene copy number 
To screen for transgene copy number, DNA from the five CMM6 and six AMM2 transgenic 
lines extracted in 2.3.1 was used for Southern blotting. Transgene copy number analysis was 
done following the DIG-High Prime DNA labeling and detection starter kit II (Roche Life 
Sciences) protocol. Africa cassava mosaic virus-[Nigeria:Ogorocco;1990] AC1/4:AC2/3 non-
mutated strand PCR fragments were produced using the primers described in Table 2.1. The 
fragments were then labeled as probes following manufactures protocol. A total 30 µg of the 
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extracted DNA was digested with HindIII which cuts once within the T-DNA at 37°C 
overnight. The digested reaction was run on a 1% agarose gel in 1X TAE and transferred by 
capillary action to a positively charged nylon N+ membrane (Amersham). The membrane 
was then hybridized with the DIG labeled probe at 42°C overnight. The next day membrane 
was washed and blocked following the DIG-High Prime DNA labeling and detection starter 
kit protocol. Biorad Chemi Doc system was used for chemiluminiscent detection by exposing 
the membrane for 30 min.  
2.3.3 PCR of GUSPLUS, hygromycin and virus-derived transgenes 
To confirm successful integration of the plant transformation cassette carrying the ACMV-
[NG:Ogo:90] IR transgene into the CMM6 and AMM2 trial lines, DNA extracted in 2.3.1 
was used as template. Transformed plants were screened for the GUSPLUS and Hygromycin 
gene (hyg) using GUSPLUS forward primer (5’-CAACATCCTCGACGATAGCA-3’), 
GUSPLUS reverse primer (5’-GGTCACAACCGAGATCTCCT-3’), and hyg forward primer 
(5’-TCTCGATGAGCTCATGCTTTGG-3’) and hyg reverse primer (5’-
AGTACTTCTACACAGCCATGGG-3’). Transformed plants were expected to amplify a 
181 bp GUSPLUS gene fragment using the GUSPLUS primers and a 485 bp hyg gene 
fragment using the hyg primers. Screening for the CMM6 and AMM2 sense and antisense 
was done using ACMV-[NG:Ogo:90] AC1/4:AC2/3 primers and AC1/4:AC2/3 modified 
primers, respectively Table 1. The PCR reaction mixture for amplification of these genes 
contained 1X Taq buffer, 0.2 mM dNTP, 0.2 µM of each primer, 1U Taq polymerase enzyme 
(Fermentas) and 50 ng template DNA. The reaction was set at 94°C for 2 min and 35 cycles, 
94°C for 30 sec, 55°C for 30 sec, primer extension at 72°C 30 sec and final extension step of 
72°C for 10 min. The reaction was set up in Thermal cycler (Biorad). The resulting amplified 
PCR fragment were analysed by electrophoresis on a 1% agarose gel in 1X TAE buffer 
containing 10 µg/ml ethidium bromide for staining. 
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Table 2.1 Primers used to amplify the ACMV-[NG:Ogo:90] DNA-A target region 
Primer                                          Primer sequence                                 
AC1/4 XbaI F                    5’-GATCTCTAGAAAGTGAGGTTCCCCATTCTG-3’ 
ACMV AC2/3 XbaI F        5’- GATCTCTAGACCAATCATGGATTTACGCACA-3’ 
AC1/4 X hoI F                  5’-GATCCTCGAGAAGTGAGGTTCCCCATTCTG-3’ 
AC2/3 X hoI R                  5’-GATCCTCGAGCCAATCATGGATTTACGCACA-3’ 
AC1/4(X hoI and SpelI )F  5’-GATCCTCGAGACTAGTAAGTGAGGTTTCCATTTTG-3’ 
AC2/3 BglII R                   5’-GATCAGATCTCCAATCATAGATTTACACACAGG-3’ 
2.4.4 RNA extraction 
Leaf tissue approximately 50 mg was collected from each of the CMM6, AMM2 transgenic 
lines and untransformed healthy cv.60444 control. Two leaves per sample were collected in 
eppendorf tubes, snap-frozen in liquid nitrogen and crushed into a fine powder. Then 500 µl 
of QIAzol lysis reagent was added to eppendorf tube and the tubes were briefly vortexed. The 
mixture was left to stand for 5 min at room temperature prior to centrifugation at 12,000 rpm 
for 5 min. After centrifugation the aqueous layer was poured in 200 µl of chloroform and 
shaken vigourously. The mixture was left to stand at room temperature for 3 min and then 
centrifuged at 12,000 rpm for 15 min at 4°C. The resulting aqueous layer was transferred to a 
new tube with 500 µl isopropanol and mixed by inverting. The mixture was left to stand at 
room temperature for 10 min and then centrifuged at 12,000 rpm for 10 min at 4°C. After 
centrifugation the supernatant was discarded and 500 µl of 75% ethanol was added to the 
tube for pellet cleanup. The mixture was then centrifuged at 75,000 rpm for 5 min at 4°C. 
The supernatant was discarded and the RNA pellet was dried for one hour before it was 
dissolved in 30 µl double distilled water. RNA was quantified on a nanodrop and the quality 
and integrity determined on a 1.2% agarose gel containing 10 ug/μl ethidium bromide run in 
0.5X TBE. 
2.3.5 T-DNA expression 
Total RNA extracted from 2.3.4 was used to check for the expression of the T-DNA. For 
cDNA synthesis 2 µg of RNA from the CMM6, AMM2 transgenic lines and untransformed 
healthy cv.60444 control was first DNAase treated with 1U DNAase (Thermo Scientific) in 
10X reaction buffer. RevertAid reverse transcriptase kit was used to synthesise cDNA strand 
using OligodT and random primers. The synthesised cDNA stranded was then directly used 
in PCR to amplify the GUSPLUS gene, hyg gene and the sense and antisense arms of the 
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respective transgene. The same primers and primer conditions described 2.3.3 were used. 
PCR amplicons were visualised on a 1% agarose gel containing 10 µg/μl ethidium bromide 
run in 1X TAE. 
Sceening trials of transgenic lines for response to ACMV challenge 
2.3.6 Bulking up and acclimatisation of selected transgenic plants  
The selected five CMM6 lines 2, 3, 5, 6, and 7 and six AMM2 lines 30, 41, 44, 52, 53 and 54 
were propagated in tissue culture on Murashige and Skoog 2 (MS2) medium containing 4.4 
g/L MS salts, 20 g/L sucrose, solidified with 6.8 g/L plant agar, pH 5.8. For experimental 
controls, healthy cv.60444 cassava plants, ACMV-[NG:Ogo:90] resistant transgenic line 
dsAC1 (Vanderschuren et al., 2009) and pCambia vector only transgenic controls were also 
propagated. The dsAC1 transgenic plants express an IR construct homologous to ACMV-
[NG:Ogo:90] AC1/Replication–associated protein (Rep) sequence (154 bp) from nt position 
1690 to 1844 (Vanderschuren et al., 2009) transformed in cv.60444. Plants were grown on 
MS2 media at 28°C under 16 h light/8 h dark photoperiod. After three weeks when roots had 
developed plantlets were removed from tissue culture and transferred to small jiffie bags 
(Jiffies International). A total of 25-30 plants were moved to jiffies per each transgenic line, 
healthy cv.60444 cassava plants, ACMV-[NG:Ogo:90] resistant transgenic line dsAC1 and 
pCambia vector only transgenic controls. The jiffies were then placed in plastic trays and 
covered with plastic wrap. Trays were placed in a phytotron facility with conditions 28°C, 16 
h light (8,000-10,000 lux) and 8 h dark cycles and 60% humidity. After one week holes were 
poked through the plastic wrap gradually for a few days to help acclimatise the plants.  
2.3.7 Experimental design 
Ten plants per each line were inoculated with ACMV-[NG:Ogo:90] infectious viral clones 
(n=10). After infection six plants per each line were randomly selected for symptom, viral 
load, height evaluation and tuber yield evaluations. The second and third upper most apical 
leaves were scored for symptom evaluation and collected for real time absolute qPCR at 14, 
36, 56 and 365 dpi. The two apical leaves collected per plant were pooled into 3 groups of 
three biological and (2 technical replicates per biological replicate) were used for real time 
qPCR. Three plants per each of the CMM6 or AMM2 transgenic lines, infected 
untransformed cv.60444, non-infected healthy cv.60444 and ACMV-[NG:Ogo:90] resistant 
transgenic line dsAC1 were harvested to determine tuber yield fresh and dry weight. 
Statistical evaluations were done on the results from each of the characterisation. Student t-
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test using (p=0.05) were used to determine the significant differences of the results obtained 
between transgenic lines and infected untransformed cv.60444. Results were deemed 
significantly different at p˂0.05 and insignificant at p˃0.05. Pearson correlation was used to 
determine the correlation between the viral load, symptom scores, height, tuber yield 
evaluation and siRNA band intensities. A positive correlation value signified a strong 
correlation between the test parameters and a negative correlation value signified no 
correlation between the test parameters. 
2.3.8 Agro-inoculation of transgenic plants with ACMV 
After 4 weeks the transgenic and control lines were agro-inoculated with ACMV-
[NG:Ogo:90] DNA-A and DNA-B infectious clones. Prior to infection Agrodimers A and B 
mobilized into pCambia 1300 vector (Vanderschuren et al., 2009) and cloned in 
Agrobactrerium tumefaciens LBA4404 were grown separately overnight in Yeast extract 
peptone (YEP) broth inoculated with antibiotics 100 µg/ml streptomycin, 50 µg/ml 
kanamycin and 50µg/ml rifampicin until an OD600 of between 1.8 and 2.0 was reached. Equal 
amounts of the appropriate A and B components were mixed. Each plantlet was injected at 
the nodes with 120µl of Agrobacterium culture containing equal volumes of ACMV-
[NG:Ogo:90] DNA-A and B dimers. Characterisation of the ACMV-[NG:Ogo:90] challenged 
transgenic and control lines were done at 14, 36, 56 and 365 dpi. The characterization 
included height evaluation, symptom scoring using a score scale of 0-3 and real time absolute 
quantitative PCR for viral load determination.  
2.3.9 Sampling and symptom monitoring  
Africa cassava mosaic virus-[Nigeria:Ogorocco;1990]-infected CMM6, AMM2 lines, 
infected untransformed cv.60444, and infected ACMV resistant line dsAC1 control plants 
were monitored and evaluated for viral response at 4 time points post infection (14, 36, 56 
and 365 dpi). For symptom severity scoring the second and third upper-most apical fully 
grown leaves were scored for symptom development using a symptom severity score index of 
0-3 (0= no symptoms, 1= faint mosaic/ chlorosis, 2= clear mosaics with or without leaf 
deformation, 3=severe mosaic, leaf distortion and reduced size). These second and third 
upper-most fully grown leaves were harvested and frozen in liquid nitrogen and stored at -
70°C for DNA and RNA extraction. The height of 6 plants from each of the ACMV-
[NG:Ogo:90]-infected CMM6, AMM2 lines, infected untransformed cv.60444, and infected 
ACMV-[NG:Ogo:90] resistant line dsAC1 control plants were also measured at each time. 
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Molecular characterization of challenged transgenic and non-transformed plants 
2.3.10 Absolute quantitative PCR of viral load 
Viral loads in ACMV-[NG:Ogo:90] infected CMM6, AMM2 transgenic lines, infected 
untransformed cv.60444, non infected healthy cv.60444 and infected ACMV-[NG:Ogo:90] 
resistant transgenic line dsAC1 were determined by real time absolute qPCR. Total DNA was 
extracted from the second and third apical leaves at 36 and 56 dpi from infected transgenic 
lines, infected untransformed cv.60444, non infected healthy cv.60444 and ACMV-
[NG:Ogo:90] resistant line dsAC1 following Doyle and Doyle (1987) CTAB based method 
described in 2.3.1. Extracted DNA was standardized to 50 ng/µl and DNA from 6 plants (2 
apical leaves per plant) was pooled into 3 groups of three biological and (2 technical 
replicates per biological replicate) were used for real time absolute qPCR. For the qPCR 
reaction 10 μl of Maxima SYBR green master mix, RepF and R primers to a final 
concentration of 0.3 μM for each primer, 1 μl of template DNA, plasmid standard or 
nuclease-free water were added to a total volume of 10 μl. To amplify ACMV-[NG:Ogo:90] 
virus multiplication primers APA9 forward primer FP2 
5’CAATTTCCACCCCAACATTCA3’ and reverse primer APA9 RP2 
5’GCGTAAGCATCATTCGCTGAT3’ were used. The primers were designed to amplify the 
core coat protein region on ACMV-[NG:Ogo:90] DNA-A (Wyatt and Brown, 1996). The 
reaction condition were set at initial denaturation 95°C for 10 min for 40 cycles, 95°C for 15 
sec, annealing at 60°C for 30 sec and extension at 72°C for 30 sec. The 10 µl sample reaction 
was setup in Light Cycler 480i (Roche Applied Sciences). The viral loads quantification of 
the pooled sample was done in triplicate. The ACMV-[NG:Ogo:90] viral loads of the 
experimental samples were calculated by reference to a standard curve generated by serial 
dilutions of pCambia 1300- ACMV-[NG:Ogo:90] DNA-A clones ranging from 0.1 pg/µl to 1 
ng/µl under the same qPCR reaction condition. 
 
Amount of molecules in pg was generated by the LightCycler software version 4 (Roche 
Applied Science, Penzberg, Germany) from the pCambia 1300- ACMV-[NG:Ogo:90] DNA-
A based standard curve. Using the pg values obtained from LightCycler software version 4 
(Roche Applied Science, Penzberg, Germany), the corresponding viral molecules were 
calculated using Equation 1. Equation 2 was used to calculate the number of viral molecules 
from the extracted DNA. The viral molecules calculated for each treatment were plotted on a 
logarithmic graph. 
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2.3.11 Northern blot detection of siRNA 
Africa cassava mosaic virus-[Nigeria:Ogorocco;1990] IR PCR amplicons were cloned into 
PTZ57R/T plasmid to facilitate in vitro transcription of the IR transgene downstream of the 
T7 promoter using T7 RNA polymerase. Then 1 µg total plasmid containing ACMV-
[NG:Ogo:90] IR PCR amplicon was linearized at the 5’end of the insert with 1U EcoRI 
restriction enzyme. DIG Northern Starter Kit (Roche) was used to produce DIG labeled RNA 
from the linearised template. For hydrolysis 1X alkaline hydrolysis buffer was used to 
hydrolyze 2 µg aliquots of the DIG labeled RNA to small sizes by heating the sample at 95°C 
for 20 min. For siRNA control, an Arabidopsis 21 nt miR167 (5-
’TAGATCATGCTGGCAGCTTCA-3’), oligonucleotide was 3’end labeled. For size marker 
a 24 nt primer (5’-TTCAGGAGCCTCCGCCTGTCT-3’), designed not share sequence 
similarily with the ACMV IR and a 30 nt positive control from the kit were 3’ end tail labeled 
using DIG Oligonucleotide Tailing kit 2
nd
 generation (Roche). Prior to infection, 30 µg of 
RNA was extracted from CMM6, AMM2 transgenic lines and non-infected healthy cv.60444. 
Post-infection 30 µg of RNA was also extracted from infected CMM6, AMM2 transgenic 
lines, non-infected healthy cv.60444 and infected untransformed cv.60444 leaf tissue using 
QIAzol reagent (Qiagen) as described in 2.3.4. Extracted RNA was separated by 
electrophoresis using 15% polyacrylamide (19:1) gel cast in 8 M urea and buffered with 20 
mM MOPS/NaOH (pH 7). Seperated RNA was blotted to Hybond-N+ membrane 
(Amersham GE Healthcare) using a semi-dry electro blotter (Sigma Aldrich, SV20-SDB, 
UK). The electrophoresis buffer was 20 mM MOPS/NaOH (pH 7). Seperated RNA was 
mobilized onto the Hybond-N+ membrane by 1-ethyl-3[3-dimethylammopropyl] 
carbodiimide (EDC) (Sigma Aldrich) according to Pall et al. (2007).  Then 245 µl of 12.5 M 
1-methylimidazole (Sigma Aldrich) was added to 9 ml of double distilled water and pH was 
adjusted to 8.0 prior to adding 0.75g EDC. The volume was then adjusted to 24 ml with 
double distilled water. The prepared EDC solution was used to soak a Whatman paper and 
the nylon membrane was placed on top of the membrane wrapped in Saran Wrap and 
incubated at 60°C for 2 h. Pre-hybridisation of the EDC crosslinked membrane was done for 
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one hour at 42°C in DIG Easy Hyb buffer. Membrane was then hybridized with the ACMV-
[NG:Ogo:90] probe at 42°C overnight. Detection of RNA was done according to the DIG 
Northern Starter Kit instruction. Biorad Chemi Doc system was used for chemiluminiscent 
detection by exposing the membrane for 15 min. Band intensity was measured using Quantity 
tool (Biorad Chemi Doc system). The highest siRNA accumulation was set at 100% 
reference. Values of the other siRNA accumulations were expressed as percentages of the 
reference value. 
2.3.12 Yield evaluation 
After 365 dpi three plants from each of the infected CMM6, AMM2 transgenic lines, infected 
untransformed cv.60444, non infected healthy cv.60444 and infected ACMV-[NG:Ogo:90] 
resistant line dsAC1 transgenic line were harvested and root yield evaluated to determine the 
fresh tuber weight. The tubers were dried at 105°C overnight in a dry oven, the next day dry 
tubers weight were measured to determine the percentage dry weight from the fresh weight. 
Student t-test statistical evaluations were done on the root fresh and dry weight to determine 
significant differences between the root yields of infected untransformed type cv.60444 in 
comparison with infected CMM6, AMM2 transgenic lines, non infected untransformed 
cv.60444 and infected ACMV-[NG:Ogo:90] resistant line dsAC1. 
2.4 Results 
Characterisation of transgenic lines 
2.4.1 Southern blot screening for transgene intergration and copy number 
Transgenic lines CMM6 line 2, 3, 5, 6 and 7 as well as AMM2 lines 30, 41, 44, 52, 53 and 54 
were screened for transgene copy number using the Southern blot method. The ACMV-
[NG:Ogo:90] IR PCR amplicon, GUSPLUS PCR amplicon and the hyg PCR amplicon probes 
were successfully labeled (fig 2.2). From the results, the DIG-labeled GUSPLUS and hyg 
probes (fig 2.2 lane b and d, respectively) migrated slower in the gel, as expected, than the 
181 bp and 485 bp unlabeled PCR amplicon (fig 2.2 a lane c, respectively). The DIG labeled 
ACMV IR probes (fig. 2.2 lane f) migrated higher than unlabeled 319 bp ACMV-
[NG:Ogo:90] IR PCR amplicon (fig. 2.2 lane e). 
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Figure 2. 2 1% agarose gel of PCR DIG labeled unmodified ACMV-[NG:Ogo:90] IR, hyg 
and GUSPLUS fragment probes. M= O’GeneRuler 1 kb Plus DNA ladder (Fermentas). DIG-
labeled GUSPLUS probe (lane b) unlabeled GUSPLUS PCR amplicon (lane a) DIG-labeled 
hyg probe (lane d) unlabeled 485 bp hyg fragment (lane c) and unmodified ACMV-
[NG:Ogo:90] IR DIG-probes (lane f) unlabeled 319 bp ACMV-[NG:Ogo:90] IR PCR 
amplicon (lane e) 
Southern blot analysis of double digested DNA from five CMM6 transgenic lines with three 
DIG labeled probes showed that all five lines had a single transgene copy (fig 2.3a). Probing 
of single digested genomic DNA with DIG labeled-hyg showed lines 2, 5 and 6 had a single 
transgene copy, while lines 3 and 7 had two transgene copies (fig. 2.3b). Southern blot results 
from double digested AMM2 genomic DNA probed with ACMV-[NG:Ogo:90] IR DIG 
probe showed that all six lines had a single transgene copy (fig 2.4a). Probing of single 
digested genomic DNA with DIG labeled-hyg showed that lines 41, 44 and 53 had a single 
transgene copy while lines 30, 52 and 54 had a double copy (fig. 2.4b). 
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Figure 2. 3 Southern blot analysis of CMM6 transgenic lines 2, 3, 5, 6 and 7 for transgene 
integration using DIG-labeled probes. M = DIG molecular weight marker (Roche), cv. = non-
infected healthy cv.60444 and +ve C = pC1305.1/CaMV35S- ACMV-[NG:Ogo:90] IR (a) 
HindIII and EcoRI-double digested genomic DNA probed with ACMV-[NG:Ogo:90] IR 
fragment and (b) HindIII-digested genomic DNA, probed with hyg probe 
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Figure 2. 4 Southern blot analysis of AMM2 transgenic lines 30, 41, 44, 52, 53 and 54 for 
transgene integration using DIG-labeled probes. M = DIG molecular weight marker (Roche), 
cv. = non-infected healthy cv.60444 and +ve C = HindIII and EcoRI-double digested 
pTZR5/T containing MM2hp cassette (a) HindIII and EcoRI-double digested genomic DNA 
probed with ACMV-[NG:Ogo:90] IR fragment and (b) HindIII-digested genomic DNA, 
probed with hyg probe. 
2.4.2 PCR of GUSPLUS, hygromycin and virus-derived transgenes 
Positive PCR amplification of hyg, GUSPLUS and ACMV-[NG:Ogo:90] IR fragment 
confirmed successful transgene integration in five CMM6 lines. Positive bands for both the 
181 bp GUSPLUS amplicons and the 485 bp hyg fragments were observed (fig. 2.5b). All the 
five CMM6 lines tested positive for PCR amplification of both the 331 bp XbaI-arm and the 
339 bp XhoI-arm of the ACMV-[NG:Ogo:90] IR construct (fig 2.5a). Positive amplification 
was achieved for the positive plasmid controls while no amplicons were obtained for the 
negative controls, healthy cv.60444 and the non template control (NTC). 
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Figure 2. 5 PCR confirmation of the transgenic status of CMM6 lines. M= O’GeneRuler 1 
kb Plus DNA ladder (Fermentas), (-) = untransformed healthy cv.60444 and +ve = positive 
pC1305.1/CaMV35S- ACMV-[NG:Ogo:90] IR and NTC = non template control. (a) PCR 
amplification of both the 331 bp XbaI-arm and the 339 bp XhoI-arm of the construct ACMV-
[NG:Ogo:90] IR. Lines were screened for (b) 181 bp GUSPLUS fragment; fragment was 
successfully amplified in all lines screened and the 485 bp hyg fragment was detected in all 
lines tested.  
All the six AMM2 lines were positive for both the 181 bp GUSPLUS amplicons and the 485 
bp hyg fragment (fig. 2.5b). Positive amplification was achieved for the plasmid controls 
while no amplicons were obtained for the negative control, namely untransformed healthy 
cv.60444 and the NTC. All the six AMM2 lines tested positive for PCR amplification of the 
337 bp mutated sense-arm but the non mutated 331 bp strand could not be detected (fig 2.5a). 
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Figure 2. 6 1% agarose gel electrophoresis of hyg, GUSPLUS and ACMV-[NG:Ogo:90] IR 
construct PCR amplicons of the six AMM2 transgenic lines 30, 41, 44, 52, 53 and 54. M= 
O’GeneRuler 1 kb Plus DNA ladder (Fermentas), (-) = untransformed healthy cv.60444 and 
+ ve = positive pC1305.1/CaMV35S- ACMV-[NG:Ogo:90]-NOg IR. Lines were screened 
for the (a) 337 bp mutated sense-arm amplicon and the 331 bp non-mutated antisense-arm 
amplicon. (b) 181 bp GUSPLUS gene amplicon and 485 bp hyg gene amplicon 
Screening of transgenic lines for resistance/tolerance or susceptibility at 14, 36, 56 and 
365 dpi 
 
2.4.3 Sampling and symptom monitoring 
A symptom severity score (sss) index (fig. 2.7) was used to evaluate severity based on a scale 
of 0-3 where 0= healthy leaves, 1= mild chlorosis, 2=clear mosaics with or without slight leaf 
deformation, 3= severe mosaics and severe leaf deformation. Differences in symptom scores 
between the infected CMM6, AMM2 transgenic lines, infected untransformed cv.60444 and 
infected ACMV-[NG:Ogo:90] resistant line dsAC1 were statistically evaluated at p= 0.05. 
Values less than this confidence interval were considered significant. P values for the t-tests 
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are in (appendix A and B)
 
Figure 2. 7 Cassava mosaic disease symptomatic leaves from trials in this study. A 0-3 
scoring scale was used for evaluation. Each image represents each score level (0 being 
healthy asymptomatic leaves and 3 being fully symptomatic) 
Symptom severity score (sss) of CMM6 transgenic lines were noticeably lower than those of 
infected untransformed cv.60444 plants at all time points (fig 2.8a). At 14 dpi CMM6 
transgenic lines 2, 3, 6 and 7 had significantly lower (p˂0.05) (Appendix A) symptom 
scores. The sss of the 4 transgenic lines were (3-fold, 2-fold, 1.7-fold and 1.7-fold) lower 
compared with infected untransformed cv.60444. CMM6-5 had a 1.5-fold lower sss 
compared with infected untransformed cv.60444, however there was no significant difference 
(p=0.3433). ACMV-[NG:Ogo:90] resistant transgenic line dsAC1 had significantly lower 
(p=0.001259) sss (3-fold) compared with infected untransformed cv.60444. At 36 dpi, 
transgenic lines CMM6-2 and CMM6-6 had a significantly (p=0.00002 and p=0.0001, 
respectively) lower sss, (2.6 and 2.1-fold, respectively) compared with infected 
untransformed cv.60444. CMM6-5, 7 and 3 also had relatively lower sss (1.2, 1.0 and 1.0-
fold, respectively) compared with infected untransformed cv.60444 however, these results 
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were not significantly different (p˃0.05). At 36 dpi, ACMV-[NG:Ogo:90] resistant line 
dsAC1 had a significantly (p=0.0000183) lower sss (3.2-fold) compared with infected 
untransformed cv.60444. At 56 dpi, CMM6-2 and CMM6-6 sss remained significantly lower 
(p=0.00000129 and p=0.0000397, respectively), (2.9 and 2-fold, respectively) compared with 
infected untransformed cv.60444. CMM6 lines 3, 5 and 7 each had 1.0-fold lower sss but the 
results were not significantly different (p˃0.05). At 56 dpi, ACMV-[NG:Ogo:90] resistant 
line dsAC1 line had a significantly (p= 0.00000221) lower sss (5-fold) compared with 
infected untransformed cv.60444. 
 
Figure 2. 8 Symptom severity score of CMM6 and AMM2 transgenic lines, infected 
untransformed cv.60444 and infected ACMV-[NG:Ogo:90] resistant transgenic line dsAC1 
agro-inoculated with infectious ACMV-[NG:Ogo:90] clones. Plants were evaluated at 14 dpi 
(blue), 36 dpi (red) and 56 dpi (green) (a) CMM6 mean symptom severity scores (b) AMM2 
mean symptom severity score. The measure of uncertainty is measured by displayed error 
bars scaled to 95% confidence level 
Symptom severity scores of AMM2 transgenic lines were also observed to be lower than that 
of infected untransformed cv.60444 (fig 2.8b) at all time points. At 14 dpi, AMM2 transgenic 
lines 30, 44, 52 and 54 had significantly (p<0.05) lower sss (2.5, 1.9, 4.5, and 2.6-fold, 
respectively) compared with infected untransformed cv.60444 (Appendix B). AMM2-41 and 
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53 had lower sss, (1.2 and 1.0-fold, respectively) compared with infected untransformed 
cv.60444, however these results were not significantly different (p=0.2080 and p=0.2997, 
respectively) compared with infected untransformed cv.60444. ACMV-[NG:Ogo:90] 
resistant transgenic line dsAC1 had significant (p=0.0005) lower sss (5-fold) compared with 
infected untransformed cv.60444. 
At 36 dpi, AMM2-52 had significantly (p=0.00001) lower sss (2.4-fold) compared with 
infected untransformed cv.60444. AMM2-30, 44 and 54 has significantly lower sss (p< 0.05), 
(1.5, 1.75 and 1.75-fold) compared with infected untransformed cv.60444. AMM2-41 and 53 
both had 1.0-fold lower sss compared with infected untransformed cv.60444 however, these 
results were not significant (p=0.2745 and p=0.1297, respectively). At 36 dpi, ACMV-
[NG:Ogo:90] resistant transgenic line dsAC1 had significantly (p=0.000001) lower sss (4.5-
fold) compared with infected untransformed cv.60444. At 56 dpi, AMM2-52 and 44 had a 
significantly (p=0.0006 and p=0.0109, respectively) lower sss, (2-fold and 1.4-fold, 
respectively) compared with infected untransformed cv.60444. AMM2-53 and 54 both had a 
1.0-fold lower sss whilst lines 30 and 41 had a 1.2 and 1.4-fold lower sss, respectively; 
however, these results were not significantly different (p˃0.05). 
2.4.3 Real time absolute quantitative PCR of viral load 
Viral load accumulation in infected CMM6 and AMM2 transgenic lines, infected 
untransformed cv.60444 and infected ACMV-[NG:Ogo:90] resistant transgenic line dsAC1 
were determined by real time absolute quantitative PCR using DNA from leaves extracted at 
36 and 56 dpi.  
For CMM6 lines, at 36 dpi CMM6-2 and CMM6-6 had significantly (p=0.030282 and 
p=0.0304), lower viral load (918 and 313-fold, respectively) compared with infected 
untransformed cv.60444 (fig 2.9a). Transgenic lines 3, 5 and 7 had 1.6, 6.8 and 2.6-fold 
lower viral load, respectively, compared with infected untransformed cv.60444 however 
these results were not significantly different (p>0.05) (Appendix A) from infected 
untransformed cv.60444. At 36 dpi, ACMV-[NG:Ogo:90] resistant transgenic line dsAC1 
had significantly lower viral load (p=0.0302) which was 4117-fold lower compared with 
infected untransformed cv.60444. At 56 dpi, CMM6-2 and CMM6-6 viral load (6149 and 
2327-fold, respectively), remained significantly lower (p=0.0462 and p=0.0462, 
respectively), compared with infected untransformed cv.60444. Transgenic lines 3, 5 and 7 
had lower viral load (1.0, 0.1 and 1.8-fold, respectively) compared with infected 
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untransformed cv.60444 however, these results were not significantly different (p>0.05) from 
infected untransformed cv.60444. ACMV-[NG:Ogo:90] resistant transgenic line dsAC1 had 
significantly lower (p=0.0462) viral load (9633-fold) compared with infected untransformed 
cv.60444. 
 
Figure 2. 9 Viral load of CMM6 and AMM2 transgenic lines, infected untransformed 
cv.60444 and infected ACMV-[NG:Ogo:90] resistant transgenic line dsAC1 agroinoculated 
with infectious ACMV-[NG:Ogo:90] clones. Plants were evaluated at 36 dpi (blue), 56 dpi 
(red) for (a) CMM6 mean absolute viral load quantification (mean viral molecules/g DNA) 
(b) AMM2 mean absolute viral load quantification (mean viral molecules/g DNA). The 
measure of uncertainty is measured by displayed error bars scaled to 95% confidence level 
For AMM2 lines, at 36 dpi AMM2-52 has significantly lower (p=0.0338) viral load (278-
fold) compared to infected untransformed cv.60444 (fig 2.9b). Transgenic lines AMM2-30, 
41, 44, 53 and 54 had 3.4, 1.4, 0.9, 5.8 and 3.6-fold lower viral load, respectively, compared 
with infected untransformed cv.60444, however these results were not significantly different 
(p>0.05) (Appendix B) from infected untransformed cv.60444. At 36 dpi ACMV-
[NG:Ogo:90] resistant transgenic line dsAC1 had significantly (p=0.0335) lower viral load 
(4657-fold) compared with infected untransformed cv.60444. At 56 dpi, AMM2-52 and 41 
had significantly lower (p=0.321 and p=0.0349, respectively) viral load (963 and 31.6-fold 
respectively) compared with infected untransformed cv.60444. Transgenic lines AMM2-30, 
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44, 53 and 54 had 5.1, 5.2, 2.1 and 2.8-fold lower viral load respectively, compared with 
infected untransformed cv.60444 however, these results were not significantly different 
(p>0.05) from infected untransformed cv.60444. At 56 dpi ACMV-[NG:Ogo:90] resistant 
transgenic line dsAC1 had significantly (p=0.0320) lower viral load (3,575-fold) compared 
with infected untransformed cv.60444. 
2.4.4 Plant height evaluation 
Plant height evaluation for infected CMM6 transgenic lines, infected untransformed 
cv.60444 and ACMV-[NG:Ogo:90] resistant transgenic line dsAC1 was measured at 14, 36 
and 56 dpi. There were no significant differences between the height of CMM6 transgenic 
lines and that of infected untransformed cv.60444 controls (fig 2.10a). At 14 dpi, CMM6-2, 
3, 5 and 6 had significantly lower average height (p< 0.05) compared with infected 
untransformed cv.60444. Only CMM6-7 (p=0.06) had an average height that was not 
significant lower compared with infected untransformed cv.60444. At 36 and 56 dpi no 
significant difference (p>0.05) in mean plant height were recorded for all CMM6 transgenic 
lines and ACMV-[NG:Ogo:90] resistant transgenic line dsAC1 compared with infected 
untransformed cv.60444 (Appendix A). 
For AMM2 transgenic lines, at 14 dpi AMM2-53 mean plant height was significantly lower 
(p=0.0171) compared with infected untransformed cv.60444 whilst AMM2-30, 41, 44, 52 
and 54 had an average height that was not significantly different (p>0.05) to infected 
untransformed cv.60444 (fig 2.10b). At 36 and 56 dpi no significant difference in mean plant 
height were recorded for all AMM2 transgenic lines and ACMV-[NG:Ogo:90] resistant 
transgenic line dsAC1 (p>0.05) compared with infected untransformed cv.60444 (Appendix 
B). 
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Figure 2. 10 Height evaluations for CMM6 and AMM2 transgenic lines, infected 
untransformed cv.60444 and infected ACMV-[NG:Ogo:90] resistant line dsAC1. Plants were 
evaluated at 14 dpi (blue), 36 dpi (red) and 56 dpi (green) (a) CMM6 mean average height 
(b) AMM2 mean average height. The measure of uncertainty is measured by displayed error 
bars scaled to 95% confidence level 
Evaluation of CMM6 and AMM2 transgenic lines at 365dpi 
2.4.5 Symptom score and viral load 
CMM6 transgenic lines were evaluated at 365 dpi. Transgenic lines CMM6-2 and CMM6-6 
were asymptomatic. ACMV-[NG:Ogo:90] resistant line dsAC1 was also asymptomatic. 
CMM6-7 had mild symptoms whilst CMM6-3 and cv.60444 had similar symptoms to those 
recorded at 56 dpi (fig 2.8a). Viral load of these transgenic lines were also quantified and we 
observed that the viral loads had decrease from those recorded at 56 dpi. For transgenic lines 
CMM6-2, 3, 5, 6 and 7 there was a 44, 13.7, 13.2, 116 and 79.3-fold decrease, respectively, 
in viral load from 56 dpi to 365 dpi (fig 2.11a). Infected untransformed cv.60444 and 
ACMV-[NG:Ogo:90] resistant transgenic lines dsAC1 had a 4.4 and 20.9 fold decrease, 
respectively, in viral load from 56 dpi to 365 dpi. At 365 dpi, the viral load of CMM6-2 and 
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CMM6-6 (60,602 fold) remained significantly lower (p=0.04695 and p=0.04695, 
respectively) compared with infected untransformed cv.60444. Transgenic lines 3, 5 and 7 
had 3.2, 6.5 and 32.7 fold lower viral load compared with infected untransformed wild type 
cv.60444 however, these results were not significant (p>0.05) (Appendix F) from infected 
untransformed cv.60444. ACMV-[NG:Ogo:90] resistant line dsAC1 had significantly 
(p=0.046951) lower viral load (44,243 fold) compared with infected untransformed cv.60444. 
 
Figure 2. 11 Mean ACMV viral molecules/g of DNA at 365 dpi compared to mean viral 
molecules/g of DNA at 56 dpi, quantified using real time absolute qPCR, (a) ACMV infected 
CMM6 transgenic lines, infected untransformed cv.60444 and infected ACMV-[NG:Ogo:90] 
resistant transgenic line dsAC1 (b) ACMV infected AMM2 transgenic lines, infected 
untransformed cv.60444 and infected ACMV-[NG:Ogo:90] resistant line dsAC1 transgenic 
line. The measure of uncertainty is measured by displayed error bars scaled to 95% 
confidence level 
Transgenic lines AMM2-41, AMM2-52 and AMM2-44 were asymptomatic at 365 dpi. 
Resistant line dsAC1 was also asymptomatic. AMM2-30, 53 and 54 has mild symptoms 
whilst infected untransformed cv.60444 had similar symptoms to those recorded at 56 dpi (fig 
2.8b). Viral loads of transgenic lines, infected untransformed cv.60444 and infected ACMV 
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resistant transgenic line dsAC1 had decreased from those recorded at 56 dpi. For transgenic 
lines AMM2-30, 41, 44, 52, 53 and 54 there was a 1.1, 197, 2.2, 20, 2 and 1.2-fold decrease, 
respectively, in viral load from 56 dpi to 365 dpi (fig 2.11b). Controls, infected 
untransformed cv.60444 and infected ACMV-[NG:Ogo:90] resistant transgenic line dsAC1 
had a 2.4 and 21.5-fold decrease respectively, from 56 dpi to 365 dpi. At 365 dpi, AMM2-41 
and AMM2-52 had a significantly (p=0.0490 and p=0.0490, respectively) lower viral load 
(2,518 and 7,882-fold, respectively) compared with infected untransformed cv.60444 viral 
load. Transgenic lines AMM2-30, 44, 53 and 54 had a 2.3, 4.6, 1.8 and 1.4-fold lower viral 
load compared with infected untransformed cv.60444 however, these results were not 
significantly different (p>0.05) (Appendix F) from infected untransformed cv.60444. Viral 
load of ACMV-[NG:Ogo:90] (31,051-fold) was significantly lower (p=0.0490) compared 
with infected untransformed cv.60444. 
2.4.6 Yield evaluation 
At 365 dpi, three plants per each of the CMM6 or AMM2 transgenic lines, infected 
untransformed cv.60444, non-infected healthy cv.60444 and ACMV-[NG:Ogo:90] resistant 
transgenic line dsAC1 were harvested. The tubers yields were weighed to determine fresh 
weight (fig 2.12). The same tubers were then dried at 105°C overnight in a dry oven and the 
dry tuber yield was measured. The percentage tuber dry weight was calculated from the tuber 
fresh weight. Fresh and dry weights (grams) are the average of three tubers per line. 
 
Figure 2. 12 Pictorial representation of the tuber exhibiting the highest yield from each of the 
CMM6 trangenic lines 2, 3, 5, 6 and 7, infected untransformed cv.60444, non-infected 
healthy cv.60444 and infected ACMV-[NG:Ogo:90] resistant transgenic line dsAC1 
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Figure 2. 13 Pictorial representation of the tuber exhibiting the highest yield from each of the 
AMM2 trangenic lines 30, 41, 44, 52, 53 and 54, infected untransformed cv.60444, non-
infected healthy cv.60444 and ACMV-[NG:Ogo:90] resistant transgenic line dsAC1 
From the non mismatched CMM6 yield evaluation, non-infected healthy cv.60444 had the 
highest average tuber fresh weight of 39.4g (fig 2.14a). For the transgenic CMM6 lines, 
CMM6-2 and CMM6-6 had an average fresh weight (34.4 and 20.2 g, respectively) that were 
lower but not significantly different (p˃0.05) (Appendix E) from the fresh weight of non-
infected healthy cv.60444. CMM6-3, 5 and 7 had average fresh weights of 5.5, 10.3 and 6.6 
g, respectively, and the results were significantly lower (p˂0.05) from the fresh weight of 
non-infected healthy cv.60444. Infected untransformed cv.60444 weighed on average 8 g and 
these results were significantly lower (p=0.0309) from the fresh weight of non-infected 
healthy cv.60444. There was a 3.5 fold difference in average fresh weight between non-
infected healthy cv.60444 and its infected counterpart. ACMV-[NG:Ogo:90] resistant 
transgenic line dsAC1 had an average fresh weight of 35.4 g and these results were lower but 
not significantly different (p=0.1686) (Appendix E) from the fresh weight of non-infected 
healthy cv.60444. The average percentage tuber dry weight of transgenic lines CMM6-2, 3, 5, 
5 and 7 were 38, 38, 37, 39 and 36%, respectively, (fig 2.15a). Infected untransformed 
cv.60444 and non-infected healthy cv.60444 had an average of 38 and 39% tuber dry weight, 
respectively. ACMV-[NG:Ogo:90] resistant dsAC1 transgenic lines had an average tuber dry 
weight of 39%. 
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From the mismatched AMM2 trial, non-infected healthy cv.60444 had the highest average 
fresh weight of 40.5g (fig 2.14a). AMM2-41 and 52 tubers weighed on average 33.4 and 33.6 
g, respectively. Fresh weight from these two lines were lower but not significantly different 
(p=0.1872 and p=0.1893) (Appendix E) from the fresh weight of non-infected healthy 
cv.60444. Transgenic lines AMM2-30, 44, 53 and 54 had 20.9, 22.5, 15.1 and 16.1 g fresh 
weights, respectively, and these results were significantly lower (p˂0.05) compared with the 
average fresh weight of non-infected healthy cv.60444. Infected untransformed cv.60444 had 
average fresh weight of 9.3 g which was significantly lower (p=0.0055) (4.3-fold) compared 
with the average fresh weight of non-infected healthy cv.60444. ACMV-[NG:Ogo:90] 
resistant transgenic lines dsAC1 had an average fresh weight of 37.2 g which was lower but 
not significantly different (p=0.3687) compared with the average fresh weight (40.5 g) of 
non-infected healthy cv.60444. The average percentage tuber dry weights of transgenic lines 
AMM2-30, 41, 44, 52, 53 and 54 was 37.4, 38, 37, 37.7, 36.9 and 38 %, respectively (fig 
2.15b). Tubers from non-infected healthy cv.60444 and infected untransformed cv.60444 had 
a 37.9 and 38% tuber dry weight, respectively. ACMV-[NG:Ogo:90] resistant dsAC1 
transgenic tubers had a 38.5 % average tuber dry weight. 
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Figure 2. 14 Mean tuber fresh weight (blue) and mean tuber dry weight (red) of (a) CMM6 
transgenic lines, infected untransformed cv.60444, non-infected healthy cv.60444 and 
infected ACMV-[NG:Ogo:90] resistant transgenic line dsAC1 (b) AMM2 transgenic lines, 
infected untransformed cv.60444, non-infected healthy cv.60444 and infected ACMV-
[NG:Ogo:90] resistant transgenic line dsAC1. The measure of uncertainty is measured by 
displayed error bars scaled to 95% confidence level 
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Figure 2. 15 Mean percentage tuber dry weight of (a) CMM6 and (b) AMM2 trial lines, 
infected untransformed cv.60444, non-infected healthy cv.60444 and ACMV-[NG:Ogo:90] 
resistant transgenic line dsAC1. The percentage was calculated from the difference between 
the tuber fresh weight and dry weight. The measure of uncertainty is measured by displayed 
error bars scaled to 95% confidence level 
 
Small interfering RNA evaluation of trial plants  
2.4.7 RNA extraction 
High quality RNA was extracted using the QIAzol method and the integrity of the RNA was 
checked on a 1.2% agarose gel containing 10 µg/μl ethidium bromide run in 0.5X TBE. The 
results show that high quality RNA was successfully extracted from pre-inoculated CMM6, 
AMM2 lines and non-infected healthy cv.60444 (fig 2.16). RNA was also extracted from 
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infected CMM8, AMM4 transgenic lines, infected untransformed cv.60444 and non-infected 
untransformed cv.60444. 
 
Figure 2. 16 1.2% agarose gel electrophoresis of total RNA extracted from (a) CMM6 
transgenic lines 2, 3, 5, 6, 7, non-infected healthy cv.60444. (b) AMM2 transgenic lines 30, 
41, 44, 52, 53, 54 and non-infected healthy cv.60444 
2.4.8 T-DNA expression results 
Total RNA (2.4.7) was used to synthesise cDNA using Random hexamers and OligodT 
primers. The cDNA was used as template for RT-PCR amplification of hyg (485 bp), 
GUSPLUS (181 bp) and ACMV-[NG:Ogo:90] IR to check for expression levels. RT-PCR of 
the cDNA from transgenic lines resulted in successful amplification of the GUSPLUS and 
hyg in both mismatched AMM2 lines (fig 2.17d) and non-mismatched CMM6 transgenic 
lines (fig 2.17c). As expected no amplicons were detected in non-infected healthy cv.60444, 
and the PCR amplification reaction controls were positive for both GUSPLUS and hyg. 
Complementary-DNA from CMM6 and AMM2 lines was successful amplified yielding the 
331 bp CMM6 XbaI and 339 bp CMM6 XhoI (fig 2.17a) fragments. The CMM6 arms were 
strongly amplified as seen by comparison with amplification of endogenous ubiquitin gene 
(fig 2.17ai). AMM2 lines showed low expression of the 337 bp mutated sense arm (fig 2.17b) 
compared to the amplification of endogenous ubiquitin gene (fig 2.17bi). The non-mutated 
antisense arm (331 bp) fragment of the AMM2 hairpin construct could not be amplified from 
cDNA even though the positive control plasmid was amplified (gel not shown) 
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Figure 2. 17 RT-PCR amplification of transgene sense arm, GUSPLUS and hyg genes from 
CMM6, AMM2 and non-infected healthy cv.60444 negative control. M= O’GeneRuler 1 kb 
Plus DNA ladder (Fermentas). cv. = non-infected healthy cv.60444 negative control. + = 
positive control transgene plasmid (a) amplication of CMM6 transgenic lines sense arm (ai) 
amplification of endogenous ubiquitin gene from CMM6 cDNA (b) amplification of AMM2 
transgenic lines mutated sense arm (bii) amplification of endogenous ubiquitin gene from 
AMM2 cDNA (c) amplification of 181 bp GUSPLUS and 485 bp hyg from CMM6 transgenic 
lines cDNA (d) amplification of 181 bp GUSPLUS and 485 bp hyg from AMM2 transgenic 
lines cDNA 
2.4.9 Northern blot detection of siRNA 
Africa cassava mosaic virus-[Nigeria:Ogorocco;1990] AC1/4:AC2/3 IR RNA was labeled 
using Northern Starter Kit (Roche). For siRNA control, an Arabidopsis 21 nt miR167 (5-
’TAGATCATGCTGGCAGCTTCA-3’), oligonucleotide was 3’end labeled. For size marker 
a 24 nt primer (5’-TTCAGGAGCCTCCGCCTGTCT-3’) and a 30 nt positive control from 
the kit were 3’ end tail labeled using DIG Oligonucleotide Tailing Kit 2nd generation (Roche). 
The labeling results showed successful labeling of the ACMV-[NG:Ogo:90] AC1/4:AC2/3 
IR RNA, siRNA control and size marker oligonucleotide (fig 2.13). The labeled RNA and 
short oligonucleotides were detected at low concentrations of 10 ng/µl and 1 ng/µl. 
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Figure 2. 18 Determination of the DIG labeling efficiency on (a) ACMV-[NG:Ogo:90]  
AC1/4:AC2/3 IR sense arm (b) ACMV-[NG:Ogo:90] AC1/4;AC2/3 antisense arm (a) a 
Northern Starter Kit (Roche) labeled RNA control.(d) labeled DIG oligonucleotide tailing kit 
2
nd
 generation (Roche) 30 nt control (d) labeled 24 nt oligonucleotide and (e) labeled 21 nt 
Arabidopsis mi167 
Africa cassava mosaic virus-[Nigeria:Ogorocco;1990] AC1/4:AC2/3 IR-derived siRNA 
molecules accumulation were detected at varying levels (based on semi quantitative relative 
band intensity comparison) (Biorad Chemi Doc Quantity tool) in CMM6 (fig 2.14a) and 
AMM2 transgenic lines prior to infection (fig 2.14b). Using the siRNAs at the highest 
concentration being equal to 100%, CMM6-2, 3, 5, 6 and 7 had a 65%, 49%, 87%, 54% and 
100% accumulation, respectively. Using the siRNAs at the highest concentration being equal 
to 100%, AMM2-30, 41, 44, 52, 53 and 54 had a 12%, 89%, 100%, 12%, 58% and 44% 
accumulation, respectively. Non-infected healthy cv.60444 did not produce siRNAs as 
expected. Loading control miRNA 167 was detected in CMM6 (fig 2.14ai) and AMM2 
transgenic lines (fig 2.14bi) after stripping of the ACMV-[NG:Ogo:90] AC1/4:AC2/3 IR. 
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Figure 2. 19 Northern blot siRNA detection (a) CMM6 transgenic lines and healthy 
cv.60444 probed with DIG-labeled ACMV-[NG:Ogo:90] IR derived probe (b) AMM2 
transgenic lines and healthy cv.60444 probed with DIG-labeled ACMV-[NG:Ogo:90] IR 
derived probe. (ai) CMM6 and (bi) AMM2 transgenic lines and healthy cv.60444 probed 
with DIG labeled Arabidopsis miRNA 167 probe. The percentage numbers above represent 
relative accumulation levels of the siRNAs 
At 365 dpi, ACMV-[NG:Ogo:90] infected CMM6 lines still produced small nucleotides 
approximately 21 nt bases in size. Using the siRNAs at the highest concentration being equal 
to 100%, CMM6-2, 3, 5, 6 and 7 had a 51%, 34%, 94%, 24% and 100% accumulation, 
respectively. Infected untransformed cv.60444 produced siRNAs of approximately 21 nt 
bases in size (6.4%) (fig 2.20a) whilst non-infected healthy cv.60444 did not produce 
siRNAs. At 365 dpi, ACMV-[NG:Ogo:90] infected AMM2 lines still produced small 
nucleotides 21 nt bases in size. Using the siRNAs at the highest concentration being equal to 
100%, AMM2-30, 41, 44, 52, 53 and 54 had a 46%, 31%, 60%, 50%, 100% and 93% 
accumulation, respectively. Infected untransformed cv.60444 produced siRNAs 21 nt bases 
in size (55%) whilst non-infected healthy cv.60444 did not produce siRNAs. 
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Figure 2. 20 Northern blot for siRNA detection (a) CMM6 transgenic lines, infected 
untransformed cv.60444 and non-infected healthy cv.60444 probed with DIG labeled 
ACMV-[NG:Ogo:90] IR derived probe (b) AMM2 transgenic lines, infected untransformed 
cv.60444 and non-infected healthy cv.60444 probed with DIG labeled ACMV-[NG:Ogo:90] 
IR derived probe. (ai) CMM6 and (aii) AMM2 transgenic lines and controls probed with DIG 
labeled Arabidopsis miRNA 167 probe. The percentage numbers above represent relative 
accumulation levels of the siRNAs 
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2.5 Discussion 
 
The application of RNA silencing to plant disease resistance is well documented (Reviewed 
in Duan et al., 2012; Kumar and Sarin, 2013; Prins et al., 2008). Introduction of DNA 
sequences or segments of viral genes leads to resistance or tolerance by sequence- specific 
binding of virus transgene-derived siRNA to the homologous infecting viral mRNA, and 
subsequent degradation. The objective of this study was to evaluate the tolerance, resistance 
or susceptibility of cassava cv.60444 transformed with a mismatched or non-mismatched 
inverted repeat (IR) transgene targeting two overlapping ORFs, namely the Rep/VSR 
(AC1/4) and TrAP/Ren (AC2/3), and to compare the efficiency of both mismatched and non-
mismatched. In both our CMM6 and AMM2 trials the transgenics symptom severity was 
observed to be lower than that of infected untransformed cv.60444 at the symptomatic stage 
(36d pi) and the recovery stage (56 dpi). A few of these transgenic lines showed mild 
symptoms and such lines with reduced symptoms in the presence of viral replication are 
termed tolerant (Bengyella et al., 2015; Lapidot and Friedman, 2002). Resistance implies no 
detection of virus replication and absence of symptoms. Notably, in the two trials we 
identified tolerant lines CMM6-2, CMM6-6 and AMM2-52 with significantly lower 
symptom severity scores in comparison with infected infected untransformed cv.60444. 
However, these three lines, while exhibiting milder symptoms compared with non-transgenic 
plants, displaced more severe symptoms than the positive ACMV-[NG:Ogo:90] dsAC1 
resistant line engineered by Vanderschuren et al. (2009). Notably, at 36 and 56 dpi CMM6-2, 
CMM6-6 and AMM2-52 had significantly lower viral load compared with infected 
untransformed cv.60444. A positive Pearson correlation was established in CMM6 and 
AMM2 trials between sss and viral load. CMM6 lines had a positive Pearson coefficient of 
0.94 at 36 dpi and positive Pearson coefficient of 0.95 at 56 dpi (Appendix G). AMM2 lines 
had a positive Pearson coefficient of 0.25 at 36 dpi and 0.59 at 56 dpi. It is generally accepted 
that a positive correlation occurs between sss and viral load. Vanderschuren et al. 2009 report 
attenuated symptoms of dsAC1 transgenic lines correlated with viral titre levels in the leaves. 
The difference between resistance reported in ACMV-[NG:Ogo:90] dsAC1 transgenic line 
engineered by Vanderschuren et al. (2009) and our study may be contributed to the different 
viral sequence regions (IR) introduced into cv.60444. Constructs from both studies were 
hairpin/IR constructs which has been shown to be efficient in RNA virus–model plant 
systems (Smith et al., 2000) and other geminivirus-plant systems (Pooggin et al., 2003; 
62 
 
Vanitharani et al., 2003). Our ACMV-[NG:Ogo:90] IR targeted 5’ AC1/AC4 and AC2/AC3 
overlaping sequence whilst the dsAC1 transgenic plants express an IR ACMV-[NG:Ogo:90] 
AC1/Replication–associated protein (Rep) sequence (154 bp) from nt position 1690 to 1844 
(Vanderschuren et al., 2009). Geminivirus resistance has been reported in transgenic plants 
expressing intron dRNA IRs (hairpins) homologous to Rep/AC1 (Ammara et al., 2015; 
Fuentes et al., 2006; Ye et al., 2014). Rep/AC1 is essential for geminivirus replication 
(Hanley-Bowdoin et al., 2000). The transgene used in this study was a stacked construct 
against 4 ORFs, namely AC1/Rep, AC4/putative VSR, AC2/TrAP, and AC3/Ren which has 
not been reported in cassava begomovirus resistance studies to date. Stacking of genes in 
transgenic plants could be a more viable method to induce broad spectrum durable resistance 
against diseases (Zhu et al., 2012). We expected that the generation of a large number of 
siRNAs targeting multiple ORFs on the ACMV viral DNA A genome would result in more 
effective resistance than the dsAC1 line, but this was not the case. Our results were however 
more consistant with previous attempts to engineer resistance in cassava against ACMV-
associated CMD by Vanderschuren et al. (2007). Vanderschuren et al. (2007) noted 
attenuated symptoms but not resistance in two out of three cv.60444 lines transformed with 
ACMV common region viral sequence. Differences in RNA silencing efficiency could be due 
to other factors such as dosage of challenging virus inoculum or method of virus challenge. In 
this study we used Agrobacterium LB4404-mediated delivery of infectious clones while 
Vanderschuren et al. (2009) attempted biolistics and Agrobacterium LB4404 and achieved 
varying levels of success with different dosages. 
Interestingly, at 56 dpi AMM2-41 had a significantly lower viral load compared with infected 
untransformed cv.60444 when previously at 36 dpi its viral load was not significantly 
different to that of infected untransformed cv.60444 (fig 2.9). This could be a consequence of 
plant recover from viral infection. Recovery from viral infection and tolerance in non-
transgenic geminivirus-infected plants had been demonstrated (Gongora-Castillo et al., 2012; 
Sahu et al., 2010). In cassava, tolerance and recovery in TME landrace post-SACMV 
infection has been demonstrated (Allie et al., 2014; Bengyella et al., 2015), and since cassava 
is perennial, transgenic resistance via basal immunity i.e. RNA silencing may be only one of 
many complex interacting factors throughout the growth stages of the crop. The role of 
resistance genes in tolerance and recovery has been demonstrated (Bengyella and Rey, 2014), 
and the interaction between RNA silencing and other immunity related pathways needs 
further study. This prompted us to evaluate the plants for tolerance after an extended period 
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of time. CMM6 and AMM2 transgenic lines were evaluated at 365 dpi. Notably, transgenic 
lines CMM6-2, CMM6-6, AMM2-41, AMM2-52 and AMM2-44 were asymptomatic. 
ACMV-[NG:Ogo:90] resistant line dsAC1 was also asymptomatic. CMM6-7, AMM2-30, 53 
and 54 has mild symptoms whilst CMM6-3 and cv.60444 had similar symptoms to those 
recorded at 56 dpi. The viral load of these infected transgenic lines CMM6-2, 3, 5, 6 and 7, 
infected untransformed cv.60444 and ACMV-[NG:Ogo:90] resistant dsAC1 transgenic line 
had decrease from those recorded at 56dpi (fig.2.11a). For AMM2 transgenic lines AMM2-
30, 41, 44, 52, 53 and 54, infected untransformed cv.60444 and ACMV-[NG:Ogo:90] 
resistant dsAC1 transgenic lines’ viral load had decrease from those recorded at 56 dpi (fig 
2.11b). The recovery of CMM6-2, CMM6-6, AMM2-41, AMM2-52 and AMM2-44 
transgenic lines could be attributed to several factors such as temperature, light intensity, 
siRNA production or other basal immunity associated genes. Since the plants were moved to 
the greenhouse with higher temperature and light intensity after 56 dpi these two factors may 
have contributed to recovery. Light intensity was also shown to play a role in siRNA 
accumulation. Patil and Fauquet (2014) showed that N. bethamiana infected with cassava 
mosaic virus showed recovery at high light intensity of ≥600 μE/m2/s compared with low 
light intensity of 150 μE/m2/s. Challappan et al. (2005) reported on the effect of temperature 
on transgene mediated silencing. At 30°C they reported a higher accumulation of viral 
derived siRNAs compared with lower temperatures of 25°C in transgenic cassava, as a result 
there were significantly lower symptom severity compared with plants grown at 25°C. It has 
been reported that low temperature inhibits RNA silencing-mediated defense by the control 
of siRNA generation (Szittya et al., 2003). 
Detection of siRNAs is a key component to determining the role of the trangene in inducing 
PTGS and the resulting resistance. Prior to infection all CMM6 and AMM4 transgenic lines 
produced transgene derived siRNA in varying levels. Kalantidis et al. (2002) showed that 
presence of siRNAs prior to infection plays an important role in the plants defence against 
viruses. From our results, surprisingly, transgenic lines CMM6-2, CMM6-6 and AMM2-52 
that exhibited tolerance did not have the highest siRNA accumulation levels compared with 
the other transgenic lines but instead there was high variability in accumulated levels (Fig 
2.9). Even after infection we could not find a positive relation between siRNAs produced and 
viral tolerance. This contradicts reports were the presence of virus specific RNA were shown 
to correlate with viral resistance (Chen et al., 2004; Hilly et al., 2005; Vanderschuren et al., 
2009). However it has also been shown that the presence of transgene specific siRNA prior to 
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infection does not always correlate with virus resistance (Noris et al., 2004; Ribeiro et al., 
2006). This was the case in our transgenic lines. Small interfering RNAs were detected in 
infected untransformed cv.60444, clearly shows that PTGS was intiated. Ntui et al. (2015) 
suggested that in infected untransformed cassava although siRNAs were being produced the 
virus was replicating faster and overcoming the plant natural defence mechanism. This was 
clearly the case for the infected untransformed cv.60444 in this research. While there was a 
decrease in ACMV-[NG:Ogo:90] infected untransformed cv.60444 viral load at 365 dpi (fig 
2.11a and b), it was not sufficient to confer resistance, but was likely due to some level of 
tolerance triggered under high temperatures and light intensity. Certainly the generation of 
vsiRNAs targeting the virus genome occurs in susceptible plants such as Arabidopsis infected 
with cabbage leaf curl virus (Aregger et al., 2012) and susceptible cassava landrace T200 
infected with SACMV (Rogans et al., 2016), but this is not effective in establishing 
resistance. The movement of the siRNA signal, timing of siRNA induction and other 
interacting factors play a role. Our findings suggest that the transgene-derived siRNAs 
detected in CMM6 and AMM2 transgenic lines prior to infection enhanced the decrease in 
virus replication while the siRNA production post infection in non-transgenic infected 
cv.60444 was not effective. The variation in CMM6 and AMM2 transgene siRNAs 
accumulation in relation to the viral tolerance or reduction appears to depend on more than 
just siRNAs accumulation. It is possible that the quality and specific target of siRNAs 
produced rather than the quantity could be the key difference between tolerant and non-
tolerant lines. While the generation of siRNAs can be predicted by software programs such as 
pssRNAit (http://plantgrn.noble.org/pssRNAit/) and certain siRNA targets on the viral 
genome desired, natural siRNA hotspots occur and these are variable and depend on multiple 
factors (Sharma et al., 2014). 
The transgenic plants showed normal height in comparison with infected untransformed 
cv.60444. No significant differences were observed between the height of CMM6, AMM2 
transgenic lines and that of untransformed cv.60444 (fig 2.10). There have been reports of 
reduced growth in transgenic plants linked to the insertion of a transgene for example 
Jorgensen et al. (2005) reported reduced growth in cassava engineered to block cytochrome 
biosynthesis pathway. This however was not the case with our CMM6 and AMM2 transgenic 
as their height was not affected by insertion of the IR. This is due to successful integration 
and non-disruption of existing growth related genes by insertion of the transgene. Our four 
promising tolerant transgenic lines CMM6-2, CMM6-6, AMM2-52 and ACMV-
[NG:Ogo:90] resistant line dsAC1 did not show reduction in average fresh tuber yield. The 
65 
 
average tuber yield was not significantly different between these lines and non-infected 
healthy cv.60444. The tubers from other transgenic lines and infected untransformed 
cv.60444 were significantly lower compared with non-infected healthy cv.60444. Indeed, 
CMD has been reported to result in yield loss (Legg et al., 2011; Patil and Fauquet, 2009) and 
these results further confirm their observations. Yields loss would be due to the physiological 
damage that the virus has on the plant and as expected the tolerant lines would not be affected 
as severely. Severe CMD symptoms result in reduced leaf size and this would greatly reduce 
the movement of nutrients from the leaves to the tuberous roots (Cock, 1976; Veltkamp, 
1985). Our results demonstrate that our tolerant transgenic lines would be of benefit to 
farmers in terms of yield output. Perhaps of importance to agro-processors and industrial use 
is the cassava tuber dry weight. From our tuber dry weight results we observed that the 
percentage tuber dry weight did not differ significantly between CMM6, AMM2 transgenic 
lines, infected untransformed cv.60444, non-infected healthy cv.60444 and ACMV-
[NG:Ogo:90] resistant line dsAC1. The percentage tuber dry weight these transgenic lines 
and controls was between 35% and 39% (fig 2.15). Our results were similar to these reported 
by Edah-Djedji et al. (2012) of 31.17-39.83%, 37.60-42.99%, 31.54-38.70% and 31.24-
39.04% percentage  tuber dry weight in non-infected healthy cassava. A good cassava harvest 
has percentage tuber dry weight that ranges from 30% to 40% (Braima et al., 2000; Teye et 
al., 2011). For agro-processing of cassava, the dry starch content is important, and water is 
removed in the process.  Dry matter includes starch content which is important. Therefore 
both parameters were measured. These results showed that the ACMV-[NG:Ogo:90] IR 
transgene in CMM6 and AMM2 lines did not interfere with root formation. 
 
Transgene constructs with self complementary sense and antisense strands (IR or hairpins) 
have been proven to be more efficient PTGS inducers as opposed to either sense or antisense 
strategies (Wang et al., 2008; Waterhouse et al., 1998). AMM2 and CMM6 lines both 
express the same IR transgene sequence targeting AC1/AC4:AC2/AC3 of ACMV-
[NG:Ogo:90], but CMM6 transgenic lines are a result of genetic engineering of cassava 
cv.60444 with a transformation cassette that has a 767 base pair intron separating the sense 
and antisense arms of the IR transgene (non-mismatched construct), while AMM2 lines base 
mutations were introduced to the sense arm only and instead of an intron a small spacer loop 
23 bp was used (mismatched construct) (Moralo, 2015). Previously Smith et al. (2000) 
observed PTGS success when a spacer loop was used to separate two arms of the transgene, 
and ACMV resistance in cassava was reported with a smaller intron 85 bp (Vanderschuren et 
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al., 2009). Exclusion of the intron in mismatched contructs was meant to reduce the size of 
the construct, and stabilize the IR for cloning and transformation (Rey et al., 2015). Taylor et 
al. (2012) went further to introduce mismatches in the sense arm of the SACMV BC1 
transgene arms separated by a small spacer. Introduction of this mismatched construct in 
model plant Nicotiana benthamiana resulted in reduced SACMV multiplication upon 
infection. However, a direct comparison between mismatched and non-mismatched 
constructs were to date not performed and was one of the objectives of this study. We 
predicted that both our mismatched and non-mismatched construct would induce resistance to 
ACMV-[NG:Ogo:90] however we only managed to identify two CMM6 lines and one 
AMM2 line that had symptom severity and viral loads which were significantly lower in 
comparison with infected untransformed cv.60444. This was observed in three independent 
trials, those in this study and previously (Moralo, 2015). However, the two tolerant CMM6 
lines-2 and 6 appeared to perform better (viral load) compared with AMM2 tolerant line-52 
with regards to levels of viral amplification. It is possible that the observed differences 
between viral loads of the two tolerant mismatched AMM2 lines and the non-mismatched 
CMM6 lines may be attributed to the presence of an intron in the non-mismatched CMM6 
transgene, providing better stability and dsRNA processing.  
Expression of the transgene could also affect siRNA production. CMM6 transgene showed 
high expression (RT-PCR) of both the sense and anti sense arm, whilst expression of the 
AMM2 transgene showed weak expression of the mutated sense arm only. Expression of 
transgene introduced by genetic engineering has been noted to be variable in plants carrying 
the same transgene (Kohli et al., 2010; Longstaff et al., 1993; Rooke et al., 2003). The 
variability was suggested to be due to possible chromosomal effects or endogenous transgene 
silencing due to presence of multiple copies of the transgene (Angell and Balcombe, 1997). 
However, tolerant transgenic lines CMM6-2, 6 and AMM2-52 had single copy numbers of 
the transgene. Dalakouran and Tzanopoulous (2011) concluded that high expression of the 
transgene does not necessarily guarantee resistance after noting that N. benthmiana 
expressing high levels of CMV CP transgene were still susceptible to CMV infection. In 
terms of recovery at 365 dpi, tolerant transgenic lines CMM6-2, 6 and AMM2-52 were 
asymptomatic. As earlier discusses recovery observed in these lines may be due to late 
transgene siRNAs biogenesis and other complex interaction factors (Bengyella and Rey, 
2014) 
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In summary, four potential ACMV-[NG:Ogo:90] tolerant cassava lines were identified from 
this study and previous trials (Moralo, 2015) and these will be subjected to larger greenhouse 
trials. There are conflicting reports with regards to the robust endurance of RNA silencing in 
the field (Beyene et al., 2015; Fuentes et al., 2016), and GM field trials are also planned in 
future. 
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Chapter 3 
Screening of cassava expressing mismatched or non-mismatched 
hairpin RNA constructs derived from South African cassava 
mosaic virus BC1/Cell-to-cell movement ORF 
3.1 Introduction 
 
In South Africa a novel cassava infecting begomovirus South Africa cassava mosaic virus 
(SACMV) was identified (Berrie et al., 1998). South African cassava mosaic like most 
begomoviruses has a DNA A (2800 nt) and DNA B (2760 nt) component and a highly 
conserved intergenic region (Berrie et al., 2001). SACMV DNA B has two genes, BC1 which 
codes for cell-to-cell movement protein (MP) and BV1 which codes for the nuclear shuttle 
protein (NSP) (Berrie et al., 2001). Begomoviruses utilise movement and cell associated-
accessory proteins such as heat shock proteins (Frischmuth et al., 2007; Gorovits et al., 2013; 
Moshe et al., 2015), for systematic movement of genome DNA-protein complexes through 
the cytoplasm and via the plasmadesmata into the next cell and into the vascular system for 
long distance movement (Henley-Bowdoin et al., 2013; Krenz et al., 2012). Expression of 
begomovirus movement gene BC1 in transgenic plants has been reported to induce resistance 
to incoming virus (Taha et al., 2016). Silencing of the begomovirus cell-to-cell movement 
protein induced by BC1 derived siRNAs in transgenic plants is expected to reduce viral 
transmission from cell-to-cell (Taha et al., 2016). Harmse (2007), identified a region on the 
SACMV BC1 genome from nt position 1532-1753 with several loops on the mRNA 
transcript which was predicted in silico to be an idea region to produce transgene induced 
siRNAs which would trigger PTGS and subsequently degradation of homologous SACMV 
MP miRNA.  
It is important to expose transgenic cassava lines to green house trials with conditions similar 
to the field environment. Resistance or tolerance has been shown to differ under variable 
conditions such as temperature, viral dosage and light intensity. Vanderschuren et al. (2009) 
reported that increasing the viral dosage from 350 to 750 ng had an adverse effect on 
transgenic resistant lines as they had infectivity percentage similar to wild types. They 
concluded that the amount of virus derived siRNAs produced in these transgenic lines were 
only sufficient to impart resistance to a certain dosage of viral inoculum. Chellappan et al. 
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(2005) reported similar findings on the effect of temperature on transgene mediated silencing. 
At 30 °C they reported a higher accumulation of ACMV-[CM] and SLCMV viral derived 
siRNAs compared to lower temperatures of 25°C in non-transgenic cassava, as a result there 
were significantly lower symptom severity compared to plants grown at 25°C. 
For resistance trials in our laboratory we adopted definitions for viral resistance, tolerance or 
susceptibility from Bengyella et al. (2015). Resistance plants show no symptom as a result of 
negligible viral replication, tolerance is defined as the presence of mild symptoms due to 
replication of low viral levels, and susceptibility refers to the presence of severe symptoms 
due to uncontrolled viral replication. Well defined symptom scoring scales (sss) have been 
published to assist with assessing the severity of symptoms. Hahn et al., (1980) described a 1-
5 sss with 1 representing no symptoms and 5 representing severe symptoms. Fauquet and 
Fargette (1990) described a 0-5 sss with 0 representing no symptoms and 5 representing 
severe leaf deformation and symptoms. A symptom severity score scale of 0-3 was reported 
by Ntui et al. (2015). To properly define whether the trial plants are resistant, tolerant or 
susceptible it is important to monitor the viral multiplication levels in the plants and establish 
a correlation between the observed symptoms and the viral load. Although a correlation 
between the observed symptom and viral load varies in different virus host cultivar, several 
researchers have reported a positive correlation between the observed symptoms and viral 
multiplication (Chellappan et al., 2004; Kaweesi et al., 2014). In other cases, a positive 
correlation cannot be established (Carrillo-Tripp et al., 2007; Gomez et al., 2009). 
Transgene-associated siRNA targeting of geminivirus movement proteins has not been well 
studied. In this research, a 221 bp SACMV BC1 (1532-1753 nt) mismatched IR construct, 
with mutated BC1 sense arm was transformed into model cultivar cv.60444 (AMM4 
transgenic lines). A non mismatched IR construct of the same selected BC1 sequence was 
also transformed into model cultivar cv.60444 (CMM8 transgenic lines). The AMM4 and 
CMM8 transgenic lines were evaluated for resistance, tolerance or susceptibility to SACMV, 
and a comparison between the two constructs was made 
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3.1.1 Specific Aims 
 
The aim of this research was to subject selected non-mismatched CMM8 transgenic lines 1, 
3, 8, 23, 25 and 27 and corresponding mismatched AMM4 lines 11, 33, 34, 46, 59, 68 and 79 
to reproducible trials and evaluate for response to virus challenge and select potential 
resistant/tolerant lines for further GM trials in future.  
Steps in achieving our aim 
 
i. To confirm successful integration of transgenes in previously transformed lines. 
ii. Micro-propagation of CMM8 and AMM4 transgenic cv.60444 lines and 
acclimatization for (6 weeks)  
iii. Agro-infection of transgenic lines with SACMV infectious virus clones 
iv. Plant evaluations for virus symptom severity, plant height and viral load at 14, 36, 56 
and 180 days post inoculation (dpi) 
v. Northern blots for siRNA detection in all lines pre and post infection. 
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3.2 Methodology flow chart 
 
Figure 3. 1 Work flow diagram for screening of transgenic cassava lines for 
resistance/tolerance to SACMV 
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3.3 Materials and Methods 
Characterisation of transgenic lines 
3.3.1 DNA extraction 
Leaf tissue collected from each of the six CMM8 and seven AMM4 trangenic lines chosen 
for this trial were used for DNA extraction using the CTAB method (Doyle and Doyle, 1987) 
for total nucleic acid (TNA) extraction. Method used is described previously in 2.3.1. 
3.3.2 Southern blot screening for transgene copy number 
Transgene copy number in the extracted DNA from the six CMM8 and seven AMM4 
transgenic lines was determined by southern blotting as earlier described in 2.3.2. BC1 non 
mutated strand PCR fragments were produced using the primers described in (Table 3.1).  
3.3.3 PCR of GUSPlus, hygromycin and virus-derived transgenes 
Integration of the plant transformation cassette carrying the transgene in the trial lines was 
confirmed by PCR. Total nucleic acid extracted in 3.3.1 was used as template. Transformed 
plants were screened for the GUSPLUS and (hyg) gene using primers listed in Table 2.1. 
Screening for the CMM8 or AMM4 sense and antisense IR was done using BC1 and BC1 
modified primers, respectively, (Table 3.1) using the same method described in 2.3.3.  
Table 3. 1 Primers used to amplify BC1 sense and antisense amplicons 
Primer                                          Primer sequence                                
BC1 F                           (5′-TACGATAACCGACCCAGTTGCGTT-3′) 
 
BC1 R                          (5′-TGCGACTCAAAGGCCGATGTATGA-3′) 
 
BC1 (mod+XhoI+SpeI) F                                                                                                                                                                                                               
(5′GATCCTCGAGACTAGTAAATATTCTACGGACATACG-3′) 
 
BC1 (mod +BglII) R                                                                                                                                                
(5′-GATCAGATCTTAGTAGCCCAATCTAAGACCTTGT-3′)] 
 
 
3.3.4 RNA extraction 
Leaf tissue was collected from each of the six CMM8 and seven AMM4 trangenic lines 
chosen for this trial. Leaf tissue was also extracted from non-infected healthy cv.60444 
plants. Method used is described previously in 2.3.4. 
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3.3.5 T-DNA expression 
Total RNA extracted from 3.3.4 was used to check for the expression of the T-DNA. The 
synthesised cDNA standed was then directly used in RT-PCR to amplify the GUSPLUS gene, 
hyg gene and the sense and antisense arms of the respective transgene using primers in 
(Table 3.1) following methods described in 2.3.5. 
Sceening trials of transgenic lines for response to ACMV challenge 
3.3.6 Bulking up and acclimitisation of selected transgenic plants 
Selected six CMM8 lines 1, 3, 8, 23, 25 and 27, seven AMM4 lines 11, 33, 34, 46, 59, 68 and 
79, healthy cv.60444 cassava plants,  resistant transgenic line dsAC1 (Vanderschuren et al., 
2009) and vector only transgenic controls were propagated in tissue culture on MS2 medium 
and acclimatized as described in 2.3.6.  
3.3.7 Experimental design 
Ten plants per each line were inoculated with SACMV infectious viral clones (n=10). The 
experiment was designed following specifications described in 2.3.7. 
3.3.8 Viral agro-inoculation of transgenic plants 
After 4 weeks the six CMM8 lines 1, 3, 8, 23, 25 and 27, seven AMM4 lines 11, 33, 34, 46, 
59, 68 and 79, healthy cv.60444 cassava plants, ACMV-[NG:Ogo:90] resistant transgenic 
line dsAC1 and pCambia vector only transgenic controls were agro-inoculated with SACMV 
DNA-A and DNA-B. Prior to infection A. tumefaciens C58C1 SACMV DNA-A and DNA-B 
infectious dimers were cultured in Yeast extract peptone (YEP) broth as described in 2.3.8 
with slight modifications. SACMV Agro-dimers were cultured in YEP inoculated with 
antibiotics kanamycin and cabenicillin. 
3.3.9 Sampling and symptom monitoring 
The SACMV infected CMM8 and AMM4 trial lines were monitored and evaluated for sss, 
viral load and height evaluation as described in 2.3.9 response at 3 time points post infection 
(14, 36, 56 and 180 dpi).  
3.3.10 Absolute quantitative PCR of viral load 
Viral load accumulation in infected CMM8, AMM4 transgenic lines, infected untransformed 
cv.60444 and ACMV-[NG:Ogo:90] resistant transgenic line dsAC1 were determined by 
absolute real time quantitative PCR at 36, 56 and 180 dpi as described in 2.3.10 with slight 
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modifications. To amplify SACMV viral multiplication primers CCP-F 5’-
GCACAAACAAGCGTCGA-3’ and reverse primer CCP-R 5’-
CTGCCAGTATGCTTAACGTCA-3’ were used. The SACMV viral loads of the 
experimental samples were calculated by reference to a standard curve generated by serial 
dilutions of pBS-SACMV DNA-A clones ranging from 0.1 pg/µl to 1 ng/µl under the same 
qPCR reaction condition. The corresponding viral molecules were calculated using Equation 
4-3. Equation 4-4 as described previously in 2.3.10. 
3.3.11 Northern blot detection of siRNA 
BC1 IR PCR amplicons were DIG labeled as previously described in 2.3.11. For siRNA 
control, an Arabidopsis 21 nt miR167 (5-’TAGATCATGCTGGCAGCTTCA-3’), 
oligonucleotide was 3’end labeled, and for size marker a 24 nt primer (5’-
TTCAGGAGCCTCCGCCTGTCT-3’ was 3’ end labeled as previously described in 2.3.11.  
 
3.4 Results 
Characterisation of transgenic lines 
3.4.1 Southern blot screening for transgene copy number 
Transgenic CMM8 lines 1, 3, 8, 23, 25, and 27 and seven AMM4 lines 11, 33, 34, 46, 59, 68 
and 79 were screened for transgene copy number using southern blot method. The BC1 PCR 
amplicon, GUSPLUS PCR amplicon and the hyg PCR amplicon were successfully amplified 
(fig 3.2). From the results, the DIG-labeled GUSPLUS and hyg (fig 3.2 lane b and d, 
respectively) migrated slower, in the gel, as expected than the 181 bp and 485 bp unlabeled 
GUSPLUS and hyg PCR amplicons (fig 3.2 lane a and c, respectively).The unmodified BC1 
DIG-probes (fig. 3.2 lane f) migrated slower than unlabeled 221 bp BC1 PCR amplicon (fig. 
3.2 lane e). 
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Figure 3. 2 1% agarose gel of DIG labeled unmodified BC1 PCR fragments, hyg and 
GUSPLUS PCR fragments probes. M= O’GeneRuler 1 kb Plus DNA ladder (Fermentas). 
DIG-labeled GUSPLUS PCR amplicon (lane b) unlabeled GUSPLUS PCR amplicon (lane a) 
DIG-labeled hyg probe (lane d) unlabeled 485 bp hyg PCR fragment (lane c) and unmodified 
BC1 DIG-probes (lane f) unlabeled 221 bp BC1 amplicon (lane e) 
Southern Blot analysis of double digested DNA from CMM8 transgenic lines with the BC1 
IR probe showed that all six lines had a single transgene copy (fig 3.3a). The same genomic 
DNA was digested with HindIII and probed with DIG labeled-hyg probe, and results showed 
that all lines except CMM8-8 had two transgene copies (fig. 3.3b). 
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Figure 3. 3 Southern blot analysis of CMM8 transgenic lines for transgene integration using 
DIG-labeled probes. M = DIG molecular weight marker (Roche), cv. = untransformed 
healthy cv.60444 and +veC = pC1305.1/CaMV35S BC1 IR (a) HindIII and EcoRI-double 
digested genomic DNA probed with BC1 probe and (b) HindIII-digested genomic DNA, 
probed with hyg probe 
Results from southern blot analysis of double digested genomic DNA from the seven AMM4 
transgenic lines probed with BC1 IR probe showed that all seven lines had a single transgene 
copy (fig 3.4a). The same genomic DNA was digested with HindIII and probed with DIG 
labeled-hyg probe, and results showed single copy of the transgene in all AMM4 lines (fig. 
3.4b).  
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Figure 3. 4 Southern blot analysis of AMM4 transgenic lines for transgene integration using 
DIG-labeled probes. M = DIG molecular weight marker (Roche), cv. = untransformed 
healthy cv.60444 and +ve = HindIII and EcoRI-double digested pTZR5/T containing MM4hp 
cassette (a) HindIII and EcoRI-double digested genomic DNA probed with BC1 IR probe and 
(b) HindIII-digested genomic DNA, probed with hyg probe 
3.4.2 PCR of GUSPLUS, hyg and virus-derived transgenes 
Positive PCR amplification of hyg gene, GUSPLUS gene confirmed successful transgene 
integration in the all 6 CMM8 lines (fig. 3.5b). All six CMM8 transgenic lines tested positive 
for PCR amplification of both the 221 bp sense and antisense arms of the BC1 IR construct 
(fig 3.5a). Positive amplification was achieved for the positive plasmid controls while no 
amplicons were obtained for the negative control untransformed healthy cv.60444.  
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Figure 3. 5 PCR confirmation of the transformation cassette in CMM8 lines transgenic 
status. M= O’GeneRuler 1 kb Plus DNA ladder (Fermentas), cv. = negative control 
untransformed cv.60444. Transgenic lines were screened for (b) 181 bp GUSPLUS fragment 
was successfully amplified in all lines screened and the 485 bp hyg gene fragment was 
detected in all lines tested.(b) PCR amplification of both the 221 bp sense and antisense-arm 
of the BC1 IR construct in CMM8 transgenic lines 
Positive PCR amplification of hyg and GUSPLUS genes confirmed successful transgene 
integration in all 7 AMM4 transgenic lines (fig. 3.6b). The 221 bp modified sense arm of the 
BC1 IR was weakly amplified whilst the antisense arms was not amplified (fig 3.6a). Positive 
amplification was achieved for the positive plasmid controls while no amplicons were 
obtained for the negative control untransformed healthy cv.60444. 
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Figure 3. 6 1% agarose gel electrophoresis of hyg, GUSPLUS and the BC1 RNAi construct 
PCR amplicons of AMM4 transgenic lines. M= O’GeneRuler 1 kb Plus DNA ladder 
(Fermentas), cv. = untransformed cv.60444 and +ve = positive plasmid controls. Transgenic 
lines were screened for the (a) 221 bp mutated sense-arm amplicon and the 221 bp non-
mutated antisense-arm. (b) 181 bp GUSPLUS gene fragment and 485 bp hyg gene 
Screening of transgenic lines for resistance/tolerance or susceptibility at 14, 36 and 56 
dpi 
 
3.4.3 Symptom severity scoring 
A symptom severity score (sss) index (fig 3.7) was used to evaluate severity based on a scale 
of 0-3. Symptom severity score (sss) of CMM8 transgenic lines were noticeably lower than 
those of non-infected healthy cv.60444 plants at all time points (fig 3.7). At 14 dpi, CMM8-8, 
23 and 25 had a lower sss (1-fold each, respectively) compared with infected untransformed 
cv.60444 however, there was no significant difference (p˃0.05) between the sss of these lines 
and infected untransformed cv.60444. CMM8-1 and 27 had a significantly (p˂0.05) 
(Appendix C) lower sss, (2 and 2.6-fold, respectively) compared with infected 
untransformed cv.60444. Africa cassava mosaic virus-[Nigeria:Ogorocco;1990] resistant 
transgenic line dsAC1 was tested for resistance or susceptibility to SACMV, and at 14 dpi, 
dsAC1 had a lower sss (1-fold) compared with infected untransformed cv.60444 however, 
these results were not significantly different (p=0.097). 
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Figure 3. 7 Cassava mosaic disease symptomatic leaves from trials in this study. 0-3 scoring 
scale used for evaluation 
At 36 dpi, CMM8-1, 8, 23 and 25 had a significantly (p˂0.05) lower sss (1.5-fold each, 
respectively) compared with infected untransformed cv.60444. CMM8-3 and 27 both had 
significantly (p˂0.05) lower sss (1.0-fold each, respectively) compared with infected 
untransformed cv.60444. Africa cassava mosaic virus-[Nigeria:Ogorocco;1990] resistant line 
dsAC1 had significantly (p˂0.05) lower sss, (1.9-fold) compared with infected untransformed 
cv.60444. At 56 dpi, CMM8-1, 8, 23 and 25 had significantly (p˂0.05) lower sss, (1.7, 1.4, 2 
and 1.7-fold, respectively) compared with infected untransformed cv.60444. CMM8-3 and 27 
had lower sss, (1.2 and 1.0-fold, respectively) compared with infected untransformed 
cv.60444 however there was no significant difference between the results (p˃0.05). 
Symptom severity scores of AMM4 transgenic lines were also observed to be lower than that 
of infected untransformed cv.60444 (fig 3.8b) at all time points. At 14 dpi, AMM4-11 and 33 
had lower sss, (1.5-fold each, respectively) compared with infected untransformed cv.60444. 
AMM4-46, 59, 68 and 79 had lower sss (2-fold each, respectively) compared with infected 
untransformed cv.60444. The sss of all AMM4 transgenic lines at 14 dpi were however not 
significantly different (p˃0.05) to the sss of infected untransformed cv.60444 (Appendix D). 
At 14 dpi, ACMV-[NG:Ogo:90] resistant line dsAC1 had a lower sss, (2-fold) compared with 
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infected untransformed cv.60444 however, these results were not significantly different 
(p=0.086). At 36 dpi, AMM4-11, 34, 46, 56, 68 and 79 had lower sss, (1.3, 1.8, 1.6, 1, 1.8 
and 1.1-fold, respectively) compared with infected untransformed cv.60444 however, these 
results were not significantly different (p˃0.05). At 56 dpi AMM4-11 and 79 had 
significantly (p˂0.05) lower sss, (1.4 and 1.7-fold, respectively) compared with infected 
untransformed cv.60444. AMM4-33, 34, 46, 56 and 79 had lower sss, (1, 1.2, 1.2, 1.5 and 
1.1-fold, respectively) compared with infected untransformed cv.60444, however these 
results were not significantly different (p˃0.05).  
 
Figure 3. 8 Symptom severity score of CMM8, AMM4 transgenic lines, infected 
untransformed cv.60444 and ACMV-[NG:Ogo:90] resistant transgenic line dsAC1 agro-
inoculated with infectious SACMV viral clones. Plants were evaluated at 14 dpi (blue), 36 
dpi (red) and 56 dpi (green) (a) CMM8 mean symptom severity scores (b) AMM4 mean 
symptom severity score. The measure of uncertainty is measured by displayed error bars 
scaled to 95% confidence level 
3.4.4. Real time absolute quantitative PCR of viral load 
At 36 and 56 dpi SACMV viral load accumulation in infected CMM8 and AMM4 transgenic 
lines, infected untransformed cv.60444 and ACMV-[NG:Ogo:90] resistant transgenic line 
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dsAC1 were determined by real time absolute quantitative PCR. At 36 dpi, CMM8 transgenic 
lines viral loads were not significantly different (p˃0.05) compared with infected 
untransformed cv. 60444 (Appendix C). CMM8 lines 1, 3, 8, 23, 25 and 27 had a lower viral 
load, (7.3, 32, 121, 26, 16 and 30-fold, respectively) compared with infected untransformed 
cv.60444. Africa cassava mosaic virus-[Nigeria:Ogorocco;1990] resistant transgenic line 
dsAC1 has a lower viral load, (121-fold) compared with infected untransformed cv.60444 
however, these results were not significantly different (p˃0.05). At 56 dpi, CMM8 lines 1, 3, 
8, 23, 25 and 27 had a lower viral load, (2.5, 2.3, 6.6, 2, 2 and 18.8-fold, respectively) 
compared with infected untransformed cv.60444 however, these results were not significantly 
different (p˃0.05). 
For AMM2 transgenic lines, at 36 dpi AMM4 lines 11, 33, 34, 46, 58, 68 and 79 had lower 
viral load, (3.2, 4.6, 2.6, 9.9, 3.7, 2.7 and 1.4-fold, respectively) compared with infected 
untransformed cv.60444. Although all AMM4 transgenic lines had lower viral load compared 
with infected untransformed cv.60444, statistically these results were not significantly 
different (p˃0.05) (Appendix D). Africa cassava mosaic virus-[Nigeria:Ogorocco;1990]  
resistant line dsAC1 has 11.8 fold lower viral load (p=0.06) compared with infected 
untransformed cv.60444. At 56 dpi, AMM4 lines 11, 33, 34, 46, 58, 68 and 79 had lower 
viral load (82.4, 19.3, 9.1, 388, 147, 85 and 12.6-fold) compared with cv.60444 however, 
these results were not significantly different from cv.60444 (p˃0.05). At 56 dpi, ACMV-
[NG:Ogo:90] resistant transgenic line dsAC1 has a lower viral load, (50-fold) compared with 
infected untransformed cv.60444 however, these results were not significantly different 
(p˃0.05). 
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Figure 3. 9 Viral load evaluation for CMM8, AMM4 transgenic lines, infected 
untransformed cv.60444 and ACMV-[NG:Ogo:90] resistant transgenic line dsAC1 agro-
inoculated with infectious SACMV clones. Plants were evaluated at 36 dpi (blue) and 56 dpi 
(red) (a) CMM8 mean absolute viral load quantification (mean viral molecules/g DNA) (b) 
AMM4 mean absolute viral load quantification (mean viral molecules/g DNA). The measure 
of uncertainty is measured by displayed error bars scaled to 95% confidence level 
3.4.5 Plant height Evaluation 
At 14 dpi, CMM8-1, 3, 8, 23, 25 and 27 had average height of 8.8, 8.5, 8.1, 9.1, 8.5 and 8.5 
cms, respectively. These results were not significantly different (p˃0.05) to plant height of 
untransformed cv.60444 which had an average of 8.1 cms. At 36 and 56 dpi no significant 
difference (p>0.05) in mean plant height was recorded for all CMM8 transgenic lines and the 
ACMV-[NG:Ogo:90] resistant line dsAC1 compared with infected untransformed cv.60444 
(Appendix C). 
Plant height evaluations of AMM4 transgenic lines showed that there weren’t significant 
differences between the height of AMM4 transgenic lines and that of infected untransformed 
cv.60444 (Fig 3.10b). At 14 dpi, AMM4-11, 33, 34, 46, 59, 68 and 79 had average heights of 
7.6, 8.6, 7.5, 9, 8.1, 8.1 and 8.1 cms, respectively. These results were not significantly 
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different (p˃0.05) from infected untransformed cv.60444 which had an average height of 7.8 
cms. At 36 and 56 dpi no significant difference in mean plant height was recorded for all 
AMM4 trial lines and ACMV-[NG:Ogo:90] resistant line dsAC1 (p>0.05) compared with 
untransformed cv.60444 (Appendix D). 
 
Figure 3. 10 Plant height evaluation of CMM8, AMM2 transgenic lines, untransformed 
cv.60444 and ACMV-[NG:Ogo:90] resistant transgenic line dsAC1. Plants were evaluated at 
14 dpi (blue), 36 dpi (red) and 56 dpi (green) (a) CMM8 mean average height (b) AMM4 
mean average height. The measure of uncertainty is measured by displayed error bars scaled 
to 95% confidence level 
Evaluation of CMM8 and AMM4 transgenic lines at 180dpi 
 
3.4.6. Symptom scores and viral load 
CMM8 transgenic lines were evaluated at 180 dpi for symptom and viral load. At 180 dpi, 
CMM8-8, 25 and 27 had mild symptoms. CMM8-1, 3, 23, cv.60444 and dsAC1 had similar 
sss compared with those at 56 dpi. The viral load of CMM8 transgenic lines and controls was 
also quantified at 180 dpi and there was a decrease in viral loads from those at 56 dpi (fig 
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3.11a). For transgenic lines CMM8-1, 3, 8, 23, 25 and 27 there was a 59, 55, 223, 7, 93 and 9 
fold decreases, respectively, in viral load from 56 dpi to 180 dpi. Infected untransformed 
cv.60444 and ACMV-[NG:Ogo:90] resistant transgenic line dsAC1 had a 2.5 and 2.3 fold 
decreases in viral load, respectively, in viral load from 56 dpi to 180 dpi. At 180 dpi there 
was however no significant difference in the viral load between CMM8 transgenic lines, 
ACMV-[NG:Ogo:90] resistant transgenic line dsAC1 and infected untransformed cv.60444 
(p>0.05) (Appendix F). 
 
Figure 3. 11 Mean viral molecules/g of DNA at 180 dpi compared with mean viral 
molecules/g of DNA at 56 dpi, quantified using absolute real time qPCR, (a) Viral load of 
SACMV infected CMM8 transgenic lines, infected untransformed cv.60444 and infected 
ACMV-[NG:Ogo:90] resistant transgenic line dsAC1 (b) SACMV infected AMM4 
transgenic lines, infected untransformed cv.60444 and infected ACMV-[NG:Ogo:90] 
resistant transgenic line dsAC. The measure of uncertainty is measured by displayed error 
bars scaled to 95% confidence level 
Evaluation of AMM4 transgenic lines at 180 dpi for symptom showed that AMM4-11, 68 
and 79 had mild symptoms. AMM4-33, 34, 46 and 59 had similar sss compared with those 
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recorded at 56 dpi. The viral load of AMM4 transgenic lines, untransformed cv.60444 and 
ACMV-[NG:Ogo:90] resistant transgenic line dsAC1 was also quantified, and there was a 
decrease in viral loads from those at 56 dpi (fig 3.11b). For transgenic lines AMM4-11, 33, 
34, 46, 59, 68 and 79 there was a 47, 3.7, 1, 1.5, 4.6, 12.9 and 47.4-fold decreases, 
respectively, in viral load from 56 dpi to 180 dpi. Infected untransformed cv.60444 and 
infected ACMV-[NG:Ogo:90] resistant transgenic line dsAC1 had a 1.9 and 56.8-fold 
decreases in viral load, respectively, from that viral load at 56dpi. At 180 dpi there was 
however no significant difference between the viral load of CMM8 transgenic lines, ACMV-
[NG:Ogo:90] resistant transgenic line dsAC1 and infected cv.60444 (p>0.05) (Appendix F). 
Small interfering RNA evaluation of trial plants  
3.4.7 RNA extraction 
High quality RNA was extracted from CMM8, AMM4 and non-infected untransformed 
cv.60444 using the QIAzol method and the integrity of the RNA was checked on a 1.2% 
agarose gel. The results show that high quality RNA was successfully extracted from CMM8, 
AMM4 transgenic lines and non-infected healthy cv.60444 (fig 3.12). RNA was also 
extracted from infected CMM8, AMM4 transgenic lines, infected untransformed cv.60444 
and non-infected untransformed cv.60444. 
 
Figure 3. 12 1.2% agarose gel electrophoresis (10mg/ml EtBr) of total RNA extracted from 
(a) CMM8 transgenic lines and non-infected untransformed cv.60444. (b) AMM4 transgenic 
lines and non-infected untransformed cv.60444 
3.4.7 T-DNA expression results 
Reverse transcriptase-polymerase chain reaction of cDNA from AMM4 and CMM8 
transgenic lines resulted in successful amplification of the GUSPLUS and hyg in both 
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mismatched AMM4 lines (fig 3.14c and d) and non-mismatched CMM8 transgenic lines (fig 
3.13c and d) and as expected no amplicons were detected in healthy cv.60444. Synthesised 
cDNA from CMM8 and AMM4 lines was used to amplify the BC1 IR transgene. The results 
showed successful amplification of the 221 bp CMM8 sense arms in all six selected lines 
except CMM8-8 (fig 3.13a). The CMM8 antisense arm was successfully amplified in all six 
selected lines except CMM8-3 (fig 3.13b). Both arms were strongly amplified in comparison 
with amplification of endogenous ubiquitin gene (fig 3.13ai and bi). AMM4 lines showed 
low expression of the mutated sense arm (fig 3.14a) compared with the amplification of 
endogenous ubiquitin gene (fig 3.14ai). The non-mutated antisense arm fragment of the 
AMM4 hairpin construct was also weakly expressed (fig 3.14b) compared with the 
amplification of endogenous ubiquitin gene (fig 3.14bi). 
 
Figure 3. 13 RT-PCR amplification of the BC1 IR transgene, GUSPLUS and hyg genes from 
CMM8, AMM4 transgenic lines and healthy cv.60444 negative control. M= O’GeneRuler 1 
kb Plus DNA ladder (Fermentas). cv. = healthy cv.60444 negative control. + = positive 
control transgene plasmid (a) amplication of CMM8 transgenic lines sense arm (aii) 
amplification of endogenous ubiquitin gene from CMM8 cDNA (b) amplication of CMM8 
transgenic lines antisense arm (bii) amplification of endogenous ubiquitin gene from CMM8 
cDNA. (c) amplification of 181 bp GUSPLUS from CMM8 transgenic lines cDNA. (d) 
amplification of 485 bp hyg from CMM8 transgenic lines cDNA 
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Figure 3. 14 RT-PCR amplification of BC1 IR transgene, GUSPLUS and hyg genes from 
AMM4 and healthy cv.60444 negative control. M= O’GeneRuler 1 kb Plus DNA ladder 
(Fermentas). cv. = healthy cv.60444. + = positive control transgene plasmid (a) amplication 
of AMM4 transgenic lines non-mutated antisense arm (aii) amplification of endogenous 
ubiquitin gene from CMM8 cDNA (b) amplication of AMM4 transgenic lines mutated sense 
arm (bii) amplification of endogenous ubiquitin gene from AMM4 cDNA. (c) amplification 
of 181 bp GUSPLUS from AMM4 transgenic lines cDNA. (d) amplification of 485 bp hyg 
from AMM4 transgenic lines cDNA 
3.4.8 Northern blot detection of siRNA 
The labeling efficiency of the Northern Starter Kit (Roche) and DIG oligonucleotide tailing 
kit 2
nd
 generation (Roche) on SACMV BC1 PCR amplicons, an Arabidopsis miR167 21 
nucleotide (5’TAGATCATGCTGGCAGCTTCA), a 24 nucleotide 
(5’TTCAGGAGCCTCCGCCTGTCT) and a 30 nucleotide positive control were tested. The 
results showed successful labeling of the BC1 RNA as well as the marker nucleotides (fig 
3.15). The labeled RNA and short oligonucleotides were detected at low concentrations of 10 
ng/µl. At 1 ng/µl the BC1 RNA (fig 3.15b) signal was weak compared with the control 1ng/ 
µl signal. 
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Figure 3. 15 Determination of the DIG labeling efficiency of the BC1 RNA as well as the 
marker nucleotides (a) a Northern Starter Kit (Roche) positive RNA control. (b) BC1 IR 
sense arm (c) labeled 24 nt primer and (d) labeled 21 nt Arabidopsis mi167 
South African cassava mosaic virus BC1 IR-derived siRNA molecules were not detected in 
CMM8 lines prior to SACMV infection (fig 3.16a) however, the probe hybridised to high 
molecular weight RNA estimated to be around 30 nt base pairs in size. The detected bands 
were varying in accumulation intensities. Using the siRNAs at the highest concentration 
being equal to 100% CMM8-1, 3, 8, 23, 25 and 27 had 27%, 49%, 53%, 46%, 77% and 100% 
accumulation, respectively. Non-infected healthy cv.60444 did not produce siRNAs as 
expected. AMM4 transgenic lines produced siRNA 21 nt in size (fig 3.16b). The detected 
bands were varying in accumulation intensities. Using the siRNAs at the highest 
concentration being equal to 100% AMM4-11, 33, 34, 46, 59, 68 and 27 had 69%, 100%, 
53%, 38%, 45%, 57 and 55% accumulation, respectively. Non-infected healthy cv.60444 did 
not produce siRNAs as expected. Loading control miRNA 167 was detected in CMM8 (fig 
3.16ai) and AMM4 transgenic lines (fig 3.16bi) after stripping the BC1 probe from the 
membrane. 
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Figure 3. 16 siRNA detection (a) CMM8 transgenic lines and non-infected healthy cv.60444 
probed with DIG labeled BC1 derived probe (b) AMM4 transgenic lines and non-infected 
healthy cv.60444 probed with DIG labeled BC1 derived probe. (ai) CMM8 and (bi) AMM4 
transgenic lines and non-infected healthy cv.60444 probed with DIG labeled Arabidopsis 
miRNA 167 probe. The numbers above represent each trial line 
At 180 dpi, SACMV infected CMM8 transgenic lines produced siRNAs approximately 21 
nucleotide bases in size. The detected bands were varying in accumulation intensities, and 
using the siRNAs at the highest concentration being equal to 100% CMM8-1, 3, 8, 23, 25 and 
27 had a 4%, 9%, 100%, 42%, 35% and 38% accumulation, respectively. Infected non-
transgenic cv.60444 produced siRNAs of approximately 21 nt bases in size with 58% 
accumulation (fig 3.17a). At 180 dpi AMM4 lines still produced small nucleotides 21 nt in 
size. The detected bands were varying in accumulation intensities, and using the siRNAs at 
the highest concentration being equal to 100% AMM4-11, 33, 34, 46, 59, 68 and 27 had an 
85%, 70%, 56%, 49%, 67%, 97 and 100% accumulation, respectively. Infected non-
transgenic cv.60444 produced siRNAs 21 nucleotide bases in size with 39% accumulation. 
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Figure 3. 17 siRNA detection (a) CMM8 transgenic lines, infected untransformed cv.60444 
(cv I) and non-infected healthy cv.60444 (cv NI) probed with DIG labeled BC1 derived probe 
(b) AMM4 transgenic lines, infected untransformed cv.60444 (cv I) and non-infected healthy 
cv.60444 (cv NI) probed with DIG labeled BC1 derived probe. (ai) CMM8 and (bi) AMM4 
transgenic lines and control line probed with DIG labeled Arabidopsis miRNA 167 probe. 
The numbers above represent each trial line 
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3.5 Discussion 
Expression of begomovirus movement gene BC1 in transgenic plants has recently been 
reported (Taha et al., 2016). Silencing of the begomovirus cell-to-cell movement protein 
(MP) induced by BC1 derived siRNAs in transgenic plants is expected to reduce virus 
transmission form cell-to-cell in host plants (Taha et al., 2016). The objective of this study 
was to evaluate the tolerance, resistance or susceptibility of cassava cv.60444 transformed 
with a BC1 mismatched IR construct (AMM4) or non-mismatched BC1 IR construct 
(CMM8), and to compare the efficiencies of both constructs. Agro-inoculation of the AMM4 
and CMM8 lines with SACMV viral cloned resulted in 90 and 95% infectivity, respectively, 
as evidenced by symptom development on the leaves. CMM8 and AMM4 lines had lower 
symptom scores compared with infected untransformed cv.60444 (fig 3.8). However the 
difference in symptom severity between CMM8 and AMM4 lines in comparison with 
infected untransformed cv.60444 were not significantly different at 36 and 56 dpi. In a study 
by Taylor et al. (2012) they used the same mismatched BC1 IR construct (nt position 1532-
1753) to agro-transform N. benthamiana, and infectivity trials were done with SACMV 
agrodimers. From their results they identified line L and M with significantly reduced 
symptoms and viral loads. The difference between their results and ours might be contributed 
to the geminivirus-plant variety interaction. The extent of PTGS initiation and success is 
dependent on virus-plant interaction (Chellappan et al., 2004). Although N. benthamiana is 
widely used in viral infectivity studies due to its near universal virus susceptibility (Goodin et 
al., 2008), variability in SACMV infection within the Nicotiana genus particularly N. 
benthamiana and N. tubacum has been reported (Berrie et al., 2001). Variation in the 
significance of symptom reduction between their results and our study might be due to 
differences in virus-plant interaction between experimental host and natural perennial host 
cassava. 
Viral load quantification by real time absolute qPCR showed that all CMM8 and AMM4 
transgenic lines has lower SACMV viral load compared with infected untransformed 
cv.60444 however the results were not significantly different (fig 3.9). Our results were 
however more consistant with recent attempts to engineer resistance in squash plants against 
begomovirus Squash leaf curl virus (SqLCV) using the full sequence of the virus BC1 gene 
by Taha et al. (2016). They noted virus reduction in transgenic squash plants, however the 
reduction was not significant, and they concluded that could be due to late expression of the 
IR construct. 
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Reduced viral load in transgenic lines could be because of the presence of siRNA prior to 
SACMV infection. High molecular weight RNA was detected in pre-infected CMM8 lines 
instead of siRNAs (fig 3.16). Absence of siRNA molecule detection could be due to 
sequestering and trapping of siRNA molecules by the higher molecular weight RNA or late 
expression of the IR construct (Taha et al., 2016). Presence of virus specific RNA has been 
shown to correlate with viral resistance (Chen et al., 2004; Hilly et al., 2005; Vanderschuren 
et al., 2009) and the viral reduction could be due to additional boast of transgene derived 
siRNA to the plants natural PTGS mechanism. All transgenic lines were producing siRNA at 
varying levels at 180 dpi, we expected siRNAs targeting the movement protein to effectively 
silence the movement and multiplication of the virus. This suggests that the response of 
transgenic plants to virus infection does not seem to be determined by the accumulation of 
siRNAs alone. Bengyella et al., 2015 suggested that RNA silencing alone is not sufficient for 
plant recovery to viral infestation but expression of R genes as a consequence of 
transcriptome reprogramming also plays a role. 
Transgenic line dsAC1 resistant to ACMV-[NG:Ogo:90] (Vanderschuren et al., 2009) was 
used as a transgenic positive control for resistance against SACMV. The ACMV-
[NG:Ogo:90] AC1/Replication –associated protein (Rep) sequence (154 bp) from nt position 
1690 to 1844 expressed in dsAC1 transgenic line has a 86% sequence similarity with the 
corresponding sequence on the SACMV AC1 ORF. We assumed that ACMV-[NG:Ogo:90] 
similarity to SACMV would render ACMV-[NG:Ogo:90] resistant line dsAC1 resistant or 
tolerant to SACMV. However from our results ACMV-[NG:Ogo:90] resistant transgenic line 
dsAC1 had lower sss and viral load at 36 and 56 dpi compared to infected untransformed 
cv.60444 but statistically we could not establish a significant difference between the two. The 
results suggest that although ACMV and SACMV are related to some extent the ACMV-
[NG:Ogo:90] AC1 IR transgene in dsAC1 could not induce broad spectrum resistance to 
SACMV. 
At 180 dpi, viral load and sss of transgenic lines CMM8 AMM4, infected untransformed 
cv.60444 and infected ACMV-[NG:Ogo:90] resistant line had decreased compared with 56 
dpi (fig 3.11). The reduction in viral load and attenuation of symptoms can be attributed to 
factors such as temperature, light intensity, siRNA production or other basal immunity 
associated genes as a suggested in chapter 2. At 56 dpi plants were moved from the growth 
facility with average temperature 28°C and light intensity 800 lux to the green house were 
maximum of 30°C was expected and 1000 lux light intensity. To sum extent, the increase in 
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light intensity and temperature played a role in plant recovery after viral infection. Patil and 
Fauquet (2014) who showed that N. bethamiana infected with cassava mosaic virus showed 
recovery at high light intensity of ≥600 μE/m2/s compared with low light intensity of 150 
μE/m2/s. While there was a decrease in viral load in SACMV infected untransformed 
cv.60444 at 180 dpi, it was not sufficient to confer resistance, and the reduction was likely 
due to some level of tolerance triggered under high temperatures and light intensity. 
Generation of vsiRNAs targeting the virus genome was reported in susceptible cassava 
landrace T200 and untransformed cv.60444 cassava infected by SACMV and ACMV, 
respectively (Chellappan et al., 2004; Rogans et al., 2016). 
At 36 dpi and 56 dpi there was a negative Pearson correlation between the viral load and 
symptom scores of CMM8 and AMM4 transgenic lines (Appendix G). Several begomovirus 
resistance trials have failed to establish positive Pearson correlation between viral loads and 
symptom severity (Cecchini et al., 1998; Kaweesi et al., 2014). Our results were consistant 
with those of Challappan et al. (2005) were a positive correlation could not be established 
between the viral load of SLCMV and the symptoms induced by the virus on cassava. 
Kaweesi et al. (2014) reported similar results with cassava brown streak virus (CBSV), and 
they suggested that two separate mechanisms might be responsible for virus multiplication 
and symptom restriction regardless of high viral loads. This further emphasizes the need to 
evaluate the two parameters independently when evaluating for viral tolerance or resistance. 
In experiments conducted by Hou et al. (1999) they observed several negative effects on the 
depelopment of tomato plants expressing geminivirus Bean dwarf mosaic virus movement 
protein BC1. The anomalies included MP gene deletion whilst surprisingly the adjacent NPT 
II gene was intact, they also observed that BC1 protein could not be expressed in the 
transgenic line and the transgenic lines had stunted growth. In our research the CMM8 and 
AMM4 transgenic plants showed normal plant height in comparison with infected 
untransfomed cv.60444. We observed that there weren’t significant differences between the 
height of CMM8 and AMM4 lines in comparison with infected untransformed cv.60444. This 
contrasts the observation of Hou et al, 1999 were stunted growth of the transgenic lines. 
Transgene expression levels in CMM8 and AMM4 lines were highly variable (fig 3.13 and 
3.14). Expression of transgene introduced by genetic engineering has been noted to be 
variable in plants carrying the same transgene (Kohli et al., 2010; Longstaff et al., 1993; 
Rooke et al., 2003). The variability could be due to chromosomal effects or transgene 
silencing due to presence of multiple copies of the transgene of sections of the transformation 
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cassette silencing each other (Angell and Balcombe, 1997; Kohli et al., 2010). A positive 
correlation between the expression of the transgene and the level of tolerance induced by the 
transgenic line after viral infection could not be established. For example AMM4 line 46 had 
the least viral load at 36 and 56 dpi but its expression was weak compared to lines 68 and 78 
which had higher viral loads. CMM8-8 and 27 performed better than all the other CMM8 
lines in terms of symptom severity and viral load however expression of the CMM8 sense 
arm was not detectable whilst CMM8-27 was strongly detected. These results were in strong 
agreement with Dalakouran and Tzanopoulous (2011) who concluded that high expression of 
the transgene does not necessarily guarantee resistance after noting that N. benthmiana 
expressing high levels of CMV CP transgene were still susceptible to CMV infection. 
From our results the mismatched construct in AMM4 lines and the non-mismatched construct 
in CMM8 lines induced the same viral and sss reduction. The large size of the transformation 
cassette has been shown to induce deletion and rearrangement of the insert (Nakano et al., 
2005). The truncated copy of the transformation cassette in CMM8 lines with the large pdk 
intron as shown by the dual copies of the hyg gene detected by southern blot is a clear 
indication of rearrangement and deletion. Surprisingly the selected AMM4 lines had a single 
copy of the transgeng.This suggests that replacing the 700bp intron in CMM8 with a small 
nucleotide loop increased the stability of the transformation cassette. These results were 
different to those of chapter 2 were the intron in the non-mismatched CMM6 transgene, 
providing better integration stability and dsRNA processing compared no mismatched 
construct in AMM2 lines. Taylor et al. (2012) showed that introduction of base pair 
mismatches in the sense arm of in IR sequence as done in the transformation cassette used to 
transform AMM4 lines can improve the efficiency of the construct to induce PTGS. 
In conclusion the BC1 transgene whether as mismatched or non-mismatched construct could 
not significantly reduce the viral load of SACMV in both AMM4 and CMM8 transgenic 
lines, respectively, from this study and previous trials (Moralo 2016). 
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Chapter 4 
Transformation of cassava landrace T200 with a hairpin RNA silencing 
construct against African cassava mosaic virus, East African cassava 
mosaic virus and South African cassava mosaic virus 
4.1 Introduction 
Cassava mosaic disease (CMD) caused by a diverse range of begomovirus species; strains 
and isolates (Brown et al., 2015; Legg et al., 2015), including African cassava mosaic virus 
(ACMV), South African cassava mosaic virus (SACMV) and East African cassava mosaic 
virus (EACMV) (Brown et al., 2015; Legg et al., 2015). CBVs are responsible for significant 
yield loss of the starchy tubers. This diversity makes genetic engineering problematic as these 
CBVs share only small regions of sequence homology which to exploit for PTGS-induced 
virus silencing. Geminiviruses like most viruses have been shown to trigger virus induced 
gene silencing by producing virus specific siRNAs (vsiRNAs) (Aregger et al., 2012; 
Hamilton and Baulcombe, 1999; Pallas and Garcia, 2011). Elevated levels of these vsiRNAs 
from the transgene have been reported to correlate with viral resistance in N. bethamiana and 
cassava (Chellappan et al., 2004a). Many of the CBVs occur in the same geographical 
location (Rey et al., 2012) and as mixed infections on the same field (Fondong et al., 2000; 
Patil and Fauquet, 2009). In southern Africa, ACMV, SACMV and EACMV have been 
reported (Berry et al., 2001; Rey et al., 2012). This invariably requires stacking multiple 
genomic regions from several viruses for construction of the IR repeats against CBVs. 
Stacking of genes in transgenic plants could be a more viable method to induce broad 
spectrum durable resistance against diseases (Zhu et al., 2012), and targeting of overlapping 
regions between two genes has been reported to be more effective in silencing (Taha et al., 
2016) 
The laboratory model cassava cultivars have been transformed with genes or segments of 
genes from the geminiviruses genome (Vanderschuren et al., 2009, 2012). Various levels of 
viral elimination or reduction have been reported in transgenic cassava expressing virus 
derived transgenes either as antisense RNA, double stranded RNA or inverted repeats (IR) 
targeting the viral genome or viral promoter region (Ntui et al., 2015; Vanderschuren et 
al.,2009,2012; Zhang et al., 2005). Selection of which sequence of the viral genome to 
97 
 
introduce as the transgene is very important, thus far the most targeted regions of the viral 
genome include AC1/Rep ORF and regions of high siRNA production on the viral open 
reading frame (Chellappan et al., 2004a; Vanderschuren et al., 2007, 2009). Hot spots on the 
genome for targeting by vsiRNAs have been reported in many geminivirus studies (Aregger 
et al., 2012; Chellappan et al., 2004a; Poogin, 2013). Recently hotspots were reported for 
cassava T200 and TME3 infected with SACMV (Rogans et al., 2016). Hot spots for targeting 
geminivirus suppressors or the promoter regions have also been identified (Aregger et al., 
2012; Sharma et al., 2014). 
The two most common methods for plant transformation are particle bombardment and 
Agrobacterium mediated transformation. Particle bombardment involves the introduction of 
target DNA into the plant material cells using gold or tungsten metal particles coated with the 
target DNA (Christon, 1992). The DNA coated particles are propelled into plant cells using 
high pressure. Particle bombardment has been reported in transformation of cassava even 
though the transformation numbers were reported to be low (Munyikwa et al., 1998; 
Raemakers et al., 1996; Schopke et al., 1997). Particle bombardment has a major 
disadvantage of having high percentages of multiple gene insertion after transformation (Dai 
et al., 2001). 
Agrobacterium-mediated transformation involves the use of a disarmed Ti plasmid from 
bacterium A. tumefaciens which inserts a portion of its T-DNA plasmid into the plant genome 
(Gelvin, 2003; Yuan and Williams, 2012). In cassava transformation the gene of interest is 
placed in the 25 bp imperfect repeat sequence which is on either side of the left and right 
border flanking the T-DNA in a binary vector, such as pCambia. Once the gene of interest 
has been inserted in this region the gene is then cloned into a disarmed A. tumefaciens. The 
transgene is then transferred using the bacterium natural ability to transfer the T DNA into 
the plant genome. According to Taylor et al. (2004), Agrobacterium-mediated transformation 
is the best method of transformation in cassava with transformation efficiency of 55% 
possible. 
Transformation depends on the source of plant material and the genotype. Several systems 
incorporating different types of plant sources have been tried for transformation of cassava. 
Stamp and Henshaw (1987) reported that transformation using germplasm explants was 
unsuccessful in cassava due to the heterozygous nature. In several studies somatic tissue has 
been used for Agrobacterium-mediated transformation of cassava (Ntui et al., 2015; 
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Raemakers et al., 1997; Zhang and Puonti-Kaelas, 2000). Somatic embryos are induced from 
auxiliary buds (AB) or leaf lobes (ILL) on Murashige and Skoog media. Continuous culture 
of these somatic embryos results in formation of mature secondary somatic embryos (SSE). 
The SSE can then be grown in auxin-supplemented Gresshoff and Doy (1974) media to 
produce friable embryogenic callus (FECs) (Taylor et al., 1996). Today the production of 
large numbers of independent transgenic plants relies on the use of FECs. Transformation of 
FECs from cassava cultivars has been successfully reported using Agrobacterium-mediated 
transformation (Bull et al., 2009; Chetty et al., 2013; Nyaboga et al., 2015; Taylor et al., 
1996). 
This chapter aims to construct an inverted repeat construct (code named DM-AES) targeting 
two regions of ACMV-[NG:Ogo:90] as well as being efficient in targeting SACMV and 
EACMV, due to the inclusion of a third region, a 21 bp sequence conserved sequence 
between EACMV, ACMV and SACMV, and subsequent transformation of cassava landrace 
T200 FECs. The construct will be derived from stacking three regions which include (i) 
sequences from the putatitive leftward promoter region between the 5’end of ACMV-
[NG:Ogo:90] AC4 complementary sense ORF to the TATA box plus an additional 49 nt 
upstream with core elements of the leftward promoter. Trangenic cassava transformed with 
this region were previously reported to recovery from ACMV infection (Vanderschuren et 
al., 2006) (ii) the overlapping sequence between ACMV-[NG:Ogo:90] AC1 3’ end and AC2 
5’ end (AC1 3’/AC2 5’). This region was previously shown to produce high levels of 
vsiRNAs and was targeted by African cassava mosaic virus Cameroon strain ACMV-[CM] 
for induction of PTGS (iii) a 21 nt conserved sequence of AC1/Rep shared between ACMV, 
EACMV and SACMV. We hypothesise that if this 21 nt conserved sequence could induce 
PTGS then the transgenic cassava would induce broad spectrum resistance across EACMV, 
ACMV and SACMV, the most widely spread CBVs. A stacked construct consisting of a 
combination of these three sequences will be designed into an IR construct where sense and 
antisense sequence of the stacked construct separated by an 85 bp intron. This IR construct 
will be used to transform cassava landrace T200 FECs using Agrobacterium mediated 
transformation. 
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4.1.1 Specific Aims 
i. Design a construct targeting ACMV-[NG:Ogo:90] putative promoter region, a 21 nt 
conserved sequence of AC1/Rep shared between ACMV, EACMV and SACMV and 
the overlapping sequence between ACMV-[NG:Ogo:90] AC1 3’ end and AC2 5’ end 
(AC1 3’/AC2 5’-ter). 
ii. Clone the IR constructs into pART7 expression vector. 
iii. Clone the hairpin cassette constructs into plant transformation vector pCambia 
1305.1. 
iv. Mobilize pCambia 1305.1/IR into Agrobacterium LBA 4404. 
Cassava T200 FEC induction. 
v. Agrobacterium-mediated transformation of FEC with pCambia/IR construct 
(described in iv) 
vi. Regeneration of transformed FECs. 
vii. Selection of plants for transgene integration using visual and molecular screening 
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4.2 Methodology flow chart 
 
 
Figure 4. 1 Flow diagram of the methodology in construct design cloning and transformation 
into cassava T200 FECs 
  
Screening and analysis for positive transgenic plants 
Regeneration of transformed plants into transgenic 
plants 
Selection of transformed FECs on selection media 
Co-culture of  FECs and Agrobacterium LBA4404 with 
construct 
Mobilize pCambia 1305.1/IR into Agrobacterium LBA 
4404 
Sequencial cloning of IR construct into pART7 and then 
into pCambia 1305.1 
Design an IR construct targeting  ACMV as well as 
being affecient against  SACMV and EACMV 
FECs induction from 
T200 explants 
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 4.3 Materials and Methods 
 
4.3.1 Target selection and alignment. 
For selection of the construct target regions, the three CBVs ACMV-[NG:Ogo:90], SACMV 
and EACMV DNA A with accession number obtained from Fauquet et al. (2008); Berries et 
al, (2001) and Fauquet et al, (2008), respectively, were obtained. Vector NTI Advance suit 
(version 10.3) software was used to align the three DNA-A sequences. ACMV-[NG:Ogo:90] 
DNA-A sequence was used to search for the putative leafward promoter region. The second 
region to be targeted on the ACMV-[NG:Ogo:90] DNA-A was the overlapping region 
between AC1 3’ end and the AC2 5’ end. The target region estimated to be between 1200 nt 
and 1600 nt on ACMV-[CM] ORF was shown by Challappan et al, 2004 to be a high target 
for PTGS. To obtain the conserved sequence of AC1/Rep shared between ACMV, EACMV 
and SACMV, the 3 accession numbers were entered into National Centre for 
Biotechnological Information site (NCBI). Clusta X Multiple Sequence Alignment Program 
(Version1.8; 1999) was used to align the 3 CBV isolates AC1 gene to search for a conserved 
region. The 3 chosen regions, ACMV-[NG:Ogo:90] putative promoter region, a 21 nt 
conserved sequence of AC1/Rep shared between ACMV, EACMV and SACMV and the 
overlapping sequence between ACMV-[NG:Ogo:90] AC1 3’ end and AC2 5’ end (AC1 
3’/AC2 5’-ter) were combined to design our transgene IR sequence. The IR construct was 
designed in Benchling software (Benchling, Inc) to consist of sense and antisense orientation 
of our transgene whilst being separated by an 85 bp intron (Vanderschuren et al., 2009). The 
IR construct design was sent to Life Technologies (SA) for synthesis. 
4.3.2 Digestion and cloning of IR hairpin in pART7 
The synthesised IR construct (Life Technologies, SA) was cloned plasmid pMK-RQ. The 
plasmid was digested with EcoRI and HindIII enzymes (Fermentas) to cut out the IR 
construct. The vector pART7 was also subsequently digested with EcoRI and HindIII 
enzymes. A 1% agarose gel was used to analyse the digested samples. The 534 bp 
corresponding to the IR size from pMK-RQ digest was then excised from the gel. The 5013 
bp fragment from the EcoRI and HindIII digested pART7 was also excised. The 2 excised 
fragments were extracted using GeneJET extraction kit (Thermoscientific), and quantified 
using NanoDrop 1000 Spectrometer (V3.7). The two fragments with cohesive EcoRI and 
HindIII ends were ligated in a 1:1 molar ratio using 1X ligation buffer and 1U T4 DNA ligase 
(Fermentas) in a 20 µl reaction. The ligation reaction was incubated at 16°C overnight. Then 
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5 µl of the ligation reaction was used to transform DH5 α chemically competent cells. The 
transformed DH5 α were spread on LB Agar plates supplemented with 100 mg/ml ampicilin. 
The plates were incubated at 37°C overnight. 
4.3.3 Screening of clones 
A few colonies were randomly selected from the LBA plate and plasmid DNA was extracted 
using the GeneJET Miniprep Kit (ThermoScientific). The plasmid extracted was screened for 
insertion of the 229 bp transgene using Pro1 forward primers and Rev3 reverse primer Table 
1. The reaction mixture contained 1X Taq buffer, 0.2 mM dNTPs, 0.2 μM of each primer, 1U 
Taq recombinant enzyme (Fermentas), 20 ng of template DNA and nuclease free water to a 
final volume of 50 μl. The  reactions was set up in a thermal cycler (Bio-Rad) with reaction 
conditions set at 94°C for 2 min and 35 cycles 94°C for 30 s, 55°C for 30 s, primer extension 
at 72°C for 30 s and final extension step of 72°C for 10 min. For detection of the sense 
orientation of the IR construct Pro1 forward primer and intron reverse primers Table 1 were 
used for PCR with the same reaction mixture and same reaction conditions as above. For 
detection of the antisense orientation, the small intron forward primer and Pro1 forward 
primers were used. The 85 bp intron was also screened using the intron forward and reverse 
primer Table 4.1 under annealing temperature of 55°C. To check the orientation of the IR 
construct in relation to the pART7 Nopaline synthase (NOS) terminator and Cauliflower 
mosaic virus (CaMV) promoter pART7 forward and intron reverse primers were used for the 
sense orientation. For the antisense orientation of the IR construct in regards to the pART7, 
pART7 reverse primer and Rev 3 primer were used for PCR with the same reaction mixture 
and reaction conditions as above. A restriction digest of the pART7/IR construct with EcoRI 
and HindIII enzymes was performed to check for the presence of the 543 bp IR.  
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Table 4. 1 Primers used to screen for the IR construct 
Primer                                                 Primer sequence   5’ -3’                             
Pro 1 forward (construt forward)        TTGAACTTTAATTTGAATTAAAAGG                        
Rev 3 reverse (construct reverse)         TGCAATCTTCATCACCCTCACAGA 
Intron forward                                     GATATTTAAATTATTTAT 
Intron reverse                                      GCGCTCGTACCTGCAGTATA 
 pART7 forward                                  GTTTGTTATTGTGGCGCTCTATC 
 pART7 reverse                                    CCCAGCTATCTGTCACTTCATC 
4.3.4 Cloning of IR cassette into pCambia 1305.1 
A restriction digest of the, pART7/IR construct was done with NotI enzyme and blunt ended 
to separate the CaMV-IR-NOS terminater cassette. Plant transformation vector pCambia 
1305.1 was digested with EcoRI and HindIII (Fermentas). T4 DNA polymerase (Fermentas) 
was used to blunt-end both the CaMV-IR-NOS cassette and pCambia 1305.1 digests. The 
blunt polished ends of pCambia 1305.1 digested fragments were then dephosphorylated using 
FastAP (Fermentas). A 1% agarose gel was used to analyse the digested samples. The 2641 
bp and 11,796 bp corresponding to the CaMV-IR-NOS cassette and pCambia 1305.1 digests, 
respectively, were then excised from the gel. The two excised fragments were extracted using 
GeneJET extraction kit (Thermoscientific) and quantifies using NanoDrop 1000 
Spectrometer (V3.7). The three fragments were ligated in a 1:6 molar ratio using 1X ligation 
buffer and 1U T4 DNA ligase (Fermentas) in a 20 µl reaction. The ligation reaction was 
incubated at 16°C overnight. Five µl of the ligation reaction was used to transform DH5 α 
chemically competent cells. The transformed DH5α were spread on LB Agar plates 
supplemented with 50 mg/ml kanamycin. The plates were incubated at 37°C overnight. 
4.3.5 Screening of plant transformation vector for presence of IR cassette. 
Plasmid DNA was extracted from the presumptive clones using GeneJET Miniprep Kit 
(ThermoScientific). The plasmids extracted were screened for insertion of the 314 bp 
transgene plus intron in the sense and antisense orientation as described in 4.3.3. The clones 
were also screened for presence of the glucuronidase (GUS) and a portion of the hyg genes. 
Both genes are found on the pCambia 1305.1 vector. To amplify the 181 bp GUS gene; 
GUSPLUS F (5’-CAACATCCTCGACGACGATAGCA-3’) and GUSPLUS R (5’-
GGTCACAACCGAGATCTCCT-3’) primers were used. For hyg screening primer set; hyg F 
(5’-TCTCGATGAGCTCATGCTTTGG-3’) and hyg R (5’-
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AGTACTTCTACACAGCCATGGG-3’) were used to amplify a 444 bp portion of the hyg 
resistance gene. The PCR reaction mixture contained 1X Taq buffer, 0.2 mM dNTPs, 0.2 μM 
of each primer, 1U Taq recombinant enzyme (Fermentas), 20 ng of template DNA and 
nuclease free water to a final volume of 50 μl. The reactions was set up in a thermal cycler 
(Bio-Rad) with reaction conditions set at 94°C for 2 min and 35 cycles 94°C for 30s, 55°C 
for 30 s, primer extension at 72°C for 30s and final extension step of 72°C for 10 min. 
Fragments were analysed by electrophoresis on a 1% agarose gel containing 10 μg/ml 
ethidium bromide in a 1X TAE buffer. The positive clones were also digested with NotI 
enzyme to separate the 2641 bp CaMV-IR-NOS cassette. Digests were analysed on 1% 
agarose gel. A positive clone of the pCambia/IR was sent off for automated sequencing by 
Inqaba Biotechnical Industries (Pretoria, South Africa). The clones were sequenced using 
P27-3 and P27-5 primers. Multiple sequence alignment to confirm correct orientation of the 
IR cassette was performed using Benchling software (Benchling, Inc). 
4.3.6 Transformation of A. tumefaciens LBA 4404 with IR hairpin cassettes  
Freeze-thaw method was used to transform A. tumefaciens LBA 4404 with a positive plasmid 
of pCambia/IR. Five hundred ng of pCambia/IR purified plasmid was added to 100 µl of 
chemically competent A. tumefaciens LBA4404 cells previously stored at -70°C. The mixture 
was placed on ice to thaw and it was mixed intermittently. This was then snap-frozen in 
liquid nitrogen for 5 min followed by thawing at room temperature. A 2 ml Yeast extract-
phosphate (YEP) broth was then added to transformed cells. This was incubated at 28°C for 3 
hrs with gentle shaking (50 rpm). After the incubation period, transformed cells were 
centrifuged for 5 min at maximum speed and the supernatant discarded. The pellet was 
resuspended in 50 µl YEP. Transformed cells were then spread on YEP plate containing 50 
µg/ml rifampicillin, 50 µg/ml kanamycin and 100 µg/ml streptomycin and incubated at 28°C 
for 2 days until colonies appeared.  
4.3.7 Screening of A. tumefaciens LBA4404 for the presence RNA silencing hairpin 
constructs. 
Colonies from the A. tumefaciens LBA4404 transformation plates were selected and grown 
overnight at 28°C and 200 rpm in YEP broth containing 50 µg/ml rifampicin, 50 µg/ml 
kanamycin and 100 µg/ml streptomycin. Plasmid DNA was then extracted from presumptive 
clones and PCR was done to screen for the presence of the GUSPLUS, hyg genes and the IR 
construct in both orientations as described in 4.3.5. Amplicons were analysed by 
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electrophoresis on a 1% agarose gel containing 10 μg/ml ethidium bromide in a 1X TAE 
buffer. 
4.3.8 Preparation of A. tumefaciens inoculums 
The pCambia 1305.1/IR construct transformed into A. tumefaciens LBA4044, and A. 
tumefaciens transformed with empty pCambia 1305.1 plant transformation vector, were 
streaked each on Yeast extract peptone (YEP) medium consisting of 5 g/L Yeast extract, 5g 
Bacto-peptone and 10 g/L Sodium chloride, solidified with 15 g/L bacterial agar and pH was 
adjusted to 7.2. Autoclaved YEP medium was supplemented with 50 µg/ml kanamycin, 50 
µg/ml rifampicin and 100 µg/ml streptomycin of antibiotics. Plates were streaked with the 2 
Agrobacterium strains and incubated at 28°C in the dark for 2 days. A single colony obtained 
from each of the plates was inoculated in YEP supplemented with appropriate antibiotics and 
2 mM MgSO4. The inoculated YEP was cultured overnight in the dark at 28°C with shaking 
at 200 rpm.  
Cultures were grown until an optical density (OD) of 0.7-1.0, at λ=600 nm was reached. 
From this culture 0.5 ml was removed and inoculated in 25 ml of YEP with appropriate 
antibiotics and 2 mM MgSO4. The culture was grown overnight in the dark at 28°C with 
shaking at 200 rpm. The OD was measured and when an OD of 0.7-1.0 at λ=600 nm was 
obtained, the bacterial suspension was centrifuged in a sterile 50 ml centrifuge tube at 4000 g 
for 10 min at room temperature. The supernatant was removed and the pellet was 
resuspended in 25 ml of liquid GD medium. The suspension was centrifuged again at 4000 g 
for 10 min at room temperature. The supernatant was removed and the centrifuge tube was 
blotted on tissue paper to remove excess liquid. The pellet was resuspended in GD liquid and 
diluted to an OD600 of 0.5. Acetosyringone was added to a final concentration of 200 μM. 
The cultures were placed on a horizontal shaker (50 rpm) at room temperature for 45 min. 
4.3.9 Agrobacterium-mediated transformation of FEC 
The transformed A. tumefaciens inoculum prepared in section 4.3.8 were used to transform 
FECs (10 FEC clumps/plate). For the experiment seven T200 FEC plates were inoculated 
with A. tumefaciens transformed with the pCambia 1305.1/IR plasmid. Then 1 plate was 
inoculated with A. tumefaciens transformed with an empty pCambia plasmid and another 
plate was inoculated with an empty A. tumefaciens culture. One of the plates was left 
untransformed and was used as a control for regeneration. For the inoculation 100 µl of the 
respective A. tumefaciens was pipette onto each FEC in order to soak the FEC clusters. Plates 
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were then incubated in the laminar flow uncovered for ~5 min and then sealed with parafilm. 
The transformed FEC with the bacterial suspensions and the controls were co-cultivated at 
24°C for 4 days in 16 h light/8h dark photoperiod. 
4.3.10 Removal of excess A. tumefaciens 
After 4 days of co-cultivation period, FECs were gently scraped off the plates using sterile 
forceps and placed in 50 ml tubes containing 25 ml of GD liquid supplemented with 500 
µg/ml carbenicillin. The suspension was vortexed briefly for 5-10 sec and the FEC were 
allowed to settle. A 25 ml pipette was then used to remove the supernatant, leaving the FECs 
at the bottom of the tube. Again 25 ml of GD liquid supplemented with 500 µg/ml 
carbenicillin was added and FECs were washed by gently inverting the tube. The washing of 
FEC in the GD liquid containing 500 µg/ml carbenicillin was repeated ~5 times until the 
supernatant became clear. Once the washing GD was clear, the FECs were resuspended in 
~10 ml of GD liquid containing 500 µg/ml carbenicillin. The FEC suspensions were pipetted 
and spread thinly and evenly onto ~10 sterile plastic meshes (pour size of 100 μm). The 
meshes with the FECs were then blotted each placed on top of 3 layers of sterile filter paper 
to allow for absorption of excess liquid off the FEC.  
4.3.11 Recovery of transformed FEC 
After A. tumefaciens mediated transformation a recovery stage for the FECs is necessary. The 
mesh/FECs were transferred to GD plates supplemented with 250 µg/ml carbenicillin to 
facilitate for recovery. The mesh/FEC GD Plates were incubated  for 4 days at 28°C for 16 h 
light/8 h dark photoperiod. 
4.3.12 Maturation of transformed FECs 
For FEC maturation and initiation of antibiotic resistance mesh/FECs were  moved to GD 
containing 250 µg/ml carbenicillin and 5 µg/ml hygromycin for a week at 28°C with 16 h 
light/8 h dark photoperiod. After a week mesh/FEC were moved to GD containing 250 µg/ml 
carbenicillin supplemented with 8 µg/ml hygromycin for another week at 28°C with 16 h 
light/8 h dark photoperiod. The step wise antibiotic selection was rounded off with moving 
the mesh/FECs to GD containing 250 µg/ml carbenicillin and 15 µg/ml hygromycin for a 
week at 28°C with 16 h light/8 h dark photoperiod. 
4.3.13 Determination of transformation success 
To determine the transformation success of the FECs a GUSPLUS assay was performed on a 
small section of putatively transformed material from the mesh/FEC. A small section of FECs 
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from untransformed T200 plates was tested as the negative control. The isolated FECs were 
incubated in GUSPLUS assay solution (100 mM Tris/NaCl buffer, 1 mg/ml 5-bromo-4-
chloro-3-indolyl-β-D-glucuronic acid (X-Gluc) and 1% Triton X-100) at 37°C overnight in 
the dark .The next day GUSPLUS solution was removed and the material were destained in 
70% ethanol, and FECs viewed for staining. 
4.3.14 Selection and regeneration of transgenic plants 
To stimulate the maturation and regeneration of transformed FECs the mesh/FECs were 
moved to MSN consisting of 4.4 g MS2 medium containing, 20g sucrose, 1 µg/ml 1-
Naphthaleneacetic acid (NAA), 15 µg/ml hygromycin and 250 µg/ml carbenicillin. The pH 
was adjusted to 5.8 and media was solidified with 8 g/L Noble agar. Mesh/FECs were 
maintained on MSN for 10 days at 28°C with 16 h light/8 h dark photoperiod. The 
mesh/FECs were subsequently transferred to fresh MSN every 10 days with incubation 
conditions 28°C with 16 h light/8 h dark photoperiod. The transfer of mesh/FECs was done 8 
times. Between cycle 4 and 8 cotyledons started emerging and these were moved to cassava 
elongation medium (CEM) which consisted of MS2 supplemented with 0.4 µg/ml 6-
benzylaminopurine (BAP) a synthetic cytokinin, 20 g/L of sucrose, 2 μM CuSO4 and 100 
µg/ml carbenicillin. The media pH was adjusted to 5.8 and solidified with 8 mg/ml gelrite 
agar. Cotyledons were moved to fresh CEM every 14 days. After 3 cycles juvenile leaves and 
shoots were supposed to appear but this was note the case and the regeneration experiment 
was abandoned. 
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4.4 Results 
4.4.1 Target selection and alignment 
ACMV-[Nigeria: Ororoco, 1990] DNA A was aligned to SACMV DNA A and EACMV 
using Clustal X Multiple Sequence Alignment Program (Version1.8; 1999). For selection of 
the ACMV-[NG:Ogo:90] DNA-A first target site, the putative promoter region was identified 
upstream in the common region from the 5’end of ACMV-[NG:Ogo:90] AC4 complementary 
sense ORF to the TATA box plus an additional 49 nt upstream with core elements of the 
leftward promoter and ending at the transcriptional start site of AC1. This 117 nt region was 
identified between 2714 nt and 49 nt. There was a 50.4% sequence similarity between this 
chosen putative promoter region on ACMV-[NG:Ogo:90] DNA-A and the corresponding 
region on SACMV DNA A and EACMV DNA A (fig 4.2). 
 
Figure 4. 2 A segment of the multiple sequence alignment output screen. Alignment was 
performed on 3 CBV isolates ACMV, SACMV and EACMV to identify the sequence 
similarity between the chosen putative promoter region on ACMV-[NG:Ogo:90] DNA-A and 
the corresponding region on SACMV DNA A and EACMV DNA A around the TATA box 
(circled) 
The second region to be targeted was the overlapping sequence between ACMV-
[NG:Ogo:90] AC1 3’ end and AC2 5’ end (AC1 3’/AC2 5’-ter). A 91 nt region between 
1530-1620 nt was chosen on the overlapping region (fig 4.7). Clustal X Multiple Sequence 
Alignment showed that there is a 64% sequence similarity between this 91 nt AC1 3’/AC2 
5’-ter overlapping region on ACMV-[NG:Ogo:90] DNA-A and the corresponding region on 
SACMV DNA A and EACMV DNA A 
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Figure 4. 3 A segment of the multiple sequence alignment output screen. Showing the second 
chosen region, a 90 nt region between 1530-1620 nt on the overlapping region of ACMV-
[NG:Ogo:90] DNA-A AC1 3’ end and AC2 5’ end (AC1 3’/AC2 5’-ter). Alignment was 
performed on 3 CBVs ACMV, SACMV and EACMV to identify the sequence similarity 
between this 90 nt AC1 3’/AC2 5’-ter overlapping region on ACMV-[NG:Ogo:90] DNA-A 
and the corresponding region on SACMV DNA A and EACMV DNA A. 
Clusta X Multiple Sequence Alignment Program (Version1.8; 1999) was used to align the 
DNA-A AC1 ORFs of ACMV-[NG:Ogo:90], SACMV and EACMV to search for a 
conserved region. The conserved 21 bp region was identified between 1970-1990 nt on 
ACMV-[NG:Ogo:90] DNA-A and the corresponding region on SACMV DNA A and 
EACMV DNA A.  
 
Figure 4. 4 A segment of the multiple sequence alignment output screen. Alignment was 
performed on DNA-A AC1 ORFs of ACMV, SACMV and EACMV to identify a 21 nt 
conserved region along the AC1 genome 
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Figure 4. 5 Diagram of ACMV-[NG:Ogo:90] DNA-A highlighting the three transgene target 
areas, ACMV-[NG:Ogo:90] 117 nt putative promoter region (2714-49 nt), 21 nt ACMV-
[NG:Ogo:90], SACMV and EACMV AC1 conserved region (1970-1990) and the 91 nt 
ACMV-[NG:Ogo:90] AC1 3’/AC2 5’ter overlapping region (1530-1620) all shown in orange 
 
The three identified sequences ACMV-[NG:Ogo:90] 117 nt putative promoter region (2714-
49 nt), 21 nt ACMV-[NG:Ogo:90], SACMV and EACMV AC1 conserved region (1970-
1990 nt) and the 91 nt ACMV-[NG:Ogo:90] AC1 3’/AC2 5’ter (1530-1620 nt) were 
combined to design our transgene sequence (229 bp) code named DM-AES (fig 4.6).  
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Figure 4. 6 The combined (DM-AES) transgene sequence consisting of the ACMV-
[NG:Ogo:90] 117 nt putative promoter region (white background), the 21 nt ACMV-
[NG:Ogo:90], SACMV and EACMV AC1 conserved region (yellow background) and the 91 
nt ACMV-[NG:Ogo:90] AC1 3’/AC2 5’ter 
 
The three proposed potential target areas were entered into pssRNAit 
(http://plantgrn.noble.org/pssRNAit/) a modified version of siRNA scan program (Xu et al., 
2006) to predict possible siRNAs target hot spots. Table 4.2 shows the 8 possible siRNAs 
from the ACMV-[NG:Ogo:90] 117 nt putative promoter region Table 4.3 shows some of the 
46 possible hit from the 91 nt ACMV-[NG:Ogo:90] AC1 3’/AC2 5’ter overlapping region. 
The 21 nt ACMV-[NG:Ogo:90], SACMV and EACMV AC1 conserved region generates 
only one possible siRNA. 
 
Table 4. 2 siRNA scan computational results predicting regions along the ACMV-
[NG:Ogo:90] 117 nt putative promoter region where effective siRNA could be generated 
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Table 4. 3 siRNA scan computational results predicting regions along the 91 nt ACMV-
[NG:Ogo:90] AC1 3’/AC2 5’ter overlapping region where effective siRNA could be 
generated 
 
 
The IR construct was designed to consist of sense and antisense orientation of our transgene 
(229 bp) sequence whilst being separated by a 85 bp intron sequence. (fig 4.7).  
 
 
Figure 4. 7 A schematic representation of the IR construct with the intron separating the 
sense transgene from the antisense transgene 
The designed IR construct sequence was entered into Mfold secondary structure prediction 
software (Zucker, 2003) (http://www.bioinfo.rpi.edu/applications/mfold) to predict the 
possible RNA structure of the IR construct once expressed. Folding was done under 
conditions 37°C; ionic condition fixed at [Na
+
]=1 M and [Mg
++
]= 0 M and energy at 
1kcal/mol. fig 4.8 shows the predicted hairpin structure. 
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Figure 4. 8 Computer predicted secondary structure of the IR construct sequence 
4.4.2 Digestion and cloning of IR hairpin in pART7 
The results showed the successful EcoRI /HindIII restriction of the 543 bp IR construct from 
pMK-RQ plasmid (fig 4.9c), and successful cloning into vector pART7.  
 
Figure 4. 9 1% agarose gel showing pMK-RQ/IR plasmid clones EcoRI and HindIII 
digestions. Lane 1= O’GeneRuler 1 kb Plus DNA ladder, Lane (a) Undigested pART7 Lane 
(b) Digested pART7 (c) Digested pMK-RQ/IR plasmid showing the released IR 543 bp 
fragment 
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4.4.3 Screening of clones 
Positive clones from the IR/ pART7 ligation and cloning were positive for PCR of the 
construct, intron, sense arm of the transgene and the antisense arm of the transgene (fig 4.10), 
and were in the right orientation (fig 4.11). The results showed a colony positive for the 
transgene in pART7 and the correct orientation  
 
Figure 4. 10 PCR amplification to screen for presence and orientation of inserts in the 
completed hairpin constructs. O’GeneRuler 1 kb Plus DNA (Fermentas) (a) 229 bp full 
transgene construct amplicon. (b) 85 bp intron amplicon (c) 314 bp amplicon to confirm the 
sense orientation (d) 314 bp amplicon to confirm the antisense orientation 
 
Figure 4. 11 A schematic representation of the IR cassette between the CaMV promoter and 
the (NOS) terminator in pART7. The figure also shows the position of the primers used to 
confirm the orientation of the IR cassette between the CaMV promoter and the NOS 
terminator 
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Figure 4. 12 PCR amplification to screen for presence and orientation of inserts 
after.ligation. Lane 1 O’GeneRuler 1 kb Plus DNA (Fermentas) (a) (b) 229 bp transgene 
amplicon (c) (d) Sense orientation confirmation amplicons.(e) (f) Antisense orientation 
confirmation amplicons 
Restriction digestion was also done to confirm the presence of the IR cassette. NotI digest of 
the pART7/IR produced the 2641 bp cassette (CaMV35S promoter, the two 229 bp sense and 
229bp antisense hairpin arms and the OCS terminator) (fig 4.13, lane a). EcoRI and HindIII 
digestion of the pART7/IR positive plasmid produced the expected 543bp IR construct (fig 
4.13, lane b). 
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Figure 4. 13 1% agarose gel showing pART7/IR plasmid digestion to screen clones for 
successful ligation of the IR. Lane 3= O’GeneRuler 1 kb Plus DNA ladder, Lane (a) NotI 
digest showing 2641 bp cassette (CaMV35S promoter, the two 229 bp sense and 229 bp 
antisense hairpin arms and the OCS terminator) Lane (b) EcoRI and HindIII digest showing 
543 bp IR released fragment (lane b) 
4.4.4 Cloning of IR cassette into pCambia 1305.1. 
The expression cassette in pART7 was restricted out using NotI enzyme (fig 4.13) and cloned 
into plant transformation vector pCambia 1305.1 restricted with EcoRI and HindIII. Both 
restricted fragments were blunt-ended before being ligated. Ligation was successful and this 
was confirmed by PCR amplification of the sense and antisense arms of the transgene as well 
as GUSPLUS and hyg marker genes on the pCambia backbone (fig 4.14). 
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Figure 4. 14 1% agarose gel of, PCR amplified products to screen for successful ligation and 
presence of IR cassette in plant transformation vector p1305.1. Lane 1= O’GeneRuler 1 kb 
Plus DNA ladder (Fermentas), Lane 2, 181 bp GUSPLUS amplicon, Lane 3, 485 bp hyg 
amplicon, Lane 4, transgene sense+ intron 314 bp amplicon, Lane 5, intron+ transgene 
antisense 314 bp amplicon 
 
Figure 4 15 A schematic representation of the transformation cassette with CaMV 35S 
promoter and NOS terminator as well as the transgene IR within the pCambia left and right 
border. The figure also shows the location of the primers used to confirm the presents of the 
transgene 
4.4.5 Transformation of constructs into Agrobacterium LBA4404 
The IR/pCambia plasmid was successfully transformed into Agrobacterium LBA4404. The 
transformation was successfully confirmed as described in 4.4.5 by PCR amplification of the 
hyg, GUSPLUS and insert gene as shown in fig 4.16.  
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Figure 4. 16 1% agarose gel of, PCR amplified products to screen for successful ligation and 
presence of IR/pCambia in Agrobacterium. Lane 1= O’GeneRuler 1 kb Plus DNA ladder 
(Fermentas); Lane 2, 181 bp GUSPLUS amplicon; Lane 3, 485 bp hyg amplicon; Lane 4, 
transgene sense+ intron 314 bp amplicon; Lane 5, intron+ transgene antisense 314 bp 
amplicon 
4.4.6 FEC transformation and cotyledon development 
Seven T200 FEC plates were inoculated with A. tumefaciens transformed with the pCambia 
1305.1/IR plasmid vector. One plate was inoculated with A. tumefaciens transformed with an 
empty pCambia 1305.1 plasmid vector and another plate was inoculated with A. tumefaciens 
(no vector) culture. Another plate of T200 FECs was left untransformed. Transformed FECs 
were positive for transformation by the GUSPLUS assay, as evidenced transformation by the 
blue stained FEC (fig. 4.17c). FECs were moved to Murashige and Skoog Media 
supplemented with 1mg/ml naphthaleneacetic acid (MSN) media for cotyledon development. 
Only untransformed T200 FECs produced few embryos after 4 cycles on MSN+H15 media 
(fig.4.17d). FEC were transferred to fresh MSN+H15 6 times (after every 10 days). The 
transformed FECs did not develop into cotyledons. 
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Figure 4. 17 Steps in producing transgenic plants (a) T200 FECs chosen for transformation 
(b) FEC clumps following co-cultivation spread onto mesh on GD + C250 (c) Blue stained 
FEC after GUSPLUS assay (d) Small cotyledon (arrow) from untransformed T200 control 
cotyledon after 4 weeks on MSN+C250+H15 
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4.5. Discussion 
The objective of this study was to design an inverted repeat IR construct to target ACMV-
[NG:Ogo:90] more efficiently, but concomitantly also be able to target other ACMV genetic 
variants, EACMV and SACMV, since all these CBVs are widely spread in eastern and 
southern Africa. Resistance against the ACMV and the other two CBVs was designed 
through selection of an ACMV-[NG:Ogo:90] 117 nt putative promoter region, 91 nt ACMV-
[NG:Ogo:90] AC1 3’/AC2 5’ter high siRNA producing overlapping region and a 21 nt 
ACMV-[NG:Ogo:90], SACMV and EACMV AC1 conserved region. The second objective 
was to transform the construct into South African cassava landrace T200 FECs. T200 was 
chosen as it is an industry-prefered landrace with high starch content. 
Selection of target region for IR construction 
Sequence similarities between ACMV variants have been reported (Fauquet et al., 2007; Pita 
et al., 2001). Full DNA sequence variations have been reported for EACMV and EACMV 
variants (Fondong et al., 2000). Only two closely related variants or strains of SACMV have 
been reported from Zimbabwe (Briddon et al., 2003) and Madagascar (Harimalala et al., 
2012). For this study it was important to target regions that would confir resistance to 
ACMV-[NG:Ogo:90]. We chose the CR in the intergenic region of DNA A/B as this is where 
the leftward promoter of AC1, TATA box as well as iterons resides (Henley-Bowdin et al., 
1999). By inducing siRNA-mediated TGS of the promoter binding regions on the ACMV-
[NG:Ogo:90] putative promoter region , it was hypothesised that transcription of the viruses 
would be impaired, leading to greater resistance. The unifying feature of geminiviruses, the 
invariant concensus nucleotide sequence TAATATTAC which makes up the stem loop 
structure of the common region. (Varma and Malathi, 2005) was identified. We then selected 
a 117 bp sequence from the 5’end of ACMV-[NG:Ogo:90] AC4 complementary sense ORF 
to the TATA box plus an additional 49 nt upstream with core elements of the leftward 
promoter.Vanderschuren et al. (2007) reported reduced symptoms and viral load when 
sequence corresponding to bidirectional promoter region and common region was used to 
transform cassava, and was also shown to target the promoter region in Mungbean yellow 
mosaic virus-infected mungbean (Pooggin et al., 2003). We expected this putative promoter 
region in our construct to induce the same resistance to CMD through TGS targeting the viral 
DNA. Transcriptional gene silencing has been shown to occur by methylation between 
similar regions of the promoter region and the target sequence (Xie et al., 2004; Wu et al., 
2010). 
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For our second target region we required a highly conserved region (100% match) of ACMV-
[NG:Ogo:90], SACMV and EACMV AC1 coding sequence. Geminivirus resistance has been 
reported in transgenic plants expressing dRNA IRs (hairpins) homologous to Rep/AC1 
(Ammara et al., 2015; Fuentes et al., 2006; Vanderchuren et al., 2009; Ye et al., 2014). The 
AC1 gene codes for REP protein essential for replication (Vanitharani et al., 2005). Targeting 
a homologous region of AC1 would inevitably stop viral replication of the three CMGs. In 
our alignment results we identified a 21 nucleotide sequence with 100% sequence similarity 
between ACMV-[NG:Ogo:90], SACMV and EACMV. We predict that if this region could 
produce siRNA it would target the mRNA of the three CMGs offering broad spectrum 
resistance to the three CBVs. This still need to be tested in future experiments as 
transformation was not successful in this study. 
The most widely used parameter for selection of target regions is the selection of siRNA 
hotspots on the viral ORF. Chellapan et al. (2004) reported that the ACMV-[CM] AC1 3’-
ter/AC2 5’-ter overlapping region produces high levels of virus induced siRNAs. For our 
third target region we selected a 91 nt sequence (1530-1620 nt) of the same region as 
Chellapan et al. (2004) but this time on ACMV-[NG:Ogo:90] strain. We predicted that the 
chosen region would produce high levels of siRNAs as there was a 97% sequence similarity 
between ACMV Cameroon [CM] and ACMV-[NG:Ogo:90]. It is therefore most likely that 
an inverted repeat construct consisting of this AC1 3’/AC2 5’ overlapping region would 
produce efficient siRNAs targeting ACMV-[NG:Ogo:90]. 
Efficiency of siRNAs production 
We investigated the probable efficiency of our designed IR construct to produce siRNAs. 
Based on the siRNA scan (Xu et al., 2006) output, eight siRNAs were predicted for the 
ACMV-[NG:Ogo:90] putative promoter region and forty six siRNAs were predicted from the 
ACMV-[CM] AC1 3’-ter/AC2 5’-ter overlapping region. Our results clearly show that the 
ACMV-[CM] AC1 3’-ter/AC2 5’-ter overlapping region is a siRNA hotspot (Table 4.3). 
These result were expected in ACMV-[NG:Ogo:90] as Chellapan et al. (2004) had previously 
shown high levels of virus induced siRNA in ACMV-[CM] which is 97% similarity to 
ACMV [NG] (Fondong et al., 2000). High levels of siRNAs from introduced transgenes in 
plants have been reported to correlate with viral resistance, and threrefore it is predicted that 
the designed construct would be in this regard efficient in inducing resistance. Stacking of 
122 
 
three regions has not been reported in the literature to our knowledge, and testing this IR 
contstruct will prove interesting in further studies. 
Stability of the inverted repeat (IR) construct 
We designed our IR construct to produce a hairpin structure on expression in a host plant. To 
confirm the secondary structure of the IR, Mfold software (Zucker, 2003) 
(http://www.bioinfo.rpi.edu/applications/mfold) was used to predict the structure of the 
expressed IR. From our result a symmetrical haipin loop was predicted (fig 4.8). 
Theoretically this structure would be ideal to induce PTGS. In a plant cell a ribonuclease III 
like enzyme called Dicer recognises foreign double stranded RNA and cuts the double 
stranded RNA into small siRNA of between 21-26 nt therefore triggering post-transcriptional 
gene silencing (Baulcombe, 2004; Hammond et al., 2000; Raja et al., 2010). In this study the 
IR construct was successfully cloned into pART7 expression vector, pCambia binary plant 
transformation vector as well as transformation into A. tumefaciens. In all cases the sense and 
antisense arms were successfully amplified and sequenced to confirm their presence in these 
vectors, thus proving that the IR was stable. Inverted repeat contructs are also reported to be 
more stable if smaller in size (Vanderschuren et al., 2009; Taha et al. 2016). The IR in this 
study was 229 nt per arm and contained a small intron (85 bp) (Vanderschuren et al., 2009), 
thereby increasing its predicted stability. The small size of IR constructs also helps to reduce 
the possibilities of off targets (Jackson et al., 2003; Pang et al., 1997). 
IR transformation into T200 FEC 
Agrobacterium tumefaciens harbouring the designed IR construct was used to transform T200 
FECs. GUSPLUS assay was performed one week after transformation of the FECs. Our 
results showed blue colour staining of the FECs confirming successful transformation (fig 
4.7c). Regeneration of transformed FECs was however unsuccessful. The seven plates of 
T200 FECs transformed with the IR construct as well as the A. tumefaciens only and 
pCambia (without IR) only controls also did not produce cotyledons. Untransformed T200 
FECs produced cotyledons but these did not produce shoots. These results were unusual 
because other researchers from our laboratory, including the study by Chetty et al. (2013) 
reported transformation success using T200 FECs. The potential of the construct having 
undesirable negative effects on the regeneration of FECs was ruled out because of the failure 
by our T200 FECs transformed with the empty pCambia vector control to regenerate.  
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We hypothesise that the FECs used for the transformation were past their prime in terms of 
their age (number of transfers onto GD media). FECs had been transferred on 15 cycles (2 
weeks per cycle) of GD media were used. (Vanderschuren, personal communication) 
highlighted that successful regeneration of model cultivar cv.60444 is possible if FECs kept 
on GD media for less than 20 cycles are used. However Nyaboga et al., 2015 recommended 
that cassava landraces need to be optimised as their regeneration conditions might be 
different to model cultivar cv.60444. It is possible that after 15 cycles on GD the FECs had 
lost regeneration potential. FEC quality determines transformation success and older FECs 
have a minimal potential to regenerate (Raemakers et al., 2001; Bull et al., 2009). The other 
reason that might have constributed to failure of our FECs to regenerate could be the 
observation that after 5 weeks on MSN H15 FECs started browning. Excessive browning of 
FECs is synonymus with production of phynolics due to stress (He et al., 2009) so it is 
possible that the FECs were stressed. 
In conclusion we were able to successfully identify two suitable regions on the ACMV-
[NG:Ogo:90] viral genome which we predict to offer resistance to ACMV, as well as identify 
a third region which could possibly target SACMV and EACMV as well, if transformed into 
cassava. The designed IR construct was stable, free from undesirable secondary structure and 
was a predicted siRNA hot spot. The IR construct was successfully transformed in T200 
FECs, however the FECs could not regenerate, and we suspect that the FECs used were past 
their regeneration capacity. We recommend using fresh FECs for transformation of the 
designed IR into T200 cassava landrace. 
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Chapter 5: Conclusions 
 
This study aimed to evaluate selected cassava transgenic lines for resistance, tolerance or 
susceptibility to SACMV or ACMV. Cassava lines were derived from cassava cv.60444 
transformed with a mismatched inverted repeat construct or non mismatched constructs 
derived from either ACMV-[NG:Ogo:90] AC1/4:AC2/3 transgene (CMM6 lines) or SACMV 
BC1 movement protein sequence (AMM2 lines). The study objective was also to design an 
inverted repeat construct consisting of viral sequence that would target ACMV-[NG:Ogo:90] 
as well as being efficient in targeting SACMV and EACMV, due to the inclusion of a 21 bp 
sequence conserved sequence between EACMV, ACMV and SACMV and to transform the 
construct into South African landrace T200. In order to evaluate CMM6 or AMM2 lines 
(cv.60444 transformed with a non-mismatched or mismatched ACMV-[NG:Ogo:90] 
AC1/4:AC2/3, respectively) the chosen lines were infected with ACMV infectious clones and 
evaluated for resistance or tolerance by evaluating the extent of symptom proliferation, viral 
multiplication and growth patterns. The same evaluation was done for CMM8 (cv.60444 
transformed with a non mismatched BC1 sequence) and AMM4 lines (cv.60444 transformed 
with a mismatched BC1 sequence) but this time after infection with SACMV infectious 
clones. In summary, all transgenic lines showed reduced symptom scores and viral loads 
compared with infected untransformed cv.60444. From the ACMV infectivity trials we 
identified three lines CMM6-2, CMM6-6 and AMM2-52 which had significantly lower 
symptom scores and viral loads. These three lines were classified as being tolerant. The term 
tolerance and resistance have been subject to debate among cassava virologists. For this 
research we termed these three lines tolerant because they had mild symptoms due to low 
virus levels. This study, for the first time, showed that stacking of ACMV viral genes in an IR 
constructs is a viable method to induce tolerance against CBVs. To date in earlier studies, 
either mismatched or non mismatched IR constructs have been reported to induce CBV 
tolerance or resistance, but in this study a direct comparison of results was evaluated. A 
comparison between mismatched inverted repeat constructs or non mismatched constructs 
showed that both constructs are able to induce tolerance, and that slight differences in the 
level of induced viral alleviation were not significant. The construct targets were identical but 
the generation of siRNAs between mismatched and non-mismatched may have been 
different. It is possible that the quality and specific target of siRNAs produced rather than the 
quantity could be the key difference between tolerant and non-tolerant lines. Additionally, 
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differences might have been due to different IR integration stability in the plant genome. In 
terms of other studies on CBV resistance in cassava, this study is the first to explore the cell 
to cell movement protein in contrast to previous studies where significant levels of resistance 
have been reported in transgenic cassava expressing sense and antisense RNA of Rep, TrAP 
or REn proteins (Vanderschuren et al., 2009; Zheng et al., 2005).  
The significance of this study to farmers is that the tuber yield fresh and dry weight of these 
three transgenic lines was not significantly different from the yield of non-infected healthy 
cv.60444 highlighting that in these lines viral infection did not affect the yield therefore these 
tolerant lines would be beneficial to farmers. Recent GM food safety endorsements by NAS 
(2016) are likely to ease farmers and consumer fears on issues of surrounding GM foods. 
Cassava agro-processors are mostly interested in the tuber yield dry weigh. From this study, 
percentage dry weight of CMM6 and AMM2 transgenic lines were between 35-49% 
signifying a good yield according to literature. These results show that transgenic lines 
CMM6-2, CMM6-6 and AMM2-52 would be ideal for agro-processing. From the SACMV 
trials all transgenic lines had lower viral load and symptom severity scores compared with 
infected untransformed cv.60444 however none of the lines were tolerant (significantly lower 
sss and viral loads). Reduced viral load reported in the transgenic lines is reported in some 
cases to be linked to the production of transgene derived siRNAs which were not present in 
non-infected healthy cv.60444 prior to infection. Although all transgenic lines produced 
siRNAs only few were tolerant, and this further suggests that reduced viral load and 
symptoms is in part but not totally dependent on siRNA production. Contradictory results 
exist in the literature (Ntui et al., 2015; Vanderschuren et al., 2009) with regard to the 
correlation between siRNA and resistance, and further work needs to be done to learn more 
about this meolcular mechanism. Other factors such as the role of basal immunity-associated 
genes that might contribute to variations in the level of tolerance need to be further examined. 
The fact that the three tolerant transgenic CMM6 lines were transformed with silencing 
constructs targeting the ACMV-[NG:Ogo:90] DNA A region, and that none of the CMM8 
lines targeting the SACMV cell-to-cell movement protein BC1 were tolerant, suggest that 
BC1 may not be a suitable target for virus reduction. Perhaps PTGS concommittantly 
targeting sites on both the AC1/Rep and BC1 ORFs may be more efficient. The siRNA scan 
in silico did predict compatible siRNA production to the target regions on both AC1 and BC1 
ORFs, but perhaps this is not sufficient in vivo. One possible disadvantage of tolerance over 
resistance is that tolerant plants still harbour some viruses, albeit at low concentrations, and 
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these could be picked up by insect vectors. However studies on the correlation between viral 
load and vector transmission in the field would prove invaluable. 
The IR construct designed from ACMV-[NG:Ogo:90] genome in chapter 4 was shown to be 
stable, free from formation of undesirable secondary structure and the sequence was chosen 
from a predicted siRNA hotspot. If the predicted siRNA from the 21 nt ACMV-
[NG:Ogo:90], SACMV and EACMV AC1 conserved region efficiently bind to the viral 
mRNA, knockdown of the virus would be achieved resulting in high level of resistance to 
ACMV, SACMV and EACMV. The IR construct was successfully transformed in T200 
FECs however, transformed FECs could not regenerate, and we suspect that the FECs used 
were past their regeneration capacity. For future work the use of fresh FECs is recommended 
for transformation of the designed IR construct into T200 cassava variety. Other possible 
technologies can be explored to improve cassava against CMD such as using endogenous 
cisgenes to genetically modify cassava. The use of endogenous genes reduces health and 
environmental concerns brought about by using exogenous genes such as those from viruses. 
The most promising new technology in crop improvement is the use of gene editing tools. In 
cassava identifying genes that are involved in resistance and either enhancing them or 
modifying them using CRISPR (gene editing) is worth exploring further. 
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Appendices 
 
Appendix A Student t-test determining the significance of symptom severity, height and viral 
load between CMM6 lines and cv.60444s at 14, 36, 56 and 180dpi. 
 
Symptom severity score  Plant height   ACMV viral  load 
Line ID 14 dpi 36 dpi 56 dpi 14 dpi 36 dpi 56 dpi 36 dpi 56dpi 
CMM6-2 0,001259 0,00002486 0,00000129 0,00038 0,466606 0,090047 0.030282 0.04622 
CMM6-3 0,010441 0,20889350 0,129786466 0,020578 0,156219 0,422745 0.28888 0.471875 
CMM6-5 0,343372 0,055692794 0,134998144 0,002863 0,309185 0,141386 0.050609 0.217455 
CMM6-6 0,010936 0,000124811 0,00000397 0,000181 0,221183 0,061022 0.030456 0.04625 
CMM6-7 0,032308 0,299735155 0,457532144 0,061165 0,5 0,144466 0.137684 0.213042 
 
Appendix B Student t-test determining the significance of symptom severity, height and viral 
load between AMM2 lines and cv.60444s at 14, 36, 56 and 360dpi. 
 
Symptom severity score  Plant height   ACMV viral  load 
Line ID 14 dpi 36 dpi 56 dpi 14 dpi 36 dpi 56 dpi 36 dpi 56dpi 
AMM2-30 0,014796 0,022093481 0,08697419 0,099127 0,255631 0,079753 0,088046 0,055434 
AMM2-41 0,208894 0,274507219 0,0724638 0,300393 0,285371 0,434198 0,347369 0,034991 
AMM2-44 0,005617 0,000731791 0,0109361 0,089034 0,193752 0,299735 0,487195 0,054868 
AMM2-52 0,000597 0,0000171 0,000676392 0,033839 0,069634 0,210197 0,033817 0,032115 
AMM2-53 0,299735 0,129786466 0,0724638 0,017164 0,063966 0,123417 0,055077 0,151964 
AMM2-54 0,003657 0,005340745 0,170446566 0,138467 0,396628 0,339588 0,098866 0,092875 
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Appendix C Student t-test determining the significance of symptom severity, height and viral 
load between CMM8 lines and cv.60444s at 14, 36, 56 and 180 dpi. 
 
Symptom severity score  Plant height   ACMV viral  load 
Line ID 14 dpi 36 dpi 56 dpi 14 dpi 36 dpi 56 dpi 36 dpi 56dpi 
CMM8-1 0,024666 0,010936 0,001754 0,271625 0,321432 0,5 0,14958671 0,251861 
CMM8-3 0,5 0,299735 0,104692 0,389807 0,171579 0,402012 0,126146045 0,265238 
CMM8-8 0,223769 0,010936 0,024666 0,5 0,202439 0,429851 0,121471665 0,176172 
CMM8-23 0,170447 0,010936 0,000597 0,196561 0,085829 0,429851 0,127349627 0,282849 
CMM8-25 0,170447 0,032308 0,001754 0,389807 0,405817 0,151766 0,132830793 0,281329 
CMM8-27 0,010936 0,299735 0,299735 0,394754 0,187143 0,258422 0,126353205 0,151745 
 
 
Appendix D Student t-test determining the significance of symptom severity, height and viral 
load between AMM4 lines and cv.60444s at 14, 36, 56 and 180 dpi. 
 
Symptom severity score  Plant height   ACMV viral  load 
Line ID 14 dpi 36 dpi 56 dpi 14 dpi 36 dpi 56 dpi 36 dpi 56dpi 
AMM4-11 0,170447 0,036694 0,060925 0,390246 0,418809 0,340773 0,129398 0,163825 
AMM4-33 0,170447 0,5 0,332126 0,154694 0,17759 0,5 0,09382 0,172586 
AMM4-34 0,5 0,343372 0,104692 0,181609 0,267491 0,223769 0,178042 0,186922 
AMM4-46 0,086974 0,170447 0,104692 0,085829 0,114332 0,429157 0,071899 0,161852 
AMM4-59 0,086974 0,001547 0,010936 0,30233 0,34821 0,147968 0,129073 0,162443 
AMM4-68 0,086974 0,3435 0,332126 0,327239 0,156895 0,274507 0,143557 0,163714 
AMM4-79 0,086974 0,010936 0,003657 0,285038 0,200517 0,343372 0,355651 0,179601 
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Appendix E Student t-test determining the significance of the fresh yield weights obtained 
between CMM6, AMM2 lines and cv.60444s at 365 dpi. 
  356 dpi  365dpi 
CMM6-2 0,462421 AMM2-30 0,025118 
CMM6-3 0,016642 AMM2-41 0,187263 
CMM6-5 0,029217 AMM2-44 0,032649 
CMM6-6 0,112426 AMM2-52 0,189356 
CMM6-7 0,031146 AMM2-53 0,011002 
dsAC1 0,16862 AMM2-54 0,012567 
cv.60444 
infected 0,030934 
dsAC1 
0,368798 
  
cv,60444 
infected 0,00555 
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Appendix F Student t-test determining the significance of the viral load of CMM6, AMM2, 
CMM8 and AMM4 at 180 and 365 dpi against wild type cv.60444. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Viral load 
365 dpi  
Viral load 
180dpi 
Line ID 
 
Line ID 
 CMM6-2 0,04695 CMM8-1 0,120483 
CMM6-3 0,105003 CMM8-3 0,120995 
CMM6-5 0,076487 CMM8-8 0,117442 
CMM6-6 0,04695 CMM8-23 0,162973 
CMM6-7 0,050662 CMM8-25 0,182527 
  
CMM8-27 0,120053 
    AMM2-30 0,181238 AMM4-11 0,15842 
AMM2-41 0,049044 AMM4-33 0,164136 
AMM2-44 0,099615 AMM4-34 0,212393 
AMM2-52 0,049012 AMM4-46 0,159105 
AMM2-53 0,283499 AMM4-59 0,158834 
AMM2-54 0,493423 AMM4-68 0,158694 
  
AMM4-79       0.159005 
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Appendix G Pearson’s correlation coefficient measuring the relationships (correlation) 
between our three test parameters, symptom severity score (sss), plant height, and viral load 
for A-MM2, A-MM4, C-MM6 and C-MM8, at 14, 36 and 56 dpi. 
CMM6 lines 14 dpi 36 dpi 56 dpi 
sss and plant height -0.5378 -0.7969 -0.7735 
  
   viral load and sss 
 
0.94016 0.95548 
  
   viral load and height 
 
-0.5038 -0.9441 
    
  AMM2  lines 14 dpi 36 dpi 56 dpi 
sss and plant height 0.60186 0.46499 0.49515 
  
   viral load and sss 
 
0.25096 0.5955 
  
   viral load and height 
 
0.24617 0.60967 
  
   CMM8 lines 14 dpi 36 dpi 56 dpi 
sss and plant height -0.10999 1.48522 -0,10999 
  
   viral load and sss 
 
-0.33485 -0.73075 
  
   viral load and height 
 
-0,55623 0.091651 
  
   AMM4  lines 14dpi 36 dpi 56dpi 
sss and height -0.60805 0.57307 -0.36148 
  
   viral load and sss 
 
-0.35572 -0.11643 
  
   viral load and height 
 
-0.38741 0.02578 
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